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Abstract	  	  This	   doctoral	   thesis	   was	   in	   collaboration	   with	   a	   research	   group	   from	   the	   Institute	   of	  Ophthalmology	  at	  Moorfields	  Eye	  Hospital	  and	  the	  London	  Project	   to	  Cure	  Blindness.	  The	  group	   was	   in	   late	   stage	   pre-­‐clinical	   development	   creating	   a	   pluripotent	   stem	   cell	   (PSC)	  derived	  therapy	  to	  produce	  retinal	  pigment	  epithelium	  cells	  (RPE)	  for	  the	  treatment	  of	  Age	  Related	  Macular	  Degeneration	  (AMD).	  Creating	  effective	  treatments	  for	  AMD	  is	  vital	  given	  that	  it	  is	  the	  leading	  cause	  of	  blindness	  in	  the	  developed	  world	  with	  around	  500,000	  people	  in	   the	   UK	   afflicted	  with	   the	   disease,	   half	   of	  which	   are	   registered	   as	   visually	   impaired.	   In	  addition,	  for	  the	  dry	  form	  of	  the	  disease,	  which	  represents	  85-­‐90%	  of	  total	  cases,	  there	  is	  no	  effective	  treatment.	  	  	  
The	  current	   lab	  based	  manufacturing	  protocols	   intended	  for	  use	  during	  Phase	  1	   trials	  are	  not	  feasible	  for	  subsequent	  larger	  scale	  clinical	  trials	  or	  for	  the	  commercial	  manufacture	  of	  an	  affordable	  mass-­‐produced	  therapy.	  The	  aim	  of	  this	  thesis	  was	  to	  explore	  the	  feasibility	  of	  applying	  methodologies	  and	  technologies	  from	  traditional	  biotechnology	  production	  to	  cell	  therapy	  manufacturing.	  	  Specifically	  use	  of	  bioreactors	  to	  scale	  up	  cell	  culture	  (Chapter	  2),	  the	  application	  of	  online	  monitoring	  and	  control	   to	  PSC	  culture	  (Chapter	   3),	   the	  use	  of	  a	  design	   of	   experiments	   (DoE)	   approach	   to	   PSC	   differentiation	   (Chapter	   4)	   and	   cell-­‐cell	  purification	  (Chapter	  5).	  	  
Taken	   as	   a	   whole	   it	   is	   clear	   that	   the	   application	   of	   traditional	   biomanufacturing	  technologies	   and	   approaches	   have	   much	   potential	   when	   applied	   to	   cell	   therapies,	   and	  specifically	   a	   PSC	   derived	   cell	   therapy	   to	   treat	   blindness.	   However	   much	   more	   work	   is	  needed	   to	   reduce	   variability	   in	   the	   process	   to	   better	   understand	   the	   impact	   of	   process	  parameters	  on	  critical	  quality	  attributes	  and	  how	  best	  to	  approach	  these	  in	  an	  environment	  where	  there	  is	  little	  clinical	  experience	  to	  define	  the	  target	  product	  profile.	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1. Introduction	  
1.1 Age	  related	  macular	  degeneration	  (AMD)	  Age	   related	  macular	   degeneration	   (AMD)	   afflicts	   8.69%	  of	   45-­‐85	   year	   olds	   globally,	  with	  estimates	  that	  195m	  people	  will	  suffer	  from	  the	  disease	  by	  2020	  and	  with	  and	  aging	  global	  population	  this	  will	  rise	  to	  288m	  in	  2040	  (Wong	  et	  al.).	  AMD	  represents	  the	  advanced	  form	  of	   the	   deteriorative	   process	   that	   happens	   in	   all	   eyes	   primarily	   as	   a	   result	   of	   the	   ageing	  process,	   although	   other	   risk	   factors	   such	   as	   genetic	   predisposition,	   hypertension	   and	  smoking	  affect	   the	  age	  at	  onset	  of	   the	  disease	  pathology	  (Evans,	  2001).	   	  AMD	  results	   in	  a	  characteristic	   loss	  of	   visual	   acuity	   in	   the	   central	   field	  of	   vision	  Figure	   1.1	   a)	   and	  b).	  The	  cause	  of	   this	  photoreceptor	  death	   is	   the	  atrophy	  of	   the	   layer	  of	   retinal	  pigment	  epithelial	  (RPE)	   cells	   that	   support	   them,	   and	   the	   degeneration	   of	   Bruch’s	  membrane	   on	  which	   the	  RPE	  adhere	  to	  (see	  Figure	  1.2	  a)	  and	  b)	  reproduced	  from	  Ramsden	  et	  al.	  (2013).	  
1.1.1 The	  role	  of	  RPE	  in	  AMD	  The	  progression	  of	  AMD	  can	  be	  seen	  in	  colour	  fundus	  photographs,	  with	  Figure	  1.3	  a),	  b)	  and	  c)	  showing	  a	  healthy	  eye,	  and	  eyes	  afflicted	  with	  late	  stage	  dry	  and	  late	  stage	  wet	  AMD	  respectively.	  These	  images	  have	  been	  reproduced	  from	  Ebrahimi	  and	  Handa	  (2011).	  	  AMD	  causes	  damage	  to	  the	  fovea	  which	  makes	  up	  only	  a	  small	  percentage	  of	  the	  surface	  area	  of	  the	  eye	  but	  is	  responsible	  for	  the	  central	   field	  of	  vision	  where	  the	  greatest	  visual	  acuity	  is	  needed	  to	  perform	  everyday	  tasks	  such	  as	  reading	  and	  driving.	  	  
The	  RPE	  monolayer	  is	  derived	  from	  the	  neuroepithelium	  of	  the	  anterior	  neural	  plate	  in	  the	  developing	   embryo.	   It	   performs	   many	   important	   turnover	   functions	   to	   support	   the	  photoreceptors	  and	  makes	  up	  part	  of	  the	  physical	  barrier	  between	  the	  photoreceptors	  and	  the	   underlying	   blood	   supply.	   There	   are	   a	   considerable	   number	   of	   specific	   functions	  required	   of	   the	   RPE	   to	   maintain	   vision	   as	   outlined	   in	   Table	   1.1	   adapted	   from	   Strauss	  (2005).	  
Late	   stage	  dry	  AMD	   is	   characterised	  by	   the	  build	  up	  of	  drusen	  deposits	  over	   the	  macular	  region	   (which	   contains	   the	   fovea)	   as	   seen	   in	  Figure	   1.3	   b).	   These	  drusen	  aggregates	   are	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formed	  from	  incomplete	  digestion	  of	  photoreceptor	  outer	  segments	  that	  form	  phagosomes	  within	  the	  RPE	  cells	  and	  other	  molecular	  by-­‐products.	  RPE	  cells	  excrete	  this	  toxic	  lipofuscin	  which	   is	   non-­‐degradable	   and	   so	   it	   accumulates	   on	   Bruch’s	   membrane	   (Young,	   1987).	  Lipofuscin	   is	   the	  same	  yellow	  brown	  pigmentation	   that	  causes	   “age	  spots”	   in	  post-­‐mitotic	  cells	  (non-­‐dividing)	  tissues.	  This	  accumulates	  as	  a	  function	  of	  age,	  resulting	  from	  a	  failure	  of	  molecular	  turnover	  mechanisms	  (Brunk	  and	  Terman,	  2002).	  	  
Drusen	   combined	   with	   other	   age	   related	   toxic	   factors	   such	   as	   advanced-­‐glycation	   end	  products	  (AGES)	  and	  a	  reduction	  in	  protective	  species	  such	  as	  the	  antioxidant	  α-­‐tocopherol	  increases	  the	  oxidative	  stresses	  in	  the	  region	  (Strauss,	  2005).	  In	  addition	  detailed	  analysis	  of	  drusen	  constituents	  showed	  the	  presence	  of	  proteins	  associated	  with	  immune-­‐mediated	  and	   inflammatory	   systems	   thereby	   suggesting	   a	   role	   of	   these	   age	   sensitive	   systems	   in	  drusen	   formation	  (Hageman	  et	  al.,	  2001).	  These	   factors	  combined	  are	  believed	   to	  cause	  a	  reduction	  in	  RPE	  cell	  density	  due	  to	  apoptosis,	  reduction	  in	  pigmentation,	  destabilisation	  of	  intracellular	  membranes	  e.g.	  the	  tight	  junctions	  between	  RPE	  cells,	  and	  damage	  to	  Bruch’s	  membrane	  (Strauss,	  2005)	  visualised	  in	  Figure	  1.2	  b).	  This	  process	  increases	  the	  amount	  of	  molecular	  debris	   that	   in	   turn	   leads	   to	   further	  degradation	  of	   the	  RPE	  cells	   as	  part	  of	   a	  positive	  feedback	  mechanism.	  Ultimately	  resulting	  in	  additional	  loss	  of	  the	  photoreceptors	  which	  the	  RPE	  support	  and	  so	  loss	  of	  sight	  (Young,	  1987).	  	  
In	  wet	  or	  neovascular/exudative	  AMD	  the	  barrier	  between	  the	  blood	  supply	  in	  the	  choroid	  and	   the	   photoreceptors	   is	   penetrated	   by	   unwanted	   neovascular	   membranes	   (choroidal	  neovascularisation),	   this	   breached	   layer	   is	   made	   up	   of	   Bruch’s	   membrane	   and	   the	   RPE	  (Chopdar	  et	  al.,	  2003).	  These	  vessels	  are	  leaky	  and	  so	  cause	  fluid	  oedema	  (extravasation	  of	  blood	   and	   lipid	   materials)	   and	   eventual	   dense	   fibrovascular	   scarring	   disrupting	   the	  architecture	  of	  the	  macular	  region	  and	  so	  photoreceptor	  death	  (Figure	  1.3	  c).	  Wet	  AMD	  can	  cause	  rapid	  sight	  loss	  especially	  if	  the	  vessels	  rupture	  and	  haemorrhage.	  Both	  wet	  and	  dry	  AMD	  can	  exist	  in	  the	  same	  patient	  and	  the	  same	  eye.	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1.1.2 Existing	  therapies	  for	  AMD	  Wet	  AMD	  is	  treated	  using	  anti	  vascular	  endothelial	  growth	  factor	  (VEGF)	  treatments	  such	  as	   ranibizumab	   (Lucentis)	  which	   is	   a	  monoclonal	   antibody	   fragment	  made	  by	  Genentech.	  Bevacizumab	  (Avastin)	  is	  also	  used	  off-­‐label	  which	  is	  a	  full	  monoclonal	  antibody	  also	  made	  by	  Genentech	   and	  EYLEA	   (aflibercept)	   a	   fusion	  protein	   from	  Regeneron	  Pharmaceuticals.	  These	  treatments	  inhibit	  the	  growth	  of	  penetrating	  vessels	  and	  require	  repeated	  injections	  into	  the	  eye.	  However	  no	  medicinal	  intervention	  is	  available	  for	  the	  dry	  form	  of	  AMD.	  
Some	  complex	  surgical	   interventions	  have	  shown	  a	  degree	  of	   success	   in	   small-­‐scale	   trials	  for	  the	  treatment	  of	  AMD.	  For	  example,	  Macular	  Translocation	  is	  an	  operation	  in	  which	  the	  retina	   is	  detached	  (retinopathy)	  and	   the	  macula	  rotated	   to	  an	  area	  of	  undamaged	  RPE.	   In	  essence	   this	   is	   an	  RPE	  allograft.	  A	   review	  by	  da	  Cruz	   et	   al.	   (2007)	  describes	   cases	  where	  both	   the	  dry	  and	  wet	   forms	  of	  AMD	  have	  been	   treated	  with	   transplantations	  of	  RPE	  cells	  from	   RPE	   biopsies.	   These	   cells	   are	   either	   “allogeneic”,	   being	   sourced	   from	   a	   donor,	   or	  “autologous”	  where	  the	  cells	  are	  sourced	  from	  the	  patients	  themselves.	  The	  mechanisms	  by	  which	   RPE	   transplantation	   rescues	   photoreceptor	   is	   unknown,	   but	   da	   Cruz	   et	   al.	   (2007)	  reports	   that	   the	   evidence	   points	   towards	   two	   types	   of	   interaction;	   1)	   Direct	   contact	  between	   RPE	   and	   photoreceptor	   and/or,	   2)	   Indirect	   contact	   through	   diffusible	   factors	  released	  by	  transplanted	  RPE,	  e.g.	  PEDF	  	  (see	  Table	  1.1).	  	  	  
In	   the	   case	   of	   RPE	   transplantation	   to	   specifically	   treat	   Dry	   AMD	   there	   is	   evidence	   in	   the	  literature	  that	  visual	  function	  has	  been	  maintained	  in	  patients	  from	  the	  results	  of	  such	  RPE	  grafting.	  For	  example	  Algvere	  et	  al.	  (1997)	  reported	  that	  RPE	  cells	  from	  foetuses	  from	  13-­‐20	   gestational	   age	   inserted	   into	   the	   subretinal	   space	   resulted	   in	   the	   disappearance	   of	  drusen	   and	   maintenance	   of	   visual	   function.	   In	   addition	   Joussen	   et	   al.	   (2006)	   reported	  success	  using	  the	  autologous	  Peripheral	  RPE-­‐choroid	  method.	  
1.1.3 Pluripotent	  stem	  cell	  (PSC)	  therapy	  to	  treat	  AMD	  It	   is	   important	   to	   consider	   that	   even	   though	   the	  previously	  described	   treatment	  methods	  appear	   to	   show	   efficacy	   in	   the	   treatment	   of	   AMD,	   they	   are	   not	   practical	   for	   treating	   the	  hundreds	  of	   thousands	  of	  prospective	  patients.	  Firstly,	   in	   the	  case	  of	   the	  allograft	  method	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the	   surgery	   is	   complex	   due	   to	   the	   need	   harvest	   cells	   from	   the	   periphery	   before	   the	  transplantation,	  and	  if	  the	  RPE	  cells	  are	  dystrophic,	  meaning	  they	  are	  all	  dysfunctional,	  the	  method	   would	   be	   ineffective.	   Second,	   the	   primary	   cell	   sources	   listed	   for	   the	   allogeneic	  therapy	   are	   limited	   as	   foetal	   and	   cadaveric	   cells	   are	   hard	   to	   source	   and	   they	   lose	   their	  phenotype	  during	  in	  vitro	  expansion.	  This	  argument	  has	  been	  made	  by	  Vugler	  et	  al.	  (2008)	  which	  cites	  the	  following	  papers	  describing	  a	  loss	  of	  the	  following	  phenotypes	  in	  extended	  primary	   cultures	   (Dutt	   et	   al.,	   1989),	   a	   loss	   of	   Fc	   receptors	   (Davis	   et	   al.,	   1995),	   loss	   of	  cytoskeletal	   polarisation,	   and	   a	   down	   regulation	   of	   the	   proteins	   RPE65	   and	   Cellular	  Retinaldehyde-­‐Binding	   Protein	   (CRALBP)	   which	   are	   both	   involved	   in	   retinoid	   recycling,	  after	  only	  as	  few	  as	  2-­‐3	  passages	  in	  vitro	  (Alge	  et	  al.,	  2003).	  Therefore,	  it	  is	  likely	  that	  there	  will	  never	  be	  enough	  cells	  available	  to	  achieve	  the	  economies	  of	  scale	  needed	  to	  provide	  a	  strong	  argument	  for	  a	  cellular	  therapy	  to	  treat	  AMD	  using	  these	  sources.	  
A	  potential	  alternative	  cell	  source	  is	  to	  use	  human	  pluripotent	  embryonic	  stem	  cells	  (PSCs).	  They	   have	   the	   capability	   of	   near	   indefinite	   expansion	   in	   culture	   whilst	   maintaining	   the	  ability	   to	   then	   differentiate	   into	   a	   large	   number	   of	   different	   cell	   types	   (pluripotency),	  making	   them	   an	   attractive	   cell	   source	   for	   many	   prospective	   cell	   replacement	   therapies.	  Human	  embryonic	   stem	  cells	  were	   first	   isolated	  by	  Thomson	  et	   al.	   (1998),	   and	  cells	  with	  the	  same	  pluripotent	  phenotype	  were	  generated	  through	  the	  use	  of	  genetic	  reprogramming	  to	  generate	  induced	  pluripotent	  stem	  cells	  (iPS)	  by	  a	  group	  lead	  by	  Yamanaka	  Takahashi	  et	  al.	  (2007);	  collectively	  these	  cells	  are	  named	  pluripotent	  stem	  cells	  (PSCs).	  
Advanced	  Cell	  Technology	  (ACT)	  and	  their	  collaborators	  first	  described	  PSCs	  as	  a	  source	  of	  human	   RPE	   for	   potential	   transplantation	   (Klimanskaya	   et	   al.,	   2004).	   Later	   a	   similar	   ACT	  collaboration	  was	   the	   first	   to	   show	   how	   PSC	   derived	   RPE	   (PSC-­‐RPE)	   could	   rescue	   visual	  function	  in	  the	  royal	  college	  of	  surgeons	  (RCS)	  rat	  (Lund	  et	  al.,	  2006).	  	  The	  RCS	  rat	  being	  an	  animal	   model	   of	   RPE	   dystrophy	   (Mullen	   and	   LaVail,	   1976).	   These	   results	   have	   been	  replicated	   using	   iPS	   cells	   by	   Carr	   et	   al.	   (2009).	   PSCs	   therefore	   present	   a	   potentially	  unlimited	   source	   of	   RPE	   cells.	   However	   their	   pluripotency	   and	   sensitivity	   to	   in	   vitro	  processing	   provides	   many	   novel	   technological	   challenges	   if	   they	   are	   to	   be	   used	   in	   a	  bioprocess	   in	   a	   future	  RPE	   cell	   therapy	   to	   treat	  AMD.	  Despite	   this	   PSC	  derived	  RPE	  have	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already	  been	  successfully	  used	  to	  treat	  patients	  in	  early	  stage	  clinical	  trials.	  A	  trial	  by	  ACT	  reported	   in	   late	   2014	   that	   transplanted	   PSC-­‐RPE	   in	   an	   open	   label	   study	   show	   initial	  promise	  of	  both	  safety	  and	  efficacy	  in	  the	  treatment	  of	  both	  AMD	  and	  Stargardt's	  macular	  dystrophy	  (a	  juvenile	  RPE	  dysfunctional	  disease)	  (Schwartz	  et	  al.,	  2014).	  Furthermore,	  the	  Riken	   institute	   in	   Japan	   released	   a	   press	   release	   in	   2014	   describing	   a	   successful	   RPE	  transplantation	  using	  iPS	  derived	  RPE	  cells.	  	  
1.2 Translating	  a	  PSC	  lab	  process	  into	  a	  therapeutic	  
bioprocess	  
1.2.1 Current	  status	  of	  cell	  therapies	  
Although	   there	  are	  no	  existing	  PSC	  derived	   therapy	  with	  market	  approval	   there	  are	   clear	  examples	  of	  these	  therapies	  starting	  to	  transfer	  into	  the	  clinic.	  Therefore,	  this	  thesis	  focuses	  on	   looking	  beyond	   these	   initial	   small	   scale	   trials	   to	   explore	  how	   the	   current	   lab	  protocol	  used	   by	   Moorfields	   Eye	   Hospital	   could	   be	   scaled	   up	   into	   a	   novel,	   mass	   produced,	   and	  validated	   commercial	   bioprocess.	   Despite	   there	   being	   no	   PSC	   cell	   therapies	   with	  market	  approval	  (FDA,	  EMA	  regions)	  living	  cell	  therapies	  as	  a	  whole	  have	  been	  on	  the	  market	  for	  many	  years.	  For	  example	  the	  Apligraf1	  and	  Dermagraf2	  allogeneic	  products	  combined	  have	  treated	  over	  300,	   000	  patients,	   primarily	   for	   venous	   leg	   and	  diabetic	   foot	   ulcers.	   Current	  estimates	  are	  now	  that	  over	  1million	  patients	  have	  been	  treated	  with	  cellular	  therapies,	  this	  excludes	   those	   treated	   for	   hematologic	  malignancies	   (Professor	   Chris	  Mason,	   UCL3).	   Like	  most	  other	  examples	  of	  cell-­‐based	  therapies	  with	  regulatory	  approval	  the	  cells	  are	  derived	  from	  a	  somatic	  cell	  biopsy	  (foreskin)	  administered	  to	  the	  exterior	  of	  the	  body.	  	  
However,	  regarding	  the	  internal	  administration	  of	  cell	  therapies	  into	  the	  body	  the	  field	  is	  at	  a	  much	   earlier	   stage	  of	   commercial	   exploitation	   	   (if	   an	   exclusion	   is	  made	   regarding	  bone	  marrow	   transplants).	   The	   two	   prime	   examples	   of	   such	   biotherapeutics	   are	   Provenge	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Bilayered skin substitute: an epidermal layer formed by human keratinocytes dermal layer is composed of 
human fibroblasts in a bovine Type I collagen lattice, from Organogenesis (USA). Used for venous leg ulcers 
(FDA 1998) diabetic foot ulcers (FDA 2001) and chronic ulcers and soft-tissue defects (Switzerland 2008) 
2 Cryopreserved human fibroblast-deriveddermal substitute composed of fibroblasts, an extracellular matrix 
and a bioabsorbable scaffold, from Advanced BioHealing (USA) (originally Advanced Tissue Sciences/ Smith 
& Nephew). For the treatment of diabetic foot ulcers (FDA2001) 
3 London Regenerative Medicine Network, April 2015 
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(Dendreon),	   and	  Prochymal	   (Mesoblast).	   Provenge	   is	   a	   treatment	   of	   autologous	  dendritic	  cells	   loaded	   with	   prostate	   antigen	   prostatic	   acid	   phosphatase	   fused	   to	   granulocyte-­‐macrophage	  colony-­‐stimulating	  factor	  and	  which	  is	  approved	  by	  the	  FDA	  in	  prostate	  cancer.	  Whereas	   Phochymal	   consists	   of	   cells	   isolated	   from	   bone	   marrow	   expressing	   the	   CD34-­‐	  marker	  (besides	  others)	  and	  is	  approved	  for	  the	  treatment	  of	  graft	  versus	  host	  disease.	  	  By	  administrating	   the	   cells	   directly	   into	   the	   blood	   stream	   the	   determination	   of	   the	  pharmacokinetics	   and	   pharmacodynamics	   of	   the	   therapy	   is	   vastly	   more	   complex	   than	  applying	  to	  external	  wounds,	  which	  results	  in	  an	  associated	  rise	  of	  clinical	  risk.	  
In	  short,	  development	  of	  novel	  allogeneic	  stem	  cell	   therapies	   from	  PSCs	  can	  draw	  on	  past	  experience	  from	  the	  growing	  commercial	  successes	  of	  somatic	  cell	  therapies	  and	  these	  first	  internally	   administered	   cells.	  However,	   development	   needs	   to	   be	  mindful	   of	   the	   evolving	  regulatory	   environment	   as	   regulators	   adjust	   to	   these	  new	   types	   of	   therapies	   for	   example	  the	   good	   tissue	   practice	   (GTP)	   final	   rule	   (FDA)	   and	   the	   advanced	   therapy	   medicinal	  products	  (ATMPs)	  regulation	  (EMA).	  	  
All	   biological	   therapies	   are	   approved	   on	   two	   criteria,	   efficacy	   and	   safety.	   To	   meet	   these	  criteria	  a	  PSC	  process	  needs	  to	  be	  able	  to	  reproducibly	  manufacture	  a	  defined	  population	  of	  cells	   to	  meet	   the	   target	  product	  profile	   (TPP).	  Understanding	  how	  the	  heterogeneous	  and	  transient	   nature	   of	   PSC	   cultures	   impact	   the	   TPP	   is	   key	   to	   scaling	   the	   lab	   protocol.	   The	  following	   sections	   explore	   some	   of	   the	   key	   considerations	   impacting	   the	   on	   safety	   and	  efficacy	  of	  the	  potential	  therapy	  that	  relate	  to	  the	  manufacturing	  process.	  	  
1.2.2 Safety	  concerns	  of	  PSC	  derived	  therapies	  The	   main	   safety	   concerns	   of	   PSCs	   are	   that	   they	   have	   a	   transient	   and	   often	   highly	  heterogonous	  phenotype	  during	  differentiation.	  The	  phenotype	  is	  both	  highly	  susceptible	  to	  external	   stimuli	   and	  also	  hard	   to	   track	  during	  culture	  with	   there	  being	   few	  rapid	  or	  non-­‐destructive	   analytical	   assays	   available.	   This	   heterogeneity	   means	   the	   safety	   of	   a	   PSC	  therapy	  will	   be	   dependent	   on	   a	   process’s	   proven	   ability	   to	   deliver	   only	   the	   intended	   cell	  type	  to	  patients,	  being	  free	  of	  potentially	  harmful	  contaminant	  cells.	  Cellular	  contaminants	  can	  be	  put	  into	  3	  broad	  categories;	  1)	  non-­‐tumorigenic	  cells,	  2)	  undifferentiated	  PSC,	  and	  3)	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proliferative	  cells.	  The	  presence	  of	  these	  cells,	  or	  masses	  they	  can	  form,	  could	  cause	  harm	  from	  either	  their	  metabolic	  activity	  and/or	  physical	  presence,	  particularly	   in	  anatomically	  sensitive	  areas	  such	  as	  the	  brain.	  The	  issue	  of	  stem	  cells	  and	  tumour	  formation	  is	  discussed	  in	  detail	  in	  the	  review	  by	  Anisimov	  et	  al.	  (2010).	  	  
1.2.3 Non-­‐tumorigenic	  cells	  (contamination	  from	  spontaneous	  
differentiation)	  During	   differentiation	   protocols	   the	   PSC	   population	   not	   only	   changes	   into	   the	   intended	  therapeutic	   cell	  but	  also	  differentiates	   into	  a	  multitude	  of	  other	   cell	   types.	  Differentiation	  yields	  can	  be	  very	   low,	   for	  example	  Klimanskaya	  et	  al.	   (2004)	  reported	  <1%	  spontaneous	  differentiation	   of	   RPE	   from	   embryoid	   bodies	   after	   6	   weeks.	   However	   with	   protocol	  optimisation	  using	  nicotinamide	  and	  Activin	  A	   the	  efficiency	  can	  be	   increased	   to	  33%	   for	  PSC-­‐RPE	  differentiation	  (Idelson	  et	  al.,	  2009).	  More	  recently	  this	  has	  been	  further	  increased	  up	   to	   80%	   with	   the	   addition	   of	   a	   larger	   number	   of	   defined	   factors	   at	   specific	   timings	  (Buchholz	  et	  al.,	  2013).	  Yet,	  this	  still	  leaves	  a	  substantial	  amount	  of	  contaminant	  “non	  RPE”	  cells	  (20%).	  Such	  contaminants	  can	  cause	  issues	  with	  the	  regulators,	  for	  example	  the	  Geron	  Corporation	   had	   their	   subsequently	   abandoned	   PSC	   clinical	   trial	   put	   on	   temporary	   hold	  when	  it	  was	  discovered	  that	  a	  certain	  unwanted	  cellular	  contaminant	  led	  to	  the	  formation	  of	  non-­‐proliferative	  cysts1.	  	  This	  potential	  risk	  is	  termed	  it	  “graft	  overgrowth”	  were	  limited	  benign	   in	   vivo	   proliferation	   of	   stem	   cells	   or	   their	   progeny	   could	   cause	   clinical	   harm	  (Anisimov	  et	  al.,	  2010).	  	  A	  recent	  example	  of	  this	  is	  where	  an	  autologous	  olfactory	  stem	  cell	  transplant	  into	  the	  spine	  at	  a	  Portuguese	  hospital	  had	  to	  be	  removed	  due	  to	  patient	  pain.	  On	  removal	  the	  growth	  was	  determined	  to	  be	  non-­‐cancerous	  containing	  nerve	  branches,	  bone	  and	  was	  secreting	  mucosal	  material2.	  Therefore	  the	  manufacturing	  process	  needs	  to	  either	  have	   a	   purification	   stage	   to	   separate	   out	   just	   the	   desired	   population	   or	   be	   able	   to	  reproducibly	  deliver	  a	  defined	  heterogeneous	  population	  with	  pre-­‐clinical	  assurances	  as	  to	  its	  safety.	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Geron press release, accessed 11,12,14 http://ir.geron.com/phoenix.zhtml?c=67323&p=irol-
newsArticle&ID=1636138 
2 New Scientist, accessed 14,07,14 http://www.newscientist.com/article/dn25859-stem-cell-treatment-causes-
nasal-growth-in-womans-back.html#.VJ09XBuQR 
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1.2.4 Teratomas	  (PSC	  Contamination)	  A	   test	   for	   the	   pluripotency	   of	   PSC	   (ability	   to	   differentiate	   into	   the	   vast	   multitude	   of	   cell	  types)	   is	   to	   inject	   them	   into	  an	   immunodeficient	  mouse,	  where	   they	   form	  what	   is	   termed	  teratomas.	  These	  teratoma	  masses	  are	  then	  removed	  and	  interrogated	  for	  the	  3	  germ	  layers	  that	   all	   cells	   types	   are	   derivatives	   of,	   thus	   proving	   their	   pluripotency	   potential.	   However	  these	   PSC	   derived	   teratoma	   like	   masses	   do	   not	   meet	   the	   classic	   definition	   of	   teratomas	  which	   contain	   acquired	   genetic	   and	   epigenetic	   alterations	   (Lensch	   and	   Ince,	   2007).	  Although	   benign	   this	   ectopic	   tissue	   either	   at	   the	   therapeutic	   site	   of	   implantation,	   or	   as	   a	  result	  of	  migration	  through	  the	  body’s	  transport	  systems	  may	  cause	  harm.	  
When	   the	   FDA	   first	   started	   exploring	   the	   potential	   regulation	   of	   PSC	   therapies	   in	   2008	   a	  meeting	   with	   industrial	   stakeholders	   was	   held.	   Here	   the	   view	   was	   presented	   that	  undifferentiated	  cells	  in	  the	  final	  therapy	  were	  a	  safety	  concern	  and	  that	  the	  further	  down	  the	   pathway	   to	   specialisation	   and	   terminal	   differentiation	   the	   lower	   the	   risk	   of	   “tumour”	  formation.	   Thus	   it	   is	   a	   key	   part	   any	   PSC	   derived	   investigational	   new	  drug	   (IND)	   filing	   to	  have	   accounted	   for	   the	   issue	   of	   undifferentiated	   PSC	   contamination.	   In	   a	   manufacturing	  process	  this	  could	  mean	  the	  tracking	  and	  ultimately	  confirming	  the	  absence	  of	  PSC	  markers	  in	  the	  final	  product.	  	  
1.2.5 	  	  Graft	  overgrowth	  and	  karyotype	  drift	  During	  prolonged	  cell	  culture	  and	  adaption	  to	  new	  methods	  PSC	  can	  experience	  Karyotypic	  drift	  (chromosomal	  changes)	  often	  resulting	  in	  decreased	  population	  doubling	  times	  which	  may	   lead	   to	   tumour	   formation	   in	  vivo	   due	   to	  uncontrolled	  proliferation	   (Mitalipova	  et	   al.,	  2005,	  Pera,	  2004,	  Draper	  et	  al.,	  2004).	  But,	  this	  has	  not	  precluded	  the	  use	  of	  a	  karyotypically	  abnormal	  cell	  line	  being	  used	  in	  therapy	  for	  example	  Carpenter	  et	  al.	  (2009)	  reported	  that	  the	  FDA	  approved	  the	  use	  of	  the	  human	  embryonal	  carcinoma	  cell	  line	  which	  has	  between	  56	   and	   61	   chromosomes	   for	   use	   in	   a	   clinical	   trial.	   	   Yet	   their	   inclusion	   would	   still	   be	  undesirable	   as	   they	  present	   a	   significant	   safety	   concern.	   This	  makes	   karyotype	   testing	   to	  prove	   stability	  over	  a	  defined	   range	  of	  passages	  a	   likely	  prerequisite	   for	   the	  working	   cell	  bank	  used	  in	  manufacture.	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1.2.6 Animal	  derived	  reagents	  PSCs	   were	   traditionally	   grown	   in	   complex	   ill-­‐defined	   media	   containing	   factors	   such	   as	  foetal	  bovine	  serum	  (FBS)	  and	  on	  inactivated	  mouse	  fibroblasts	  (MEFs).	  The	  FDA	  guidance	  from	   the	   Center	   for	   Biologics	   Evaluation	  &	  Research	   (CBER)	   considers	   that	   PSC/MEF	   co-­‐culture	  fit	  the	  definition	  of	  xenotransplantation,	  but	  it	  does	  not	  intend	  this	  to	  preclude	  the	  use	  of	  PSC	  in	  clinical	  trials.	  This	  was	  demonstrated	  by	  the	  FDA	  approval	  for	  the	  use	  of	  the	  H1	  cell	   line	   in	  clinical	  trials	  by	  the	  Geron	  Corporation,	  which	  was	  derived	  and	  maintained	  on	  mouse	   feeders.	  More	   recently	  great	  efforts	  have	  been	  made	   to	  move	   towards	  a	   feeder	  free	   and	   Xeno	   free	   culture	   platform,	   for	   example	   Invitrogen’s	   KnockOut™	   SR	   XenoFree	  product	   which	   replaces	   FBS	   is	   formulated	   with	   human	   sourced	   or	   human	   recombinant	  proteins	   derived	   under	   cGMP	   conditions.	   This	   can	   be	   used	   in	   combination	   with	   other	  products	   such	   as	  CELLstart	   also	   from	   Invitrogen	  or	   flasks	   coated	   in	  Corning’s	   Synthemax	  (synthetic	   peptides)	   that	   replace	   the	   need	   for	   a	  mouse	   feeder	   layer.	   Such	   advances	   have	  enabled	  the	  production	  of	  cGMP	  PSC	  lines	  for	  eventual	  clinical	  use.	  Although	  using	  animal	  products	   presents	   a	   risk	   it	   has	   not	   stopped	   products	   reaching	   the	   market	   e.g.	   Apligraf	  (Organogenesis)	   uses	   bovine	   serum	   albumin	   in	   manufacture.	   Even	   so,	   the	   difficulties	   in	  sourcing	   the	   large	   amounts	   of	   serum	   from	   countries	   who	   are	   BSE	   free,	   and	   issues	   with	  batch	  to	  batch	  variability,	  puts	  significant	  limitations	  on	  the	  industry	  as	  a	  whole	  with	  there	  potentially	  only	  being	  enough	  BSA	  to	  support	  only	  one	  ‘blockbuster’	  cell	  therapy	  (Brindley	  et	  al.,	  2012).	  This	  conclusion	  further	  necessitates	  the	  need	  to	  develop	  economically	  viable	  animal	  alternatives.	  
1.2.7 Efficacy	  The	   efficacy	   of	   a	   therapy	   is	   derived	   from	   its	   target	   product	   profile	   (TPP).	   This	   is	   a	   set	   of	  attributes	  which	  can	  be	  measured	  as	  a	  predictor	  of	  clinical	  efficacy.	  Complicating	  matters	  is	  that	   the	   current	   therapeutic	   action	   of	   PSC	   derived	   cells	   is	   poorly	   understood	   exhibiting	  potentially	   multifactorial	   modes	   of	   action	   e.g.	   it	   could	   be	   both	   a	   physical	   and	   paracrine	  interaction,	  which	  may	  or	  may	  not	  require	  integration	  of,	  or	  be	  dependent	  on,	  the	  long	  term	  survival	   of	   the	   implanted	   cells.	   However	   such	   predictive	   assays	   of	   potency	   are	   vital	   for	  clinical	   success	   and	   so	   will	   define	   the	   targeted	   critical	   quality	   attributes	   (CQAs)	   of	   any	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commercial	   process.	   For	   example,	   is	   was	   concluded	   by	   some	   that	   the	   Phase	   3	   trials	   of	  Prochymal	   in	   the	  USA	   failed	   in	  part,	  but	  was	  not	   limited	   to,	  a	  poor	  understanding	  of	  how	  MSCs	  work	   in	  humans	   -­‐	  despite	  powerful	   immunosuppressive	  effects	  seen	   in	  vitro	  and	   in	  animal	   models,	   as	   “No	   predictive	   assays	   for	   efficacy	   exist,”	   according	   to	   Francesco	   Dazzi1	  (Allison,	  2009).	  	  
Such	  assays	  are	  typically	  refined	  during	  later	  stage	  clinical	  development	  based	  on	  previous	  experience.	  The	  current	  release	  criteria	  for	  the	  PSC-­‐RPE	  therapy	  is	  based	  on	  assessment	  of	  the	  RPE	  patch	  for	  variables	  such	  as	  viability,	  cell	  coverage,	  morphology,	  pigmentation	  and	  patch	  size.	  With	  other	  markers	  associated	  with	  pluripotency	  (absence),	  the	  RPE	  phenotype,	  and	   PEDF/VEGF	   secretions	   recorded	   on	   the	   quality	   control	   patch	   as	   additional	   critical	  quality	   attributes	   (CQAs).	   	   But,	   although	   such	   markers	   are	   linked	   to	   the	   functional	   RPE	  phenotype	   they	  are	  not	  part	  of	  a	   functional	  assay.	  The	  gold	  standard	   in	  vitro	   test	   for	  PSC	  derived	  RPE	  is	  their	  ability	  to	  process	  fluorescently	  labelled	  rod	  and	  cone	  outer	  segments.	  This	   assay	   is	   time	   consuming	   and	   not	   well	   suited	   to	   lot	   release	   criteria;	   thus	   validation	  studies	  will	  be	  needed	   to	   link	   the	  CQAs	  to	  performance	   in	   this	   test	  should	   it	  be	  used	  as	  a	  predictor	   of	   efficacy.	   Given	   the	   poorly	   defined	   nature	   of	   the	   variables	   in	   the	   existing	   lab	  protocol	   this	   thesis	  will	   seek	   to	   try	   and	  explore	  how	  possible	   critical	  process	  parameters	  (CPP)	   impact	   these	   critical	   quality	   attributes	   (CQA)	   of	   RPE	   marker	   expression	   with	   the	  intention	  of	  generating	  the	  most	  efficacious	  TPP.	  
1.2.8 Overview	  of	  the	  existing	  lab	  protocol	  The	  existing	  lab	  based	  protocol	  is	  outlined	  in	  Figure	  1.4;	  currently	  all	  processing	  is	  manual	  and	   takes	   place	   in	   T25	   flasks.	   In	   brief,	   PSC	   (hESC	   in	   the	   case	   of	   the	   Moorfield’s	   Phase	   I	  clinical	  trial)	  are	  expanded	  on	  inactivated	  human	  fibroblasts	  and	  once	  over-­‐confluent	  bFGF	  is	  removed	  from	  the	  media	  and	  the	  flasks	  cultured	  for	  up	  to	  12	  weeks	  until	  pigmented	  foci	  appear	  and	  grow.	  These	  foci	  are	  then	  manually	  excised	  in	  a	  laborious	  process	  using	  the	  tips	  of	   hypodermic	   needles.	   The	   excised	   RPE	   are	   then	   expanded	   on	   matrigel	   to	   increase	  numbers	   before	   being	   detached	   a	   final	   time	   and	   seeded	   onto	   the	   permeable	   structure	   of	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transwell	  membranes.	  These	  RPE	  coated	  membranes	  are	   cut	   to	   size	  before	   insertion	   into	  the	  macular	  region	  of	  the	  eye.	  	  
1.3 Thesis	  aims	  and	  objectives	  This	   thesis	   explores	   the	   feasibility	   of	   applying	   methodologies	   and	   technologies	   from	  traditional	   biotherapeutic	   production	   to	   cell	   therapy	   manufacturing,	   specifically	   the	  creation	   of	   a	   PSC-­‐RPE	   therapy	   to	   treat	   AMD.	   The	   approach	   was	   to	   split	   the	   existing	   lab	  process	  into	  its	  constituent	  parts	  (Figure	  1.5)	  and	  so	  identify	  the	  key	  manufacturing	  issues	  of	  the	  current	  process.	  Each	  results	  chapter	  is	  in	  essence	  a	  proof	  of	  concept	  feasibility	  study	  for	   that	   stage;	   either	   applying	   a	   new	   method,	   approach	   or	   technology.	   The	   Specific	  objectives	  of	  each	  chapter	  are	  summarised	  below:	  
Chapter	   2:	   Bioreactor	   culture	   of	   pluripotent	   stem	   cells	   using	   the	   Quantum	   Cell	   Expansion	  
System	  
The	   aim	   of	   this	   chapter	   was	   to	   explore	   the	   feasibility	   of	   growing	   PSC	   at	   large	   scale	   on	  commercially	  available	  machinery	  that	  was	  initially	  designed	  for	  the	  growth	  of	  MSCs.	  	  
Chapter	  3:	  Control	  of	  the	  pluripotent	  stem	  cell	  environment	  using	  the	  Xpansion	  One	  System	  
The	  aim	  of	  this	  chapter	  was	  to	  explore	  the	  feasibility	  of	  growing	  PSC	  on	  the	  Xpansion	  One	  system	   to	   determine	   the	   platform’s	   suitability	   for	   growing	   PSC	   prior	   to	   scaling	   up	   to	   the	  industrial	   scale	   reactors.	   	   Of	   particular	   interest	  was	   to	   explore	   how	   the	   online	   control	   of	  environmental	   conditions	   such	   as	   pH	   available	   on	   the	   Xpansion	   system	   impacted	   cell	  growth	  and	  the	  target	  phenotype.	  
Chapter	   4:	   A	   Design	   of	   Experiment	   (DoE)	   approach	   to	   retinal	   pigment	   epithelium	  
differentiation	  
The	  aim	  of	  this	  chapter	  was	  to	  explore	  the	  feasibility	  of	  the	  factorial	  DoE	  approach	  for	  the	  screening	   and	  optimising	   of	   the	  PSC-­‐RPE	  differentiation.	  Key	  process	   variables	   that	  were	  poorly	   understood	   were	   investigated	   to	   determine	   which	   had	   the	   greatest	   impact	   on	  performance.	  Key	  variables	  were	  then	  modelled	  to	  predict	  optimal	  conditions.	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Chapter	  5:	   Isolation	  of	  retinal	  pigment	  epithelium	  from	  differentiating	  pluripotent	  stem	  cell	  
monolayers	  
The	   aim	   of	   this	   chapter	   was	   to	   assess	   alternatives	   to	   the	   current	   manual	   purification	  method	   of	   excising	   pigmented	   RPE	   foci	   from	   the	   heterogeneous	   differentiating	   cell	  population.	   An	   alternate	  method	   being	   a	   prerequisite	   for	   large	   scale	   manufacture	   in	   the	  future.	   The	   characterisation	   and	   performance	   of	   a	   novel	   filter	   based	   separation	   was	  explored.	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2.	  Bioreactor	  culture	  of	  pluripotent	  stem	  cells	  using	  the	  Quantum	  Cell	  Expansion	  System1	  
2.1 Introduction	  and	  aims	  
2.1.1 Use	  of	  bioreactors	  to	  scale	  up	  stem	  cell	  culture	  
The	   use	   of	   bioreactors	   that	   grow	   cells	   on	   fibres	   or	   microcarriers	   as	   opposed	   to	   tissue	  culture	   plastic	   vastly	   increases	   the	   surface	   area	   available	   for	   cell	   growth.	   This	   enables	  potential	  scale-­‐up	  as	  it	  effectively	  allows	  cells	  to	  be	  grown	  in	  three	  dimensions,	  facilitating	  higher	  cell	  densities	  (i.e.,	  the	  number	  of	  cells	  grown	  within	  a	  given	  vessel	  volume,	  defined	  as	  volumetric	  productivity).	  Pluripotent	  stem	  cells	  (PSCs)	  have	  been	  successfully	  cultured	  on	  plates	   and	   small	   scale	   spinner	   flask	   culture	   on	   a	   variety	   of	   micro-­‐carrier	   materials	  (Fernandes	  et	  al.,	  2009,	  Phillips	  et	  al.,	  2008,	  Nie	  et	  al.,	  2009),	  with	  optimisation	  efforts	  made	  through	  control	  of	  process	  variables	   (Serra	  et	   al.,	   2010).	   In	  addition,	   Steiner	  et	   al.	   (2010)	  successfully	   derived	   and	   cultured	   hESC	   in	   suspension	   as	   aggregates	   without	   the	   use	   of	  microcarriers	  whilst	  maintaining	  their	  pluripotential	  ability.	  The	  use	  of	  such	  bioreactors	  to	  scale	  up	  cell	  culture	  is	  required	  to	  achieve	  the	  economies	  of	  scale	  neeed	  to	  facilitate	  the	  use	  of	  cell	  therapies	  in	  routine	  clinical	  practice	  (Mason	  and	  Dunnill,	  2009).	  
2.1.2 Design	  and	  operation	  of	  the	  Quantum	  Cell	  Expansion	  System	  The	   Quantum	   cell	   expansion	   system	   Figure	   2.1	   a),	   and	   b)	   is	   a	   functionally	   closed	   and	  temperature-­‐controlled	  hollow	  fibre	  perfusion	  bioreactor	  with	  a	   touch	  screen	   interface	   to	  run	  either	  pre-­‐loaded	  tasks	  -­‐	  for	  example,	  cell	  seeding	  -­‐	  or	  custom	  settings	  particular	  to	  the	  given	  cell	   culture.	  The	  bioreactor	  and	   its	  protocols	  were	   initially	  developed	   for	   the	   large-­‐scale	  commercial	  culture	  of	  mesenchymal	  stem	  cells	  (MSCs),	  however	  its	  use	  to	  grow	  other	  cell	  types	  had	  been	  proposed.	  Two	  prototype	  machines	  were	  made	  available	  on	  loan	  from	  the	  manufacturer	  to	  assess	  the	  feasibility	  of	  growing	  hESC	  on	  the	  Quantum	  cell	  expansion	  system	  in	  a	  pilot	  study.	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Many	   of	   the	   tasks,	   such	   as	   cell	   seeding,	   washes,	   and	   harvesting,	   are	   fully	   automated,	  requiring	  only	  that	  the	  operator	  sterile	  weld	  reagent	  bags	  to	  the	  system.	  This	  reduction	  of	  manual	   handling	   and	   its	   closed	   nature	   should	   not	   only	   reduce	   the	   risk	   of	   adventitious	  agents	   infecting	   the	   culture	   but	   will	   also	   significantly	   reduce	   the	   time	   demands	   of	   the	  operator	  in	  completing	  tasks	  such	  as	  media	  changes.	  
The	  3D	  nature	  of	  hollow	  fibre	  and	  other	  bioreactor	  designs	  effectively	  remove	  the	  gas	  liquid	  interface	  required	  for	  gas	  transfer	  found	  in	  flask	  culture.	  Additionally,	  the	  high	  cell	  densities	  achievable	   in	   such	   3D	   environments	   will	   likely	   lead	   to	   the	   rapid	   depletion	   of	   media	  components	   and	   build-­‐up	   of	   wastes.	   To	   address	   these	   issues,	   the	   Quantum	   system	   is	  comprised	  of	  two	  semi-­‐independent	  flow	  paths,	  known	  as	  the	  intra	  capillary	  (IC)	  and	  extra	  capillary	  (EC)	  loops,	  each	  of	  which	  has	  access	  to	  multiple	  inlet	  sources.	  A	  flow	  schematic	  of	  the	  Quantum	  system	  is	  outlined	  in	  Figure	  2.2.	  The	  IC	  loop	  includes	  the	  inside	  of	  the	  hollow	  fibres,	  where	  the	  cells	  attach	  and	  grow	  in	  a	  low	  shear	  environment.	  The	  EC	  loop	  circulates	  media	   around	   the	   outside	   of	   the	   fibres	   and	   through	   the	   gas	   transfer	   module	   (GTM)	   for	  continual	  contact	  between	  the	  media	  and	  the	  pressurized	  gas	  supply	  (5%CO2,	  20%	  O2,	  75%	  N2).	   Media	   can	   be	   perfused	   through	   either	   loop	   to	   facilitate	   mass	   transfer	   of	   media	  components	  and	  removal	  of	  waste,	  such	  as	  lactate.	  The	  porous	  nature	  of	  the	  fibres	  also	  acts	  essentially	   as	   a	   membrane	   restricting	   the	   loss	   of	   components	   larger	   than	   15	   kDa.	   This	  means	   expensive	   growth	   factors	   such	   as	   bFGF,	   can	   be	   concentrated	   on	   the	   inside	   of	   the	  fibres,	  whilst	  smaller	  molecules	  such	  as	  lactate	  can	  be	  diluted	  and	  removed	  by	  perfusion	  on	  the	  external	  loop.	  Sterile	  media	  samples	  can	  be	  taken	  from	  the	  system	  for	  off-­‐line	  analysis	  as	  illustrated	  in	  Figure	  2.3,	  however	  direct	  sampling	  of	  the	  cells	  is	  not	  possible.	  The	  entire	  flow	  path	  including	  the	  bioreactor	  and	  gas	  transfer	  module	  are	  all	  disposable	  as	  highlighted	  in	  Figure	  2.4.	  Critically,	  the	  only	  environmental	  variable	  that	   is	  monitored	  and	  controlled	  online	  is	  the	  temperature	  inside	  the	  unit.	  
The	  bioreactor	  module	  itself	   is	  comprised	  of	  ~10,000	  hollow	  fibres	  of	  diameter	  ~200	  µm,	  yielding	   a	   total	   area	   available	   for	   growth	   of	   2.1	   m2	   (21,000	   cm2).	   An	   overview	   of	   the	  hollowfibres	  shows	  their	  physical	  packing	  into	  the	  bioreactor	  unit	  Figure	  2.5	  a)	  and	  b),	  and	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their	  structure	  at	  the	  micro	  scale	  Figure	  2.5	  c)	  and	  attachment	  of	  mesenchymal	  stem	  cells	  
Figure	  2.5	  d).	  The	  total	  surface	  area	  of	  2.1m2	  equates	  to	  approximately	  840	  T25	  flasks.	  	  
2.1.3 Aims	  The	   aim	   of	   this	   chapter	   was	   to	   explore	   the	   feasibility	   of	   growing	   hESC	   at	   large	   scale	   on	  commercially	  available	  machinery	  that	  was	   initially	  designed	  for	   the	  growth	  of	  MSCs.	  The	  specific	  objectives	  were:	  
• To	  develop	  a	  working	  hESC	  protocol	  based	  on	  experiences	  from	  hESC	  scoping	  runs	  and	  initial	  runs	  with	  other	  cell	  types.	  
• Determine	  the	  ability	  of	  the	  system	  to	  replicate	  the	  environmental	  conditions	  and	  cell	  expansion	  achieved	  in	  flask	  culture.	  
• Analyse	  whether	  maintenance	  of	  the	  target	  hESC	  phenotype	  can	  be	  achieved	  on	  the	  bioreactor.	  
• To	  generate	  data	  as	  a	  proof	  of	  concept	  study	  to	  inform	  the	  future	  work	  required	  to	  move	  this	  process	  to	  a	  defined,	  optimised,	  and	  validatable	  commercial	  process.	  
2.2 	  Materials	  and	  Methods	  
2.2.1 Cell	  culture	  in	  T25	  Flasks	  
The	  Shef	  3	  hESC	   line	  was	  passaged	  using	   the	  TrypLE	  Express	  enzyme	  (Life	  Technologies)	  and	   co-­‐cultured	   on	   mitomycin	   c	   inactivated	   mouse	   embryonic	   fibroblasts	   (MEFs).	   MEFs	  were	   originally	   grown	   in	   Dulbecco’s	   Modified	   Eagle	   Medium	   (DMEM,	   Life	   Technologies)	  with	   10%	   v/v	   heat	   inactivated	   fetal	   bovine	   serum	   (FBS,	   Sera	   Laboratories	   International)	  and	   1%	   v/v	   100X	  MEM	  non-­‐essential	   amino	   acids	   (NEAA,	   Life	   Technologies).	   hESC	  were	  grown	  in	  Knockout	  DMEM,	  (Life	  Technologies)(+	  4.5	  g	  D-­‐glucose	  /L,	  +	  sodium	  pyruvate,	  –	  L-­‐glutamine),	   20%	   Knockout	   Serum	   Replacement	   (Life	   Technologies),	   GlutaMAX,	   (Life	  Technologies),	   0.1	   mM	   beta-­‐mercaptoethanol,	   human	   basic	   fibroblast	   growth	   factor,	   4	  ng/ml	   (bFGF,	   R&D	   systems),	   and	   1%	  100X	  MEMNEAA	   (Life	   Technologies).	   	  Medium	  was	  exchanged	   daily	   at	   a	   ratio	   of	   0.2	  ml	   cm-­‐2.	   All	   cell	   counting	   and	   cell	   viability	   analysis	  was	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performed	   on	   the	   Vi-­‐Cell	   (Beckman	   Coulter),	   using	   the	   trypan	   blue	   exclusion	   viability	  assessment.	  
2.2.2 In	  vitro	  differentiation	  Cell	   suspensions	   were	   allowed	   to	   aggregate	   to	   form	   embryoid	   bodies	   (EBs)	   in	   low	  attachment	  plates.	  These	  cells	  were	  cultured	  in	  the	  hESC	  media	  described	  above	  excluding	  bFGF	   for	   approximately	   1	  week	   before	   being	   pelleted,	   dried	   and	   frozen	   at	   -­‐80oC	   for	   PCR	  analysis.	  In	  addition,	  a	  portion	  of	  the	  EBs	  were	  transferred	  to	  tissue	  culture	  vessels	  coated	  with	   0.1%	  gelatine	   and	   cultured	   until	   a	  monolayer	   of	   cells	  was	   seen	   emanating	   from	   the	  attached	  EB	  before	  fixing	  for	  immunocytochemistry.	  
2.2.3 Immunocytochemistry	  Cells	  were	  fixed	  in	  a	  1.33	  M	  PFA	  solution	  and	  0.25%	  v/v	  Triton	  X	  was	  used	  to	  permeabilise	  cells.	   Primary	   antibodies	   used	  were	   as	   follows:	  mouse	   IgM	  anti-­‐TRA	  1-­‐60	   (kind	   gift	   from	  Professor	  Peter	  Andrews,	  Sheffield	  University),	  mouse	  IgG	  anti-­‐Oct3/4	  (Santa	  Cruz),	  rabbit	  IgG	   anti-­‐Sox	   17	   (Millipore),	   mouse	   IgG	   anti-­‐brachyury	   (Millipore),	   and	   mouse	   IgG	   anti-­‐nestin	  (Millipore).	  The	  following	  secondary	  antibodies	  were	  used	  at	  1:200	  dilutions,	  Alexa	  fluor	  488	  goat	  anti-­‐mouse	  IgM,	  Alexa	  Fluor	  488	  goat	  anti-­‐mouse	  IgG,	  Alexa	  fluor	  488	  goat	  anti-­‐rabbit	   IgG	   (Life	   Technologies).	   Images	   were	   taken	   with	   an	   epifluorescence	   Nikon	  Eclipse	   2000	   inverted	   microscope	   and	   the	   NIS-­‐elements	   software.	   Where	   applicable,	  isotype	  controls	  were	  run	  in	  parallel.	  
2.2.4 Karyology	  Cell	  karyotyping	  was	  carried	  out	  by	  TDL	  Genetics	  (London,	  UK)	  using	  standard	  G	  banding.	  A	  minimum	  of	  20	  metaphase	  spreads	  were	  counted	  per	  sample.	  
2.2.5 Reverse	  transcriptase-­‐polymerase	  chain	  reaction	  (PCR)	  Following	   manufacturer’s	   guidelines,	   RNA	   was	   extracted	   using	   the	   RNeasy	   mini-­‐kit	  (Qiagen),	   and	   first-­‐strand	   synthesised	   using	   the	   RetroscriptKit	   (Ambion).	   Bio-­‐Taq	  polymerase	   (Bioline)	   was	   used	   for	   the	   PCR	   reaction	   in	   a	   Verity	   cycler	   (Applied	   Bio-­‐	  systems).	  Primer	  sequences	  are	  outlined	  in	  Table	  2.1.	  
	   	  
	   - 41 -	  
2.2.6 Lactate	  dehydrogenase	  (LDH)	  assay	  0.5%	  v/v	  Triton	  X	  was	  used	  to	  disrupt	  any	  cells	  remaining	  on	  the	  bioreactor’s	  surfaces	  after	  the	  harvesting	  protocol.	  Roche	  Applied	  Science	  Cytotoxicity	  Detection	  Kit	   (LDH)	  was	   then	  used	   as	   per	   the	  manufacturer’s	   instructions	   to	   compare	   the	   bioreactor	   sample	   against	   a	  standard	   curve	   of	   known	   cell	   concentrations	   obtained	   from	   the	   successfully	   harvested	  fraction.	  
2.2.7 Real-­‐time	  PCR	  Following	   first-­‐strand	   synthesis	   with	   the	  method	   described	   above,	   quantitative	   PCR	  was	  carried	  out	  using	  the	  MESA	  BLUE	  qPCRMasterMix	  Plus	  for	  SYBR	  Assay	  (Eurogentec)	  in	  the	  in	   the	   CFX	   Connect	   Real-­‐Time	   System	   (Bio-­‐Rad).	   20	   µL	   reactions	   were	   run	   in	   triplicate	  using	   the	   following	   primers	   from	   Qiagen:	   b-­‐ACTIN	   (QT00095431),	   UBC	   (QT00234430),	  POU5F	   (QT00210840),	   NANOG	   (QT01844808),	   and	   SOX2	   (QT00237601).	   Analysis	   of	  relative	   quantification	   used	   b-­‐ACTIN	   and	   UBC	   to	   normalise	   expression,	   and	   primer	  efficiencies	   were	   calculated	   using	   a	   cDNA	   dilution	   curve	   and	   analysed	   using	   Bio-­‐Rad	  software.	  
2.2.8 Flow	  cytometry	  The	   following	   antibodies	   were	   used:	   mouse	   anti-­‐SSEA-­‐4	   PE	   conjugate	   (Millipore)	   and	  mouse	   anti-­‐TRA	   1-­‐85	   Alexa	   fluor	   488	   conjugate	   (Millipore).	   A	   1%	   cut-­‐off	   gate	   was	  implemented	   based	   on	   conjugated	   isotype	   controls.	   All	   samples	   were	   analysed	   using	  Beckman	  Coulter	  Epics	  XL	  MCL	  flow	  cytometer,	  and	  Summit	  software.	  
2.2.9 Quantum	  cell	  expansion	  system	  protocol	  100	  million	  MEFs	  were	   seeded	  onto	   the	  bioreactor	   that	  had	  been	  previously	   coated	  with	  10mg	  fibronectin	  (BD	  bioscience),	  using	  automated	  protocols.	  	  Cells	  were	  allowed	  to	  attach	  for	   48	   hours,	   during	   which	   time	   there	   was	   no	   flow	   on	   the	   intra	   capillary	   (IC)	   loop	  containing	  the	  cells.	  However,	  media	  was	  perfused	  through	  the	  extra-­‐capillary	  (EC)	  loop	  to	  refresh	   media	   components	   and	   remove	   the	   waste.	   Circulation	   around	   the	   EC	   loop	   also	  enabled	  gas	  transfer	  via	  access	  to	  the	  gas	  transfer	  module.	  After	  this	  MEF	  attachment	  step,	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the	  MEF	  media	  was	  washed	  out	  and	  replaced	  with	  hESC	  media	  and	  60	  million	  hESC	  cells	  (~3000	  cells/cm2)	  were	  added	  to	  the	  reactor	  (Day	  0)	  in	  the	  same	  manner	  as	  the	  MEFs.	  Cells	  for	  Run	  1	  were	  seeded	  at	  passage	  93,	  and	  cells	  for	  Run	  2	  were	  seeded	  at	  passage	  118.	  After	  an	   additional	   52	   hours	   of	   cell	   attachment,	   a	   low	   IC	   inlet	   rate	   was	   initiated	   to	   replenish	  factors	  such	  as	  bFGF,	  which	  were	  too	  big	  to	  be	  supplied	  across	  the	  fibres	  from	  the	  EC	  loop.	  IC	   circulation	   was	   also	   employed	   to	   encourage	   homogeneity	   of	   media	   components	  surrounding	   the	   cells.	   Sterile	  media	   samples	  were	   taken	   twice	   daily	   for	  measurement	   of	  glucose	   and	   lactate	   levels	   via	   the	   YSI	   2700	   media	   analyser.	   	   Comparisons	   of	   these	  concentrations	   were	   made	   with	   spent	   media	   from	   flask	   controls,	   and	   inlet	   rates	   were	  increased	   to	   the	   bioreactor	   in	   an	   effort	   to	  mimic	   the	   environment	   provided	  within	   these	  control	  flask	  cultures.	  	  
On	  day	  8	  (after	  5	  days	  of	  hESC	  expansion),	  cells	  were	  harvested	  by	  first	  flushing	  both	  the	  IC	  and	  EC	  loops	  with	  three	  times	  the	  total	  reactor	  volume	  of	  DPBS,	  followed	  by	  an	  additional	  two	  volumes	  of	  0.1	  mM	  (1,085	  mL)	  EDTA	   	   (Sigma)	  and	  a	  15	  minute	   incubation	  period.	  A	  volume	   of	   200	  ml	   of	   0.25%	   trypsin	  was	   then	   added	   to	   the	   IC	   loop	   and	   circulated	   for	   45	  minutes.	   Finally,	   the	   cell	   suspension	   was	   flushed	   into	   the	   harvest	   bag	   using	   20%	   serum	  media	  to	  quench	  the	  trypsin.	  Cell	  counts	  and	  viability	  analysis	  were	  performed	  on	  the	  cells	  using	  the	  ViCell	  cell	  counter	  (Beckman	  Coulter).	  
2.3 	  Results	  and	  discussion	  
2.3.1 Developing	  a	  working	  pluripotent	  stem	  cell	  protocol	  based	  on	  
experiences	  from	  7	  trial	  runs	  using	  multiple	  cell	  types.	  	  In	  order	  to	  adapt	  the	  manufacturers	  recommended	  protocols	  for	  the	  culture	  of	  MSCs	  to	  the	  working	   hESC-­‐MEF	   co-­‐culture	   protocol	   described,	   it	   was	   necessary	   to	   conduct	   initial	  experiments	   with	   MSCs,	   hESC	   and	   the	   ARPE-­‐19	   cell	   line	   (ATCC).	   In	   all	   7	   runs	   were	  conducted	  at	  full	  scale	  prior	  to	  the	  2	  PSC	  runs	  reported	  here.	  The	  ARPE-­‐19	  line	  was	  chosen	  to	  generate	  additional	  experience	  with	  the	  machine	  before	  moving	  onto	  PSC	  culture	  due	  to	  limited	   availability	   of	   isolated	   MSCs	   for	   use	   in	   this	   project.	   In	   addition,	   it	   has	   been	  previously	   suggested	   the	   ARPE-­‐19	   cell	   line	   might	   be	   of	   clinical	   use,	   as	   it	   has	   reportedly	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rescued	  visual	  function	  in	  the	  dystrophic	  royal	  college	  of	  surgeons	  (RCS)	  rats	  (McGill	  et	  al.,	  2004)	  
In	  an	  attempt	  to	  reduce	  costs	  alternatives	  to	  the	  expensive	  fibronectin	  (10mg)	  coating	  stage	  recommended	  by	  the	  manufacturer	  were	  investigated	  under	  their	  guidance.	  Pre-­‐coating	  the	  fibres	  with	  10%	  foetal	  bovine	  serum	  prior	  to	  seeding	  with	  MSCs	  resulted	  in	  a	  loss	  of	  nearly	  all	  the	  cells	  seeded	  after	  a	  5	  day	  expansion	  protocol.	  Coating	  the	  fibres	  with	  0.1%	  gelatine	  proved	  successful	  with	  the	  ARPE-­‐19	  cell	  line,	  with	  30m	  cells	  expanding	  to	  344m	  cells	  (93%	  viability)	   during	   a	   9	   day	   protocol	   in	   the	   bioreactor.	  However,	  when	   gelatine	  was	   used	   to	  coat	  fibres	  in	  a	  MEF-­‐hESC	  co-­‐culture	  system	  there	  was	  a	  net	  loss	  of	  cells.	  An	  additional	  trial	  run	  was	  then	  conducted	  using	  the	  MEF-­‐hESC	  co-­‐culture	  system	  using	  10	  mg	  fibronectin	  as	  the	   coating	   material,	   which	   showed	   a	   modest	   net	   expansion	   in	   cells	   (21m	   cells),	   and	  maintenance	   of	   the	   hESC	   phenotype	   (data	   not	   shown).	   Thus	   it	   was	   concluded	   that	  fibronectin	  was	  a	  necessity	  even	  in	  a	  co-­‐culture	  environment,	  but	  from	  a	  cost	  effectiveness	  perspective	   further	   work	   is	   called	   for	   to	   identify	   an	   optimum	   amount	   of	   fibronectin	  material	   needed,	   or	   if	   other	   coating	  materials	   such	   as	  matrigel	   are	   computable	   with	   the	  system,	  which	  would	  be	  required	  for	  feeder	  free	  culture.	  
This	  trial	  hESC	  protocol	  using	  fibronectin	  was	  then	  further	  refined	  to	  generate	  the	  protocol	  described	   in	   this	   thesis	   and	  used	   to	   generate	   the	  data	  presented	  here.	  The	  main	   areas	  of	  modification	  to	  the	  manufacturer’s	  existing	  MSC	  protocols	  using	  data	  from	  the	  7	  trial	  runs	  were	   the	   following:	   1)	   increasing	   the	   volume	   of	   the	   wash	   used	   during	   harvest;	   2)	   the	  addition	  of	  an	  EDTA	  incubation	  stage	  (to	  aid	  cell	  release);	  3)	  loading	  of	  the	  cells	  in	  a	  more	  dilute	  suspension;	  and	  4)	   to	  reduce	  the	  number	  of	  mouse	   feeder	  cells	  used	  by	  half.	  These	  last	  two	  alterations	  were	  made	  in	  the	  assumption	  that	  cell	  aggregation	  during	  seeding	  was	  impacting	   the	   ability	   for	   the	   cells	   to	   expand,	   based	   on	   observations	   of	   large	   cell	  masses/clumps	  during	  harvest	  for	  the	  first	  hESC-­‐MEF	  co-­‐culture	  run	  on	  fibronectin	  which	  yielded	  a	  net	  cell	  expansion	  of	  only	  21m	  cells.	  
	   	  
	   - 44 -	  
2.3.2 Suitability	  of	  using	  a	  karyotypically	  abnormal	  cell	  line	  as	  a	  model	  
cell	  line	  for	  large-­‐scale	  experimentation	  Prior	   to	   the	   discussion	   of	   results	   from	   the	   final	   two	   runs	   using	   the	   refined	  protocol,	   it	   is	  important	  to	  discuss	  the	  cell	  line	  used	  in	  this	  chapter.	  	  In	  particular,	  these	  proof	  of	  concept	  studies	  use	  a	  Shef3	  hESC	  line	  that	  has	  been	  adapted	  to	  enzymatic	  passaging	  and	  has	  been	  shown	  to	  be	  resilient	  to	  low	  seeding	  densities.	  	  From	  a	  practical	  perspective,	  both	  of	  these	  characteristics	  are	  valuable	  for	  large-­‐scale	  production	  in	  a	  bioreactor.	  	  Manual	  passaging	  of	  PSC	  colonies	  is	  not	  realistic	  for	  large	  surfaces	  and	  is	  impossible	  in	  a	  hollow	  fibre	  bioreactor.	  	  With	  respect	  to	  seeding	  density,	  typical	  hESC	  cell	  lines	  require	  seeding	  densities	  of	  ~20,000	  cells/cm2	   to	  establish	  healthy	  cultures,	  whereas	   the	  adapted	  Shef3	  hESC	   line	  can	  produce	  confluent	  cultures	  from	  a	  low	  seeding	  density	  of	  ~3,000	  cells/cm2.	  Therefore,	  in	  the	  context	  of	  the	  limited	  resources	  of	  an	  academic	  setting,	  it	  becomes	  possible	  to	  produce	  the	  number	  of	  cells	  needed	  to	  inoculate	  this	  large-­‐scale	  reactor	  which	  is	  only	  available	  at	  a	  single	  scale.	  
Given	  the	  advantages	  of	  this	  adapted	  Shef3	  hESC	  line,	  it	  is	  important	  to	  note	  the	  karyotypic	  abnormalities,	   namely	   48,X,+i(12)(p10),+14,+i(17(q10))	   (additions	   to	   chromosomes	   12	  and	  17),	  do	  not	  make	  the	  line	  unsuitable	  for	  use	  in	  a	  study	  such	  as	  this.	  	  Such	  abnormalities	  are	   a	   common	   occurrence	   in	   later	   passage	   hESC	   lines,	   particularly	   when	   enzymatic	  passaging	   methods	   are	   used	   (Amps	   et	   al.,	   2011),	   however	   these	   abnormalities	   have	   not	  impacted	  this	  line’s	  characteristic	  hESC	  pluripotent	  phenotype	  and	  differentiation	  potential.	  The	   pluripotent	   phenotype	   was	   not	   only	   present	   in	   the	   stock	   cell	   line	   but	   it	   was	   also	  retained	  after	  expansion	  on	  the	  system	  as	  evidenced	  in	  Figure	  2.6	   a)	  and	   b)	  which	  show	  that	  cells	  harvested	  from	  the	  Quantum	  Cell	  Expansion	  System	  still	  express	  the	  pluripotency	  markers	   TRA	   1-­‐60	   and	   Oct-­‐3/4	   after	   replating.	   	   Additionally,	   once	   taken	   through	   an	  embryoid	  body	  differentiation	  protocol,	   the	  cells	  expressed	  markers	  representative	  of	   the	  three	  germ	  layers	  Figure	  2.6	  c),	  d),	  e)	  and	   f).	  Such	  findings	  are	  corroborated	  by	  Sun	  et	  al.	  (2008)	   who	   previously	   compared	   the	   properties	   of	   normal	   and	   abnormal	   hESC	   lines,	  concluding	  that	  given	  the	  similarity	  in	  their	  biological	  properties	  abnormal	  cell	   lines	  were	  useful	  experimental	  materials	  for	  cell	  therapy,	  developmental	  biology	  and	  genetic	  research.	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Crucial	  practical	  advantages	  and	  phenotypic	  data	  validates	  the	  use	  of	  this	  adapted	  line	  for	  the	  purpose	  of	  generating	  important	  proof	  of	  concept	  data	  and	  valuable	  experience	  with	  the	  large-­‐scale	  bioreactor.	  Therefore,	  a	  working	  protocol	  can	  be	  developed	  before	  moving	  to	  a	  clinical	   grade	   line	   and	   a	   human	   feeder	   or	   feeder-­‐free	   culture	   system,	   examples	   of	  which	  were	  evaluated	  by	  Hernandez	  et	  al.	  (2011).	  Such	  systems	  where	  considered	  for	  this	  study	  but	  the	  cost	  implications	  of	  using	  these	  expensive	  systems	  at	  scale	  and	  considerations	  as	  to	  how	   matrix	   coatings	   such	   as	   Matrigel	   (BD	   bioscience)	   might	   impact	   the	   porosity	   of	   the	  hollowfibres	  led	  to	  the	  conclusion	  to	  first	  generate	  this	  working	  protocol	  using	  the	  cheaper	  MEF-­‐hESC	  co-­‐culture	  system.	  
2.3.3 Perfusion	  rate	  rationale	  Given	  the	  differences	  in	  operation	  between	  continual	  perfusion	  of	  media	  into	  the	  bioreactor	  versus	  daily	  media	  changes	  in	  a	  normal	  flask	  culture,	  there	  are	  two	  possible	  approaches	  to	  take	  regarding	  the	  supply	  of	  media.	  The	  first	  would	  be	  to	  apply	  media	  at	  a	  flow	  rate	  to	  the	  system	  that	  exactly	  matches	  that	  used	  in	  flasks	  i.e.	  0.2	  ml	  cm-­‐2	  day-­‐1,	  which	  equates	  to	  ~4.2	  L	   day-­‐1	   on	   the	   Quantum	   system.	   However,	   based	   on	   the	   earlier	   preliminary	   experiments	  using	  adult	  stem	  cells	  (described	  in	  2.3.1),	  it	  was	  believed	  that	  such	  an	  approach	  could	  be	  an	   unnecessary	  waste	   of	  media,	   thus	   not	  making	   best	   use	   of	   the	   system	   design.	   In	   flask	  culture,	  additional	  media	  has	  to	  be	  supplied	  in	  order	  to	  ensure	  that	  the	  base	  of	  the	  flask	  is	  covered	  with	  media	   even	  when	   cell	   densities	   are	   comparably	   low,	   for	   instance	   after	   cell	  seeding.	  With	  a	  total	  bioreactor	  volume	  of	  413	  ml,	  it	  was	  thought	  that	  the	  provision	  of	  4.2	  L	  day-­‐1	   to	   the	   bioreactor	   from	   the	   beginning	   of	   the	   run	  would	   be	   an	   unnecessary	  waste	   of	  resources.	   	   It	  was	   also	   considered	   that	   this	  might	   actually	   remove	   key	   cell-­‐cell	   signalling	  components	   from	   the	   system,	   thus	   hindering	   cell	   growth.	   Therefore,	   an	   alternative	  approach	   was	   deployed:	   inlet	   rates	   were	   adjusted	   with	   the	   intention	   of	   approximating	  glucose	  and	  lactate	  levels	  observed	  in	  the	  T25	  control	  flasks.	  Glucose	  being	  used	  as	  a	  proxy	  measure	  of	  other	  components	   in	  the	  media	  such	  as	  knock	  out	  serum	  replacement	  (KOSR)	  which	  fuel	  cell	  growth.	  In	  this	  manner,	  the	  usage	  of	  expensive	  media	  would	  be	  minimised,	  while	   presumably	   providing	   an	   environment	   for	   the	   cells	   that	   was	   similar	   to	   that	  experienced	   by	   the	   cells	   in	   the	   control	   flasks.	   	   Such	   a	   ‘reactive’	   approach	   i.e.	   altering	   the	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feeds	  based	  on	  readings	  as	  opposed	  to	  predicting	  the	  cell	  requirements	  was	  recommended	  by	  the	  machines	  supplier	  Terumo/BCT	  based	  on	  their	  success	  culturing	  MSCs.	  
2.3.4 Ability	  of	  the	  Quantum	  Expansion	  System	  to	  replicate	  the	  
environmental	  conditions	  and	  cell	  expansion	  achieved	  in	  flask	  
culture	  	  
In	  Run	  1,	  an	  initial	  inlet	  rate	  of	  0.2	  ml/min	  was	  used	  on	  the	  extra	  capillary	  (EC)	  loop,	  with	  a	  zero	  inlet	  rate	  on	  the	  intracapillary	  (IC)	  loop	  to	  allow	  the	  cells	  to	  attach.	  	  See	  Figure	  2.2	  for	  flow	   schematic	   of	   the	   loops	   and	   Figure	   2.7	   a)	   for	   the	   media	   perfusion	   rates	   used	   and	  observed	  glucose	  and	   lactate	   levels	   for	  Run	  1.	  At	  hour	  28	  of	   this	  cell	  attachment	  protocol,	  similar	   depletion	   in	   glucose	  was	   seen	   in	   both	   the	   flask	   and	   the	   Quantum	   system,	  with	   a	  difference	  of	  0.30	  g	  glucose	  /L	  between	  them	  (Figure	   2.7	   a).	  However,	  by	  hour	  52	  of	   the	  protocol	   the	  difference	   in	  glucose	   levels	  between	  the	   flasks	  and	  the	  Quantum	  system,	  had	  over	  doubled	  to	  0.77	  g	  glucose/L.	  Glucose	  levels	  remained	  outside	  that	  seen	  in	  flasks	  for	  the	  rest	  of	  the	  run,	  despite	  incrementally	  increasing	  the	  inlet	  rate	  into	  the	  IC	  loop.	  
Over	   the	   5	   day	   hESC	   expansion	   in	   Run	   1,	   0.15	  ml	  media	   cm-­‐2	  was	   perfused	   through	   the	  Quantum	  cell	  expansion	  system	  in	  total,	  compared	  to	  1	  ml	  media	  cm-­‐2	  supplied	  to	  the	  flasks	  through	  daily	  media	  changes.	  Figure	  2.7	  e)	  shows	  the	  accompanying	  media	  volumes	  used	  during	  Run	  1	  each	  hour	  per	  cm2.	  It	  is	  hypothesised	  that	  this	  undersupply	  of	  media	  resulted	  in	   the	   lower	  glucose	   levels	   seen	   in	   the	  Quantum	  system,	  and	  so	   the	   likely	  explanation	   for	  the	  relatively	  poor	  cell	  yield	  of	  the	  Quantum	  system	  compared	  to	  the	  flask	  culture:	  1.8E+4	  cells	   cm-­‐2	   for	   the	   Quantum	   system	   and	   1.9E+5	   cells	   cm-­‐2	   or	   flasks.	   See	   Table	   2.2	   for	   a	  summary	  of	  the	  expansion	  achieved	  in	  Run	  1.	  
A	  second	  run	  (Run	  2)	  sought	  to	  feed	  the	  cells	  in	  a	  more	  proactive	  manner	  from	  the	  start	  of	  the	   run.	   	   The	   initial	   inlet	   rate	  was	   doubled	   relative	   to	   that	   in	  Run	  1,	   namely	   0.4	  ml/min.	  Additionally,	   inlet	   rates	  were	   increased	  at	  higher	   increments	   throughout	   the	  run,	  (Figure	  
2.7	  b)	  and	   e),	   in	  an	  effort	  to	  maintain	  higher	  glucose	  levels.	  Total	  media	  provision	  during	  the	  5	  day	  expansion	  was	  therefore	  increased	  from	  0.15	  ml	  cm-­‐2	  in	  Run	  1	  to	  0.32	  ml	  cm-­‐2	  in	  Run	   2.	   As	   a	   result,	   the	   expansion	   in	   the	   bioreactor	   was	   markedly	   improved	   in	   Run	   2,	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achieving	  708	  m	  cells	  (3.4E+4	  cells	  cm-­‐2)	  from	  60	  m	  seeded	  hESC,	  as	  compared	  to	  the	  383	  m	  cells	  (1.8E+4	  cells	  cm-­‐2)	  achieved	  in	  Run	  1	  (Table	  2.2).	  	  
The	  performance	  of	   the	  Quantum	  system	  was,	  however,	   still	  not	   the	  equivalent	   to	   that	  of	  the	  flask	  culture,	  which	  yielded	  1.9E+5	  cells	  cm-­‐2	  (Table	  2.2).	  Lactate	  levels	  throughout	  Run	  2	  may	   help	   provide	   an	   explanation	   for	   the	   lower	   yields	   per	   surface	   area.	  Figure	   2.7	   b)	  illustrates	  the	  disparity	  between	  flask	  and	  Quantum	  system	  concentrations	  of	  glucose	  and	  lactate	   for	   Run	   2.	   	   It	   can	   be	   seen	   that	   glucose	   and	   lactate	   levels	   differed	   significantly	  between	  the	  flask	  and	  the	  Quantum	  system	  for	  much	  of	  the	  expansion.	  	  Though	  higher	  inlet	  rates	  relative	  to	  Run	  1	  were	  used,	  a	  rapid	  rise	  in	  lactate	  levels	  was	  also	  observed	  over	  the	  first	  52	  hours,	  perhaps	  indicating	  comparatively	  increased	  cell	  expansion.	  	  Although	  levels	  of	  lactate	  and	  glucose	  were	  brought	  to	  within	  levels	  observed	  in	  flask	  culture	  by	  the	  end	  of	  the	  run	  by	  increasing	  the	  inlet	  rates,	  the	  long	  period	  of	  exposure	  to	  high	  lactate	  levels	  may	  have	   inhibited	   growth.	  The	  detrimental	   impact	   of	   high	   lactate	   levels	   on	  hESC	   growth	  has	  been	  described	  by	  Chen	  et	  al.	  (2010)	  who	  reported	  that	  supplementing	  hESC	  cultures	  with	  1–5	   g	   lactate/L	   for	   3	   days	   resulted	   in	   15%–50%	   reduction	   in	   cell	   growth.	   	   Thus	   a	  combination	   of	   high	   lactate	   levels	   and	   low	   glucose	   levels	   recorded	   in	   Run	   2	   is	   the	   likely	  cause	  of	  expansion	  on	  the	  Quantum	  System	  not	  matching	  the	  flask	  controls.	  
Readings	  for	  pH	  were	  also	  taken	  ‘off-­‐line’	  on	  the	  sampled	  media	  (Figure	  2.7	  c	  and	  d)	  and	  follows	  a	  inverse	  correlation	  to	  that	  of	  lactate	  (Figure	  2.7	  a	  and	  b),	  the	  pH	  remaining	  lower	  than	   the	   flask	   controls	   for	   the	   majority	   of	   the	   runs.	   Unfortunately	   with	   no	   online	  measurement	  of	  CO2	  or	  ability	  to	  control	  the	  gas	  mix,	  to	  reduce	  the	  supplied	  CO2	  below	  5%,	  it	  is	  not	  possible	  to	  have	  the	  required	  control	  over	  pH	  which	  might	  be	  critical	  to	  obtain	  and	  maintain	  higher	  cell	  densities.	  	  
The	  manufacturer	  reported	  that	  such	  a	  decrease	  in	  pH	  had	  not	  been	  seen	  with	  the	  other	  cell	  lines	  previously	  tested	  on	  the	  machine	  and	  that	  this	  was	  part	  of	  the	  reason	  that	  no	  online	  measurement	   is	   available.	   It	   is	   critical	   in	   any	   bioreactor	   that	   the	   gas	   transfer	   rate	   (GTR)	  achievable	  is	  not	  less	  than	  the	  oxygen	  uptake	  rate	  (OUR)	  that	  the	  cells	  have	  become	  adapted	  to	   in	  flask	  culture.	  A	  failure	  to	  achieve	  a	  GTR	  equal	  or	  greater	  to	  the	  OUR	  would	  force	  the	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cells	   to	  respire	  anaerobically	   likely	   impacting	  both	  growth	  and	  phenotype	  given	  these	  are	  pluripotent	  cells	   that	  have	  not	  been	  adapted	  to	  hypoxia.	  The	  component	  parts	  of	   the	  GTR	  are	   described	   in	   Equation	   1	   below-­‐	   where	   C*	   represents	   the	   solubility	   of	   oxygen	   in	   the	  medium,	   CL	   is	   the	   oxygen	   concentration	   in	   the	   medium;	   thus	   (C*-­‐CL)	   is	   known	   as	   the	  concentration-­‐difference	   driving	   force	   of	   the	   mass	   transfer.	   Due	   to	   the	   low	   solubility	   of	  oxygen,	   it	   being	   only	   a	   value	   of	   about	   10ppm	   under	   ambient	   temperature	   and	   pressure,	  makes	  it	  vital	  that	  the	  contribution	  of	  KLa	  in	  the	  equation	  is	  as	  large	  as	  possible	  to	  overcome	  this	  limitation	  to	  increase	  the	  OTR.	  KLa	  represents	  the	  volumetric	  mass	  transfer	  coefficient	  for	   oxygen	   transfer	   and	  describes	   the	   ability	   for	   a	   bioreactor	   and	   its	   operation	   to	  deliver	  oxygen	  into	  the	  liquid	  medium.	  KLa	  is	  split	  into	  two	  parts,	  KL	  (ms-­‐1)	  is	  the	  liquid-­‐phase	  mass-­‐transfer	  coefficient	  and	  “a”	  (m2m-­‐3)	  is	  the	  gas-­‐liquid	  interfacial	  area	  per	  unit	  volume	  of	  fluid.	  Considering	  the	  design	  of	  the	  hollowfibre	  perfusion	  bioreactor	  there	  are	  3	  possible	  courses	  of	  action	  to	  maximise	  OTR:	  1)	  increase	  the	  surface	  area	  available	  for	  gas	  and	  mass	  transfer,	  by	  increasing	  the	  number,	  or	  length	  of	  the	  fibres	  in	  the	  gas	  transfer	  module	  and	  bioreactor;	  2)	   increase	   the	   O2	   concentration	   in	   the	   supplied	   gas	   mix	   above	   20%;	   3)	   increase	   the	  circulation	   rate	  of	   the	  media	   to	   the	  gas	   transfer	  module.	  As	   it	  was	  not	  possible	   to	   impact	  either	  1)	  or	  2)	  due	  to	  the	  fixed	  design	  of	  the	  bioreactor,	  a	  high	  circulatory	  flow	  rate	  of	  200	  ml/min	   was	   used	   on	   the	   extracapillary	   side	   of	   the	   bioreactor	   to	  maximise	   the	   OTR	   (the	  standard	   protocol	   used	   30mL/min).	   	   With	   200	   ml/min	   being	   the	   maximum	   value	  recommended	  by	  the	  manufacturer	  for	  the	  system	  with	  assurances	  made	  that	  the	  residence	  times	   in	   the	   gas	   transfer	   module	   and	   the	   bioreactor	   itself	   were	   such	   that	   equilibration	  between	  the	  gas	  and	   liquid	  phases	  (in	   the	  gas	   transfer	  module)	  and	  the	   two	   loops	  (in	   the	  bioreactor)	  could	  take	  place.	  
However	  with	  no	  online	  O2	  measurement	  it	  was	  not	  possible	  to	  ascertain	  whether	  the	  GTR	  rate	   became	   growth	   limiting,	   particularly	   at	   the	   higher	   cell	   densities	   later	   in	   the	   runs.	   In	  addition	   ,values	  of	  KLa	   for	   the	  bioreactor	  were	  not	  available	   from	   the	  manufacture	  which	  would	   have	   made	   useful	   comparisons	   with	   other	   bioreactor	   designs.	   The	   addition	   of	   a	  retrofitted	   O2	   probe	   to	   the	   bioreactor	   for	   tracking	   dissolved	   oxygen	   during	   culture	   and	  determination	  of	  KLa	  was	  discussed	  with	  the	  manufacturer,	  however	  difficulties	  regarding	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the	   maintenance	   of	   sterility	   and	   time	   pressures	   rendered	   this	   avenue	   of	   investigation	  impractical.	  
Equation 1: 𝑂𝑇𝑅 = 𝐾!𝐴 𝐶∗ − 𝐶! 	  
	  
2.3.5 Maintenance	  of	  the	  target	  PSC	  phenotype	  on	  the	  Quantum	  Cell	  
Expansion	  system	  In	  both	  Runs,	  there	  was	  a	  net	  expansion	  of	  hESC	  and	  atrophy	  of	  nearly	  all	  MEFs	  by	  the	  time	  of	  harvest,	  as	  evidenced	  by	  high	  expression	  of	  the	  human	  specific	  marker	  TRA	  1-­‐85.	  Table	  
2.3	   displays	   a	   summary	  of	  marker	   expression	   in	   the	   seeded	  and	  harvested	   cells	   showing	  similarities	   in	   TRA	   1-­‐85	   between	   these	   populations.	   The	   harvested	   cells	   also	  maintained	  high	   levels	   of	  pluripotency	  marker	   expression,	  with	  96.2%	  and	  97.7%	  of	   cells	   expressing	  SSEA-­‐4	  in	  Runs	  1	  and	  2,	  respectively,	  compared	  to	  99.9%	  in	  flask	  controls	  (Table	  2.3).	  PCR	  analysis	  of	  pluripotency	  markers	  appear	  to	  show	  decreased	  Nanog	  expression	  in	  both	  runs;	  however,	   both	  Pou5f	   and	  Sox2	   normalised	   fold	   expression	  were	   comparable	   to	   the	   range	  seen	  in	  the	  triplicate	  flask	  controls	  of	  the	  same	  seeding	  density	  (Figure	  2.8).	  It	  is	  believed	  that	   this	   data	   demonstrates	   not	   only	   that	   the	   Quantum	   system	   can	   maintain	   cells	   in	   a	  pluripotent	   state	   but	   also	   that	   minimum	   optimisation	   of	   the	   protocol	   could	   maintain	   a	  healthier	   cell	   population,	   thus	   proving	   equivalence	   to	   traditional	   flask	   culture	   in	  maintaining	  the	  target	  phenotype.	  	  
2.3.6 Cell	  attachment	  and	  release	  from	  the	  hollowfibres	  All	  waste	  bags	  containing	  the	  perfused	  media	  from	  the	  runs	  had	  their	  contents	  spun	  down	  to	  check	  for	  cells/cell	  debris.	  However,	  no	  discernible	  cell	  pellet	  was	  produced,	  suggesting	  a	  high	   seeding	   efficiency	   and	   cell	   strong	   attachment	   to	   the	   fibres	   throughout	   the	   runs	   and	  wash	   stages	   at	   the	   flow	   rates	   used.	   	   Viability	   was	   slightly	   reduced	   in	   the	   runs,	   but	   still	  greater	  than	  93%	  (Table	  2.2).	  This	  is	  a	  likely	  result	  of	  the	  harsh	  conditions	  used	  to	  harvest	  the	  cells	  from	  the	  hollow	  fibres,	  0.25%	  Trypsin	  for	  45	  minutes	  on	  the	  reactor,	  compared	  to	  TrypLE	  enzyme	  for	  10	  minutes	  in	  the	  T25	  Flasks.	  The	  suboptimal	  media	  provision	  may	  also	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have	  impacted	  cell	  viability	  and	  their	  susceptibility	  to	  the	  harvest	  protocol	  used.	  Some	  cells	  did	   remain	   attached	   to	   the	   reactor	   after	   harvest,	   as	   evidenced	   by	   lactate	   dehydrogenase	  assay	  (Table	  2.2).	  The	  remaining	  cells	  could	  have	  been	  released	  using	  different	  dissociating	  agents	   such	  as	  higher	  percentage	   concentration	   trypsin,	   collagenase	  or	  accutase	  mixtures	  with	   a	   higher	   concentration	   of	   EDTA.	  Wash	   volumes	   and	   incubation	   times	   could	   also	   be	  optimised.	  Such	  optimisation	  has	  been	  done	  with	  success	  by	   the	  manufacture	  using	  other	  cell	   types	   on	   the	  machine	   such	   as	  mesenchymal	   stem	   cells	   (source:	   communication	  with	  manufacturer).	  
2.4 	  Conclusions	  
2.4.1 Areas	  for	  optimisation	  
The	   data	   presented	   in	   this	   chapter	   from	   this	   initial	   proof	   of	   concept	   study	   using	   the	  Quantum	   Cell	   Expansion	   System	   demonstrates	   that	   hESC	   cultures	   can	   be	   scaled	   up	  significantly	   through	  use	  of	  a	  hollow	   fibre	  bioreactor	  whilst	  maintaining	   their	  pluripotent	  phenotype	   and	   differentiation	   potential.	   Yet	   is	   clear	   that	   in	   order	   to	   maximise	   hESC	  expansion	  on	   the	  system	  to	  achieve	   the	  cell	  densities	  obtained	   in	   flasks,	  1.9E+5	  cells	  cm-­‐2	  (~4	   billion	   cells	   in	   the	   Quantum	   system),	   several	   aspects	   of	   the	   current	   protocol	   would	  need	  to	  be	  optimised	  and	  aspects	  of	  the	  machine	  developed.	  
Optimisation	  of	  media	  perfusion	  rates	   is	   likely	   to	  be	   the	  key	  to	  realising	   the	  potential	  cell	  yields.	  Although	   the	   Initial	   cell	  attachment	   to	   the	   fibres	  did	  not	  appear	   to	  be	   impacted	  by	  the	  resultant	  shear	  at	  the	  flow	  rates	  used;	  further	  work	  is	  required	  to	  determine	  what	  the	  optimum	  perfusion	  and	  circulation	  rates	  are	  to	  provide	  an	  environment	  for	  the	  cells	  which	  enables	  optimum	  growth.	  For	  instance	  from	  the	  results	  presented	  here	  it	  would	  be	  assumed	  higher	  flow	  rates	  would	  be	  needed	  to	  maintain	  an	  environment	  akin	  to	  flask	  culture;	  thus	  it	  would	  need	  to	  be	  determined	  whether	  there	  is	  a	  trade-­‐off	  due	  to	  shear	  or	  dilution	  effects	  at	  higher	   perfusion	   and	   circulation	   rates.	   For	   example,	   Titmarsh	   et	   al.	   (2011)	   investigated	  hESC	  growth	  in	  a	  perfusion	  microbioreactor	  and	  identified	  significant	  correlation	  between	  flow	  rate	  and	  growth.	  Optimisation	  of	  media	  use	  could	  also	  improve	  the	  process	  economics	  by	   concentrating	   larger	   (>15kDa)	   expensive	  media	   components	   on	   the	   loop	   surrounding	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the	  cells,	  such	  as	  bFGF,	  and	  not	  supplying	  media	  in	  unnecessary	  excess.	  Optimisation	  efforts	  could	   be	   made	   through	   further	   iterative	   experiments	   using	   the	   approach	   outlined	   here.	  Alternatively,	  a	  more	  effective	  approach	  would	  be	  to	  link	  the	  Quantum	  system	  to	  an	  online	  media	  monitoring	  and	  control	  system	  such	  as	  those	  offered	  by	  YSI	  Life	  Sciences	  (Ohio,	  USA)	  with	   minimal	   modifications.	   This	   would	   provide	   far	   better	   ‘real	   time’	   control	   over	   the	  system	   then	   the	   empirical	   operator-­‐driven	   method	   used	   here.	   For	   example	   Chen	   et	   al.	  (2010)	  concluded	  that	  reducing	  the	  concentration	  of	  glucose	  in	  the	  later	  stages	  of	  high	  cell	  density	  hESC	  cultures	  with	  online	  control	  of	  pH	  could	  reduce	  the	  high	  lactate	  levels	  and	  low	  pH	   which	   detrimentally	   impact	   cell	   growth	   and	   pluripotency.	   Other	   variables	   such	   as	  seeding	   densities	   would	   need	   to	   be	   optimised,	   as	   explored	   by	   Hewitt	   et	   al.	   (2011)	   who	  found	   the	   seeding	   density	   of	   mesenchymal	   stem	   cells	   onto	   microcarriers	   had	   a	   critical	  impact	  on	  expansion	  
2.4.2 Monitoring	  of	  more	  variables	  noninvasively	  In	  addition,	  given	   that	   it	   is	  not	  possible	   to	  sample	   the	  cells	  directly	  during	  culture,	   if	   long	  differentiation	  experiments	  were	  to	  be	  conducted	  on	  the	  machine	  it	  would	  be	  of	  interest	  to	  explore	   a	   wider	   number	   of	   components	   in	   the	   media	   sample	   to	   track	   the	   process.	   For	  instance,	   factors	  such	  as	  of	  α-­‐fetoprotein	  (AFP),	  β-­‐human	  chorionic	  gonadotropin	  (ß-­‐hCG)	  and	  activin	  A,	  were	   tracked	   in	   the	  paper	  by	  Stachelscheid	  et	   al.	   (2012)	  where	  hESC	  were	  differentiated	  in	  bioreactors.	  Additionally	  the	  work	  by	  Csaszar	  et	  al.	  (2013)	  sort	  to	  control	  the	   concentration	   of	   TGF-­‐β1	   in	   a	   bioreactor	   culture	   of	   umbilical	   cord	   cells	   though	   use	   of	  quantum	  dot	  microbeads	  and	  a	  fed	  batch	  system.	  
2.4.3 More	  information	  is	  needed	  on	  Quantum	  Cell	  Expansion	  System’s	  
fluid	  flow	  characteristics	  Regrettably,	   there	   is	   a	   remaining	   concern	   that	   the	   environment	  within	   the	  Quantum	  Cell	  Expansion	   System’s	   bioreactor	   is	   not	   homogenous	   and	   so	   creates	   microenvironments	  which	   could	   be	   impacting	   cell	   growth	   and	   phenotype.	   The	   manufacturer	   was	   unable	   to	  provide	  either	  experimental	  data	  or	  computational	   fluid	  dynamic	  data	  to	  validate	  that	  the	  gas	   and	  mass	   transfer	  was	  uniform	  between	   the	   two	   loops	   in	  both	   axial	   and	   longitudinal	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directions	   in	   the	  bioreactor	   to	  back	  up	   their	   claims	  of	  homogeneity.	  Conversely	  given	   the	  manufacturers	   protocols	   call	   on	   ~3	   full	   bioreactor	   volumes	   of	   wash	   to	   both	   loops	  when	  changing	   from	   one	   media	   to	   another	   the	   likelihood	   of	   the	   bioreactor	   being	   truly	  homogeneous	   is	   assumed	   to	   be	   low.	   Furthermore,	   as	   the	   gas	   and	   mass	   transfer	   of	   the	  system	   is	   reliant	  on	  unimpeded	   flow	  along	   the	   intracapillary	   side	  of	   the	   fibres	  where	   the	  cells	   attach	   and	   grow	   it	   would	   also	   be	   desirable	   to	   have	   more	   information	   on	   how	   cell	  expansion	   impedes	   this	   flow.	   For	   example,	   when	   harvested	   the	   cells	   often	   appear	   to	   be	  released	  as	  large	  ‘clumps’	  of	  cells	  and	  given	  the	  width	  of	  the	  hollowfibres	  is	  only	  200	  µm	  it	  could	  be	  very	  possible	  that	  fibres	  are	  ‘fouled’	  with	  cells	  as	  a	  function	  of	  cell	  growth.	  Efforts	  were	   made	   to	   stain	   fibres	   to	   identify	   whether	   cell	   growth	   was	   homogeneous	   across	   the	  bioreactor,	   yet	   due	   to	   autofluorescence	   of	   the	   fibres	   this	   was	   not	   possible.	   Although	  scanning	  electron	  microscopy	  had	  been	  shown	  by	  the	  manufacturer	  as	  a	  successful	  method	  to	  image	  cells	  due	  to	  practical	  and	  time	  limitations	  this	  approach	  was	  not	  attempted	  and	  it	  was	  believed	  it	  would	  not	  answer	  the	  question	  of	  whether	  flow	  was	  impeded.	  What	  would	  be	  of	  use	  is	  a	  way	  to	  measure	  the	  pressure	  drop	  across	  individual	  fibres	  or	  sections	  of	  the	  bioreactor	  online	  to	  determine	  if	  fouling	  was	  taking	  place,	  but	  requires	  significant	  re-­‐design	  of	   the	  machine.	  Pressure	  readings	  were	  available	   for	   the	  whole	  bioreactor	  unit;	  but	   these	  fluctuated	  widely	  and	  so	  were	  not	  of	  use	  for	  the	  purpose	  of	  determining	  cell	  build-­‐up	  on	  the	  fibres.	  
2.5 	  Summary	  
Based	   on	   this	   feasibility	   study	   using	   this	   novel	   large-­‐scale	   bioreactor	   to	   grow	   hESC	   two	  general	   issues	  of	  paramount	   importance	  can	  be	   identified	   for	  a	  successful	   transition	   from	  standard	  flask	  culture	  to	  successful	  scale-­‐up	  in	  bioreactors.	  
2.5.1 The	  need	  for	  small	  scale	  bioreactor	  mimics,	  and	  flexibility	  of	  
reactor	  sizes	  The	  number	  of	  experiments	  required	  to	  generate	  a	   truly	  optimised	  protocol	   is	  simply	  not	  feasible	  as	   the	  scale	  used	  here.	  The	  generation	  of	   the	  cell	  numbers	  needed	  to	  seed	  such	  a	  large-­‐scale	  reactor,	  and	  the	  media	  required	  to	  maintain	  their	  culture	  on	  the	  reactor	  would	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not	   be	   resource	   or	   time	   efficient.	   Small-­‐scale	  mimics	   and	  micro	   scale	  mimics	   are	  widely	  used	   in	   biopharmaceutical	   process	   development	   and	   design.	   They	   enable	   a	   number	   of	  experiments	   to	   be	   carried	   out	   in	   parallel	   producing	   results	  which	   can	   predict	   large	   scale	  performance.	   Ideally	   the	  mimic	  would	   exhibit	   the	   same	   shear	   and	   gas	   and	  mass	   transfer	  properties	  as	  the	  large	  scale,	  with	  the	  attachment	  surface	  having	  the	  same	  physicochemical	  properties.	   For	   example	   to	   take	   the	   work	   forward	   towards	   clinical	   trials	   manufacture	   it	  would	   be	   important	   to	   determine	   the	   seeding	   efficiency	   of	   the	   cells	   under	   a	   xeno	  free/feeder	   free	   alternatives	   for	   hESC	   culture	   such	   as	   CELLstart	   (Life	   Technologies).	  Furthermore,	   due	   to	   the	   correlation	   between	   seeding	   densities	   and	   cell	   proliferation	   a	  bioreactor	  technology	  needs	  to	  be	  available	  at	  a	  number	  of	  scales	  and	  so	  a	  ‘seed	  train’	  can	  be	  used	  to	  expand	  the	  cells	  up	  to	  the	  required	  production	  scale	  whilst	  making	  best	  use	  of	  the	  reduction	   in	  manual	  handling	  and	  additional	  process	  control	  bioreactors	  provide.	  The	  Quantum	   Expansion	   System	   being	   only	   available	   in	   one	   size	   is	   extremely	   limited	   in	   this	  respect.	  
2.5.2 The	  need	  for	  online	  monitoring	  and	  control	  Due	  to	  the	  aforementioned	  lack	  of	  the	  gas	  liquid	  interface	  in	  bioreactors	  that	  is	  present	  in	  flask	   culture,	   bioreactors	   require	   alternate	   methods	   of	   aeration	   necessitating	   mixing.	  Furthermore,	   in	   perfusion,	   or	   fed	   systems,	   mixing	   is	   also	   required	   to	   facilitate	   mass	  transfer.	  Thus	   it	   is	   critical	   that	   the	   important	  environmental	  processing	  variables	   such	  as	  pH,	  CO2	  and	  O2	  are	  both	  monitored	  and	  controlled	  to	  optimise	  expansion	  and	  maintenance	  of	  the	  target	  phenotype.	  The	  ability	  to	  link	  such	  online	  data	  to	  the	  phenotype	  required	  for	  the	  target	  product	  profile	  and,	  therby	  clinical	  outcome	  will	  be	  key	  in	  the	  validation	  of	  such	  processes.	  
Investigations	   exploring	   the	   importance	   of	   these	   issues,	   in	   particular	   the	   need	   for	   online	  control	  of	  the	  process	  environment,	  will	  be	  addressed	  in	  the	  next	  chapter	  using	  an	  alternate	  bioreactor	  design.	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3.	  Control	  of	  the	  pluripotent	  stem	  cell	  environment	  using	  the	  Xpansion	  One	  System	  	  
3.1 	  Introduction	  and	  aims	  
3.1.1 The	  Integrity	  Xpansion	  Multiplate	  bioreactor	  The	   Xpansion	   bioreactor	   system	   (Figure	   3.1	   a	   and	   b)	   is	   designed	   by	   ATMI	   to	   scale-­‐up	  adherent	   culture	   into	   large-­‐scale	   bioreactors	   with	   minimal	   process	   development.	   As	  illustrated	  in	  the	  previous	  chapter	  there	  are	  a	  large	  number	  of	  complex	  issues	  that	  need	  to	  be	   addressed	  when	  moving	   from	   a	  well-­‐understood	   protocol	   in	   flasks	   to	   a	   novel	   system	  such	  as	  hollowfibres	  or	  suspension	  culture.	  For	  example,	  if	  cells	  cannot	  be	  directly	  sampled	  or	   imaged	   (an	   important	   tool	   to	   visualise	   differentiation),	   different	   analytical	  methods	   to	  track	   cell	   growth	   and	   phenotype	   will	   be	   needed,	   such	   as	   tracking	   cell	   metabolites	   or	  cytokines	  in	  the	  media.	  Also	  a	  great	  concern	  of	  regulatory	  bodies	  is	  the	  ability	  to	  prove	  that	  cells	  grown	  in	  these	  3D,	  shear	  inducing,	  dynamic	  environments,	  are	  clinically	  equivalent	  to	  those	  produced	  in	  flask	  culture.	  There	  might	  be	  the	  requirement	  to	  repeat	  clinical	  work	  if	  the	   culture	   system	   is	   changed	   to	   accommodate	   larger	   scale,	   later	   stage,	   clinical	   trials.	  Thereby	   making	   the	   decision	   point	   of	   when	   to	   change	   production	   systems	   and	   the	  associated	  development	  time/costs	  required	  critical.	  It	  was	  this	  requirement	  to	  facilitate	  a	  move	   to	   large-­‐scale	   cell	   culture	  whilst	  making	   as	   little	   change	   as	   possible	   to	   the	   existing	  flask	  based	  paradigm	   that	   defined	  ATMI’s1	  development	   of	   the	   Integrity	  Xpansion	   system	  after	  requests	  by	  customers.	  
The	   approach	   of	   the	   Xpansion	   system	   to	   scale-­‐up	   cell	   culture	   involves	   increasing	   the	  volumetric	   productivity	   of	   2D	   adherent	   culture	   by	   removing	   the	   large	   dead	   spaces	   of	   air	  above	  the	  media	  and	  then	  stacking	  a	  large	  numbers	  of	  alternating	  liquid	  and	  plastic	  layers	  in	  a	  single	  unit	  see	  Figure	  3.2.	  This	  reduces	  the	  gaps	  between	  each	  plastic	  culture	  layer	  to	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 The work with the Xpansion system was conducted with Artelis, who were then bought by ATMI during the 
project who subsequently sold the technology to the Pall Corporation.   
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1.6mm,	   vastly	   increasing	   the	   volumetric	   productivity	   compared	   to	   other	   multilayer	  systems.	   For	   instance	   the	   potential	   volumetric	   productivity	   of	   a	   40	   layer	   CellSTACK	  (Corning)	  is	  0.56	  cm2	  available	  for	  adherent	  growth	  per	  cm3	  of	  vessel	  volume,	  whereas	  the	  Xpansion	   system	   increases	   volumetric	   productivity	   over	   10	   fold	   to	   5.59	   cm2/cm3	   by	  removing	   the	   stagnant	   gas	   layer.	   This	   approach	  makes	   it	   still	   possible	   to	   grow	   the	   cells	  using	   the	   same	   adherent	   based	   protocols	   developed	   in	   flasks	  whilst	   gaining	   productivity	  advantages	   of	   bioreactor	   culture.	   Furthermore,	   visualisation	   of	   the	   cells	   is	   achievable	  through	  use	  of	  a	  holographic	  microscope	  (also	  supplied	  by	  ATMI).	  But,	  the	  trade-­‐off	  in	  such	  a	   simplistic	   layered	   approach	   to	   minimise	   process	   development	   for	   scale	   up	   is	   that	   the	  theoretical	   volumetric	   productivity	   of	   the	   bioreactor	   is	   reduced	   when	   compared	   to	  suspension	   systems.	   For	   example	   using	   typical	   flask	   harvest	   densities	   as	   a	   guide	   the	  Xpansion	   system	   could	   only	   yield	   0.56m	   cells/cm3	  whereas	  Kehoe	   et	   al.	   (2010)	   reported	  yields	  of	  	  3.4m	  PSCs	  per	  ml	  for	  cells	  grown	  in	  suspension.	  
Without	  a	  gas	  layer	  above	  the	  media,	  the	  gas	  exchange	  to	  the	  media	  is	  driven	  via	  a	  system	  located	   within	   the	   central	   column	   of	   the	   reactor	   (Figure	   3.3	   a).	   Gas	   mix	   is	   circulated	  through	  a	  coil	  of	  gas	  permeable	  silicon	  tubing	  in	  this	  central	  column	  where	  it	  equilibrates	  with	   the	   media.	   When	   values	   of	   pH	   or	   O2	   drop	   below	   set	   points	   the	   mixing	   system	   is	  initiated	  which	  forces	  liquid	  through	  the	  gaps	  between	  each	  layer	  of	  plates	  (Figure	  3.3	  b)	  to	  circulate	  around	  the	  reactor.	  The	  aim	  of	  this	  discontinuous	  system	  is	  to	  cause	  a	  minimal	  amount	  of	  shear	  stress	  to	  the	  cells.	  	  
The	   sizing	   of	   each	   of	   the	   Xpansion	   plates	   is	   equivalent	   to	   a	   single	   layer	   in	   a	   CellSTACK	  (Corning);	  so	  the	  Xpansion	  MPB-­‐10	  which	  contains	  10-­‐layers	  has	  approximately	  the	  same	  growth	   surface	   area	   as	   a	   10	   layer	   CellSTACK.	   The	   various	   scales	   the	   Xpansion	   system	   is	  currently	  available	   in	  are	  outlined	   in	   Table	   3.1.	  The	   reactors	  are	  designed	   to	   sit	   inside	  a	  temperature-­‐controlled	  incubator.	  	  
3.1.2 Description	  of	  Xpansion	  One	  	  As	   discussed	   in	   the	   previous	   chapter	   experimentation	   at	   large-­‐scale	   to	   develop	   an	  optimised	   protocol	   is	   prohibitively	   expensive	   and	   wastes	   resources,	   thus	   ATMI	   have	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designed	  a	   small-­‐scale	  mimic	  of	   their	   system	  named	   the	  Xpansion	  One	   (Figure	   3.4).	   The	  Xpansion	  One	  has	  a	  growth	  area	  of	  128cm2	  and	  mimics	  the	  fluid	  dynamics	  and	  gas	  exchange	  control	   system	   exhibited	   on	   the	   far	   larger	   0.6m2,	   3.m2	   and	   11.m2	   Integrity	   Xpansion	  bioreactors.	  The	  resin	  sealed	  polystyrene	  Xpansion	  plate	  (XP)	   includes	  optical	  sensors	   for	  pH	   and	   DO	   measurements	   and	   sits	   on	   a	   docking	   station	   (Figure	   3.4	   a).	   Gas	   transfer	   is	  driven	   by	   a	   pump	   that	   circulates	   the	   media	   through	   a	   gas	   permeable	   silicon	   tube	   to	  equilibrate	  with	   the	   gasses	   in	   the	   incubator	   (Figure	   3.4b)	   –	   in	   essence	   this	   is	   the	   same	  method	  employed	  at	  the	  large	  scale,	  the	  difference	  being	  there	  that	  the	  media	  is	  circulated	  around	  the	  outside	  of	  the	  tubing.	  Thus,	  the	  Xpansion	  one	  exhibits	  the	  same	  physicochemical	  properties	  as	  the	  large	  scale	  system	  as	  well	  as	  the	  same	  linear	  velocities	  and	  discontinuous	  mixing	  system	  to	  control	  environmental	  variables.	  The	  drawback	  of	  the	  simplified	  method	  employed	  in	  this	  small-­‐scale	  mimic	  is	  that	  the	  gas	  mix	  cannot	  be	  altered/controlled	  as	  it	  is	  set	  to	  the	  set-­‐points	  of	  the	  incubator	  in	  which	  the	  unit	  is	  situated,	  typically	  5%	  CO2,	  18.5%	  O2.	  
3.1.3 Description	  of	  Xpansion	  One	  regulatory	  mechanism	  An	  example	  plot	  illustrating	  how	  the	  pump	  action	  is	  used	  to	  control	  pH	  in	  the	  Xpansion	  One	  system	   is	   outlined	   in	   Figure	   3.5.	   In	   brief,	   as	   cells	   respire	   and	   grow	   the	   CO2	   produced	  reduces	   the	  pH	  below	   the	   chosen	   set-­‐point	   pH.	  When	   the	   recorded	   value	   falls	  more	   than	  0.05	  pH	  units	  below	  the	  set-­‐point	  (the	  alarm	  setting)	  this	  change	  is	  picked	  up	  by	  the	  optical	  sensor	   measurement	   system	   which	   initiates	   the	   pump	   system.	   The	   pump	   causes	   the	  circulation	  of	  media	  through	  the	  plate	  and	  around	  a	  section	  of	  gas	  permeable	  silicon	  tubing,	  allowing	  the	  gas	  in	  the	  liquid	  phase	  to	  equilibrate	  with	  that	  of	  the	  incubator	  and	  so	  raises	  the	  pH.	  Once	  the	  pH	  reaches	  a	  value	  of	  set-­‐point	  -­‐0.03	  (Hyst)	  the	  pump	  action	  stops.	  
3.1.4 Aims	  As	   with	   the	   Quantum	   Cell	   Expansion	   system	   the	   Xpansion	   systems	   were	   not	   developed	  using	   PSCs.	   For	   example,	   much	   of	   the	   development	   work	   used	   mesenchymal	   stem	   cells.	  Unlike	  many	  other	   cell	   types,	   PSCs	   require	   daily	  media	   changes	   and	  when	   these	   cultures	  become	  confluent	  they	  have	  a	  significant	  impact	  on	  the	  pH	  of	  the	  media	  causing	  phenol	  red	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indicators	   to	   turn	   yellow.	   Thus,	   PSCs	   have	   would	   appear	   to	   put	   higher	   mass	   and	   gas	  transfer	  requirements	  on	  a	  bioreactor	  system	  than	  other	  cell	  types.	  
The	  aim	  of	  this	  chapter	  was	  to	  explore	  both	  the	  feasibility	  of	  growing	  hESC	  on	  the	  Xpansion	  One	   system	   to	   access	   the	   possibility	   of	   using	   the	   large	   scale	   machines	   for	  clinical/commercial	   production.	   Of	   particular	   interest	   was	   to	   build	   on	   the	   experience	  generated	   in	   the	   previous	   chapter	   using	   the	   Quantum	   Cell	   Expansion	   System	   to	   explore	  how	  the	  online	  control	  of	  environmental	  conditions,	  such	  as	  pH	  available	  on	  the	  Xpansion	  system	  impacts	  cell	  growth	  and	  the	  target	  phenotype.	  The	  specific	  objectives	  were:	  
• Determine	  if	  the	  Xpansion	  One	  system	  is	  compatible	  with	  hESC	  culture,	  e.g.	  will	  the	  cells	  attach	  to	  the	  plastic	  used	  and	  not	  be	  washed	  out	  by	  the	  flow	  regime?	  
• Maximise	   cell	   growth	  with	   respect	   to	   flask	   culture	  whilst	  maintaining	   the	   target	  PSC	  phenotype.	  	  	  
It	   was	   not	   the	   goal	   to	   generate	   a	   detailed	   understanding	   of	   the	   impact	   of	   experimental	  variables	   e.g.	   explore	   a	   multitude	   of	   pH	   setpoints,	   seeding	   densities,	   and	   flowrates	   in	  combination	  due	  to	  the	  limited	  number	  of	  bioreactor	  plates	  available.	  Rather,	  the	  goal	  was	  to	  perform	  select	  experiments	  altering	  these	  variables	  to	  try	  and	  generate	  a	  semi-­‐optimised	  working	  protocol	  for	  future	  optimisation.	  
3.2 	  Materials	  and	  methods	  
3.2.1 Cell	  culture	  in	  T25	  Flasks	  
The	  Shef	  3	  hESC	   line	  was	  passaged	  using	   the	  TrypLE	  Express	  enzyme	  (Life	  Technologies)	  and	   co-­‐cultured	   on	   mitomycin	   c	   inactivated	   mouse	   embryonic	   fibroblasts	   (MEFs).	   MEFs	  were	   originally	   grown	   in	   Dulbecco’s	   Modified	   Eagle	   Medium	   (DMEM,	   Life	   Technologies)	  with	   10%	   v/v	   heat	   inactivated	   fetal	   bovine	   serum	   (FBS,	   Sera	   Laboratories	   International)	  and	   1%	   v/v	   100X	  MEM	  non-­‐essential	   amino	   acids	   (NEAA,	   Life	   Technologies).	   hESC	  were	  grown	  in	  Knockout	  DMEM,	  (Life	  Technologies)(+	  4.5	  g	  D-­‐glucose	  /L,	  +	  sodium	  pyruvate,	  –	  L-­‐glutamine),	   20%	   Knockout	   Serum	   Replacement	   (Life	   Technologies),	   GlutaMAX,	   (Life	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Technologies),	   0.1	   mM	   beta-­‐mercaptoethanol,	   human	   basic	   fibroblast	   growth	   factor,	   4	  ng/ml	   (bFGF,	   R&D	   systems),	   and	   1%	  100X	  MEMNEAA	   (Life	   Technologies).	   	  Medium	  was	  exchanged	   daily	   at	   a	   ratio	   of	   0.2	  ml	   cm-­‐2.	   All	   cell	   counting	   and	   cell	   viability	   analysis	  was	  performed	   on	   the	   Vi-­‐Cell	   (Beckman	   Coulter),	   using	   the	   trypan	   blue	   exclusion	   viability	  assessment.	  
3.2.2 Reverse	  transcriptase-­‐polymerase	  chain	  reaction	  (PCR)	  
Following	  manufacturers	  guidelines	  RNA	  was	  extracted	  using	  the	  RNeasy	  mini-­‐kit	  (Qiagen),	  and	   first-­‐strand	   synthesised	   using	   the	   RetroscriptKit	   (Ambion).	   Bio-­‐Taq	   polymerase	  (Bioline)	  was	  used	  for	  the	  PCR	  reaction	  in	  a	  Verity	  cycler	  (Applied	  Bio-­‐systems).	  	  
Following	   first-­‐strand	   synthesis	   with	   the	  method	   described	   above,	   quantitative	   PCR	  was	  carried	  out	  using	  the	  MESA	  BLUE	  qPCRMasterMix	  Plus	  for	  SYBR	  Assay	  (Eurogentec)	  in	  the	  CFX	  Connect	  Real-­‐Time	  System	  (Bio-­‐Rad).	  20	  µL	  reactions	  were	  run	  in	  triplicate	  using	  the	  following	   primers	   from	   Qiagen:	   b-­‐ACTIN,	   UBC,	   POU5F,	   NANOG,	   EPAS1,	   HIF1	   alpha	   and	  VEGF	   alpha.	   Analysis	   of	   relative	   quantification	   used	   b-­‐ACTIN	   and	   UBC	   to	   normalise	  expression,	   and	   primer	   efficiencies	   were	   calculated	   using	   a	   cDNA	   dilution	   curve	   and	  analysed	  using	  Bio-­‐Rad	  software.	  
3.2.3 Flow	  cytometry	  
The	   following	   antibodies	   were	   used:	   mouse	   anti-­‐SSEA-­‐4	   PE	   conjugate	   (Millipore)	   and	  mouse	   IgM	   anti-­‐TRA	  1-­‐60	   (kind	   gift	   from	  Prof.	   Peter	  Andrews,	   Sheffield	  University)	  with	  Alexa	   fluor	  488	  goat	   anti-­‐mouse	   (Life	  Technologies).	  A	  1%	  cut-­‐off	   gate	  was	   implemented	  based	   on	   conjugated	   isotype	   controls.	   All	   samples	  were	   analysed	   using	   Beckman	   Coulter	  Epics	  XL	  MCL	  flow	  cytometer,	  and	  Summit	  software.	  
3.2.4 Matching	  Xpansion	  One	  culture	  to	  flask	  culture	  As	   far	   as	   was	   feasible	   the	   culture	   of	   hESC	   on	   the	   Xpansion	   Plates	   was	   matched	   to	   flask	  culture	  so	  as	  to	  be	  able	  to	  make	  direct	  comparisons	  between	  the	  two	  systems.	  For	  instance,	  instead	  of	  operating	  the	  plate	  in	  perfusion	  mode	  it	  was	  decided	  to	  replace	  the	  entire	  media	  volume	  daily	  in	  a	  single	  change,	  as	  is	  the	  case	  with	  flask	  culture.	  Furthermore	  the	  volumes	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of	  media	  and	  reagents	  such	  as	  TrypLE	  Express	  (Invitrogen)	  for	  cell	  detachment	  were	  used	  at	   the	   same	  ml/cm2	   ratio	   in	  both	   systems,	  and	  other	   culture	  variables	   such	  as	   incubation	  times	  were	  also	  kept	  the	  same.	  Online	  measurements	  of	  pH	  and	  O2	  were	  taken	  every	  30	  s	  from	  optical	  patches	  attached	   to	   the	  plate	   (Figure	   3.6	   a).	  The	  Polestar	  unit	  only	  displays	  the	  most	   recent	   reading	  with	   historic	   readings	   saved	   to	   a	   USB	   stick	   (Figure	   3.6	   b).	   The	  system	   was	   calibrated	   following	   manufacturers	   instructions	   and	   recommendations	   via	   a	  one-­‐point	   calibration	   based	   on	   an	   offline	   pH	   reading	   (Mettler	   Toledo	   Seven	   Easy)	   taken	  from	  excess	  seeded	  cell	  suspension	  run	  through	  the	  plate.	  Flask	  controls	  were	  also	  run	   in	  triplicates	  in	  the	  same	  incubator	  as	  the	  Xpansion	  plates	  (XP)	  for	  comparison.	  An	  outline	  of	  the	  experimental	  protocol	  can	  be	  seen	  in	  Table	  3.2.	  
3.3 	  Results	  and	  Discussion	  
3.3.1 pH	  Monitoring	  Following	   the	   manufacturer’s	   guidance	   a	   one-­‐point	   calibration	   was	   performed	   on	   the	  system	   on	   day	   0	   using	   run-­‐through	   media	   from	   the	   seeding	   stage.	   Based	   on	   the	  manufacturer’s	  experience	  this	  one-­‐point	  calibration	  gives	  accurate	  pH	  readings	  when	  the	  experimental	  pH	  remains	  near	  this	  calibration	  point.	  However,	  due	  to	  the	  large	  falls	  in	  pH	  seen	  in	  hESC	  cultures	  as	  the	  experiments	  progressed	  over	  time	  there	  was	  a	  larger	  disparity	  between	  the	  readings	  given	  via	  the	  online	  patches	  to	  those	  recorded	  offline	  on	  spent	  media	  using	   the	   bench	   top	   pH	   probe.	   Therefore,	   both	   offline	   and	   online	   pH	   readings	   were	  recorded	  for	  all	  experiments	  to	  allow	  the	  Xpansion	  plates	  (XP)	  to	  be	  directly	  compared	  to	  the	   flasks	  using	  offline	  measurements	  and	  using	   the	  online	  measurements	   to	  compare	  XP	  run	  with	  XP	  run.	  	  
3.3.2 Limited	  resources	  of	  the	  feasibility	  study	  The	  prototype	  equipment	  used	   in	   this	   chapter	  was	  made	  available	  under	  agreement	  with	  ATMI	  to	  determine	  the	  feasibility	  of	  their	  using	  bioreactor	  platform	  to	  grow	  PSC.	  Therefore,	  the	   utilisation	   of	   the	   prototype	   bioreactor	   Xpansion	   Plates	   (XPs)	  was	   at	   a	   premium,	   this	  limited	  the	  number	  of	  experiments	  possible.	  However,	  the	  overriding	  aim	  of	  this	  study	  was	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to	  maximise	  cell	  growth	  to	  get	  as	  close	  to	  the	  flask	  controls	  as	  possible,	  whilst	  maintaining	  the	  target	  PSC	  phenotype,	  as	  opposed	  to	  generating	  a	  detailed	  understanding	  of	  the	  impact	  of	  experimental	  variables	  such	  as	  shear.	  	  
When	   scoping	   the	   study	   it	   was	   the	   intention	   to	   eventually	   move	   the	   work	   from	   the	  Xpansion	   One	   on	   to	   the	   larger	   scale	   Integrity	   Xpansion	   bioreactor.	   With	   this	   large-­‐scale	  experimentation	   in	  mind	   the	   same	   karyotypically	   abnormal	   hESC	   line	   from	   the	   previous	  chapter	   was	   used	   under	   the	   same	   rationale	   i.e.	   it	   being	   best	   suited	   to	   large-­‐scale	  experimentation.	  But,	   due	   to	   time	   constraints	   a	  move	   to	   large	   scale	   experimentation	  was	  not	  made.	  	  
3.3.3. Impacts	  of	  a	  constant	  flow	  regime	  (experiment	  XP1)	  In	   order	   to	   determine	   whether	   increasing	   flow	   rate	   detrimentally	   impacted	   growth,	   3	  Xpansion	  Plates	  (XP)	  were	  run	  in	  parallel	  over	  a	  range	  of	  constant	  flow	  rates,	  i.e.	  as	  opposed	  to	  the	  discontinuous	  flow	  regime	  applied	  during	  regulation	  mode.	  	  The	  following	  flow	  rates	  were	  used	  0.2	  mm/s	  (XP1.1),	  1.0mm/s	  (XP1.2)	  and	  5mm/s	  (XP1.3),	  representing	  a	  25	  fold	  change	  in	  linear	  velocities.	  In	  this	  experiment	  a	  low	  seeding	  density	  of	  4500	  cells/cm2	  was	  used	   in	   an	   attempt	   to	   ensure	   that	   oxygen	   uptake	   rate	   (OUR)	   of	   the	   cells	   would	   not	   be	  greater	  than	  the	  gas	  transfer	  rate	  (GTR)	  or	  the	  reactor	  (see	  previous	  Chapter	  2,	  Equation	  1	  for	  definitions).	  By	  ensuring	  that	  the	  GTR	  is	  not	  limiting	  at	  any	  of	  the	  flow	  rates	  used	  it	  was	  predicted	  that	   the	   liquid	  phase	  should	  be	   fully	  equilibrated	  with	  the	   incubator	  gasses	  and	  thus	  maintain	  a	  pH	  of	  ~7.32	  throughout	  all	  flasks	  and	  plates	  allowing	  the	  impact	  of	  the	  flow	  rate	  to	  be	  separated	  from	  the	  other	  variables.	  The	  pH	  value	  of	  7.32	  is	  the	  pH	  of	  hESC	  media	  when	   left	   to	   equilibrate	   in	   the	   5%	   CO2,	   18.5%	   O2	   and	   37˚C	   environment	   of	   our	   lab’s	  incubators.	  
From	  Figure	  3.7	  a)	  it	  can	  be	  seen	  that	  the	  online	  pH	  across	  all	  3	  flow	  rates	  was	  maintained	  at	  ~7.32	  as	  expected.	  There	  is	  a	  slight	  discrepancy	  in	  pH	  readings	  between	  the	  XPs	  from	  D0	  to	  D2,	  which	  was	  due	  to	  poorly	  calibrated	  pH	  sensors.	  This	  was	  remedied	  by	  recalibration	  using	   spent	  media,	   when	   the	  media	   was	   exchanged	   on	   D2,	   after	   which	   there	  was	   closer	  agreement	  between	  the	  online	  pH	  readings.	  In	  addition	  the	  pH	  level	  maintained	  in	  the	  XPs	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closely	  matched	  that	  seen	  in	  flasks	  based	  on	  spent	  media	  analysis	  (Figure	  3.7	  b).	  Even	  so,	  despite	  the	  pH	  levels	  being	  very	  similar	  between	  the	  XPs	  and	  the	  flasks	  it	  can	  be	  seen	  that	  a	  far	  lower	  cell	  density	  was	  achieved	  on	  the	  XPs	  than	  on	  the	  flasks	  at	  harvest	  (Figure	  3.8	  a),	  with	   the	   cell	   growth	   on	   the	   plates	   being	   between	   42%	   and	   33%	   of	   that	   seen	   in	   flasks	  (Figure	   3.8	   b).	   The	  media	   analysis	   data	   (Figure	   3.8	   c)	   shows	   that	   the	   flask	   culture	   has	  slightly	  lower	  glucose	  levels	  and	  slightly	  higher	  lactate	  levels	  at	  harvest	  when	  compared	  to	  the	  XPs	  which	  correlates	  with	  the	  higher	  cell	  densities	  achieved.	  Increasing	  flowrate	  across	  a	  25	  fold	  range	  (0.2mm/s	  to	  5mm/s)	  did	  not	  appear	  to	  impact	  cell	  growth,	  given	  there	  was	  a	  larger	  standard	  deviation	  across	  the	  3	  control	  flasks	  (technical	  repeats)	  than	  between	  the	  3	  Xpansion	  plates	  running	  at	  different	  speeds	  (Figure	  3.8	  a).	  
However	  the	  highest	  flowrate	  of	  5.0mm/s	  (XP1.3)	  did	  correspond	  with	  a	  large	  reduction	  in	  viability	   (Figure	   3.8	   d).	   There	   were	   also	   clear	   visible	   differences	   seen	   on	   this	   plate	   as	  illustrated	   in	   Figure	   3.9.	   The	   area	   denoted	   by	   A)	   shows	   a	   large	   amount	   of	   precipitated	  protein	  accumulating	  in	  the	  centre	  of	  the	  plate	  and	  the	  area	  denoted	  by	  B)	  shows	  a	  steady	  stream	  of	  bubbles	  focusing	  on	  the	  edge	  of	  the	  flow	  distributor	  element.	  So,	   it	  was	  decided	  not	  to	  run	  the	  XP	  at	  this	  highest	  flowrate	  again	  in	  future	  experiments.	  
Unfortunately,	   online	   DO	   readings	   from	   this	   experiment	   were	   inconclusive	   due	   to	   the	  practical	   limitations	   of	   needing	   to	   run	   3	   plates	   simultaneously	   but	   with	   only	   4	   channels	  available	  on	  the	  Polestar	  equipment	  for	  optical	  readings.	  	  Therefore,	  3	  of	  the	  channels	  were	  used	  for	  constant	  online	  pH	  monitoring	  with	  the	  final	  fibre	  optic	  channel	  being	  devoted	  to	  DO.	  This	  meant	  that	  instead	  of	  a	  constant	  DO	  reading	  the	  probe	  had	  to	  be	  manually	  moved	  between	   all	   3	   plates	   to	   take	   readings	   at	   different	   time-­‐points.	   The	   consequence	   of	   this	  manual	  moving	  of	  the	  probe	  between	  plates	  was	  erratic	  and	  inconclusive	  DO	  data.	  This	  was	  believed	  to	  be	  due	  to	  calibration	  errors	  as	  it	  was	  not	  possible	  to	  calibrate	  each	  optical	  patch	  independently.	   Subsequent	   experiments	   did	   not	   involve	   running	   more	   than	   two	   XPs	   in	  parallel	  to	  enable	  both	  pH	  and	  DO	  to	  be	  recorded	  continuously	  online.	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3.3.4 Regulation	  through	  discontinuous	  mixing	  (experiment	  XP2)	  From	  the	  constant	   flow	  experiments	  (XP1.1,	  XP1.2,	  XP1.3)	   it	  was	  seen	  even	  when	  pH	  was	  maintained	   to	   the	   same	   level	   in	   flasks	   that	   cell	   densities	   achieved	   on	   the	   XP	  were	   lower	  than	  in	  flasks	  (Figure	  3.8	  b).	  It	  was	  first	  hypothesised	  that	  this	  could	  be	  due	  to	  one	  of	  two	  causes:	   either	   the	   differing	   chemistry	   of	   the	   plastic	   between	   the	   XPs	   and	   the	   flasks	   was	  adversely	   effecting	   growth;	   or	   that	   that	   any	   flow	   rate	   on	   the	   XPs	   no	   matter	   how	   low	  negatively	  impacted	  growth.	  	  
The	  first	  hypothesis	  was	  tested	  by	  comparing	  growth	   in	  Nunc	  branded	  T25	  plastic	  versus	  Corning	  branded	  T25	  plastic.	  The	  latter	  being	  plasma	  treated,	  as	  opposed	  to	  electric	  current	  treated,	  and	  so	  according	  to	  the	  XP	  manufacturer	  (ATMI)	  the	  Corning	  plastic	  flasks	  should	  have	  the	  same	  characteristics	  as	  the	  Xpansion	  plates.	  Under	  this	  direct	  growth	  comparison	  there	  was	  no	  significant	  difference	  in	  growth	  (data	  not	  shown)	  and	  so	  the	  reduced	  growth	  observed	  on	  the	  XPs	  was	  not	  believed	  to	  be	  down	  to	  incompatible	  surface	  chemistry.	  	  
To	  test	  the	  second	  hypothesis	  i.e.	  that	  is	  was	  the	  very	  effect	  of	  having	  any	  flow	  at	  all	  which	  reduces	  cell	  growth,	  it	  was	  decided	  to	  change	  operation	  from	  one	  of	  constant	  flow	  to	  one	  of	  regulation	  using	  discontinuous	  mixing.	   In	   this	  regime	  flow	  is	  only	   initiated	  to	  regulate	  pH	  when	  it	  is	  away	  from	  the	  target	  set	  point	  described	  in	  Figure	  3.5.	  A	  pH	  set	  point	  of	  7.32	  was	  chosen	  as	  this	  matches	  the	  pH	  of	  hESC	  media	  that	  has	  been	  allowed	  to	  equilibrate	  in	  a	  5%	  CO2	  incubator	  environment	  overnight.	  A	  linear	  flow	  rate	  of	  2.9mm/s	  was	  chosen	  based	  on	  outcomes	   from	   the	   constant	   flow	  experiment	   and	   advice	   from	   the	  manufacturer	   on	  what	  had	  been	  used	  successfully	  with	  other	  cell	  types.	  The	  seeding	  density	  was	  also	  increased	  to	  13,000	  cells/cm2	  in	  this	  experiment	  to	  increase	  the	  number	  of	  cells	  available	  at	  harvest	  for	  analysis.	  The	  regulation	  loop	  which	  includes	  the	  gas	  permeable	  silicon	  tube	  was	  added	  on	  D2	  to	  allow	  the	  hESC	  to	  attach	  for	  a	  full	  24h	  before	  flow	  was	  initiated.	  
From	  Figure	  3.10	  a)	   it	  can	  be	  seen	  that	  the	  system	  operated	  under	  regulation	  during	  the	  D3-­‐D4	   period,	   as	   evidenced	   by	   the	   fluctuations	   in	   DO	   and	   pH	   during	   this	   period.	   An	  enlarged	  plot	  of	  this	  time	  period	  with	  a	  caption	  explaining	  the	  pump	  operation	  is	  shown	  in	  
Figure	  3.10	  b).	  The	  regulation	  system	  managed	  to	  maintain	  pH	  at	  or	  around	  the	  setpoint	  of	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7.32	  until	   the	   latter	   stages	  of	  D4,	  with	  a	   final	  online	  pH	  before	  harvest	  of	  7.24.	  When	   the	  offline	  readings	  of	  pH	  of	   the	  control	   flask	  culture	  (7.08)	  and	  the	  XP2	  (7.16)	  are	  compared	  directly	  (Figure	  3.11)	  it	  can	  be	  seen	  that	  although	  the	  XP	  regulation	  system	  failed	  to	  keep	  the	  system	  at	  the	  desired	  setpoint	  of	  7.32,	  the	  harvest	  pH	  was	  still	  higher	  than	  that	  seen	  in	  the	   control	   flasks.	   The	   differences	   between	   the	   online	   DO	   patch	   readings	   and	   the	   offline	  spent	  media	  analysis	  was	  a	  result	  of	  only	  using	  a	  1-­‐point	  calibration	  method	  (as	  opposed	  to	  2	  or	  3	  points).	  As	  described	  earlier	  this	  required	  the	  logging	  of	  both	  online	  and	  spent	  media	  pH	  for	  all	  experiments	  and	  as	  such	  both	  readings	  are	  plotted	  in	  spate	  charts	  in	  the	  Figures	  to	  allow	  direct	  comparisons	  to	  be	  made	  between	  the	  XPs	  and	  the	  control	  plates.	  
Again,	   it	   can	  be	  seen	   that	  despite	   the	  similarities	   in	  pH	   levels	   the	  cell	  density	  achieved	   in	  flasks	  was	  still	  considerably	  higher	  than	  that	  achieved	  on	  the	  XPs	  (Figure	  3.12	  a).	  However,	  the	   introduction	   of	   the	   discontinuous	  mixing	   regime	   to	   control	   the	   pH	   has	   improved	   the	  respective	  performance	  of	  the	  XP,	  with	  the	  XP2	  regulation	  experiment	  achieving	  52.50%	  of	  the	  flask	  cell	  density	  (Figure	  3.12	  b)	  compared	  to	  the	  best	  result	  of	  42.16%	  achieved	  in	  the	  XP1	  constant	  flow	  experiment	  Figure	  3.8	  b).	  As	  before,	  the	  higher	  cell	  density	  achieved	  in	  the	  flasks	  resulted	  in	  lower	  levels	  of	  glucose	  and	  higher	  levels	  of	  lactate	  in	  the	  flasks	  when	  compared	   to	   the	   XP	   (Figure	   3.12	   c).	   In	   addition	   the	   viability	   at	   this	   flowrate	   (2.9mm/s)	  remained	  high	  at	  97.0%	  (Figure	  3.12	  d).	  
3.3.5 Initiating	  regulation	  earlier	  (experiment	  XP3)	  With	  regulation	  producing	  better	  results	   than	  constant	   flow	  it	  was	  decided	  to	  explore	   the	  impact	  of	  adding	   the	  regulation	   loop	  earlier	   than	  the	  24h	  time	  point	  used	   in	   the	  previous	  experiment	   (experiment	   XP2).	   Therefore,	   2	   plates	   were	   run	   in	   parallel	   one	   with	   no	  regulation	  (XP3.1)	  and	  one	  in	  which	  regulation	  would	  be	  started	  at	  6h	  post	  seeding	  of	  PSC	  XP3.2,	   with	   both	   flasks	   being	   harvested	   at	   24h	   post	   seeding.	   Furthermore,	   the	   seeding	  density	  was	   increased	   to	  20,000	  cells	   to	   try	  and	  ensure	   that	   cell	  metabolism	  would	  bring	  the	  pH	  down	  to	  the	  setpoint	  within	  this	  24	  hour	  time	  period	  to	  trigger	  the	  regulation	  and	  so	  flow/mixing.	  This	  higher	  seeding	  density	  also	  matches	  that	  used	  when	  using	  karyotypically	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normal	   cell	   lines	   in	   our	   lab.	   The	   linear	   flowrate	  was	   also	   reduced	   to	   1	  mm/s	   to	   try	   and	  reduce	  the	  likelihood	  of	  the	  recently	  attached	  cells	  being	  lifted.	  
From	  Figure	  3.13	  a)	  it	  can	  be	  seen	  that	  the	  regulated	  plate	  (XP3.2)	  maintained	  a	  higher	  pH	  at	  harvest	  of	  7.28,	  and	  so	  closer	  to	  the	  setpoint	  of	  7.32,	  compared	  to	  the	  non-­‐regulated	  plate	  (XP3.1)	  which	  had	   a	   harvest	   pH	  of	   7.09.	  When	   compared	   to	   the	   offline	   pH	  of	   the	   control	  flask	  culture	  (Figure	  3.13	  b)	  it	  can	  be	  seen	  that	  the	  regulated	  plate	  (XP3.2)	  maintained	  a	  pH	  far	  closer	  to	  the	  pH	  of	  the	  flask	  controls	  than	  the	  unregulated	  plate	  (XP3.1)	  did.	  In	  addition,	  from	  microscope	  analysis	  during	  the	  run	  the	  flowrates	  did	  not	  appear	  to	  cause	  the	  cells	  to	  lift	  (data	  not	  shown).	  	  
From	  Figure	  3.14	  a)	  it	  can	  be	  seen	  that	  the	  plate	  undergoing	  regulation	  (XP3.2)	  yielded	  a	  higher	  density	  (82%	  relative	  to	  the	  control)	  than	  that	  under	  no	  regulation	  (XP3.1,	  72.74%	  relative	  to	  the	  control).	  The	  viability	  of	  the	  regulated	  plate	  was	  also	  higher	  (Figure	  3.14	  b),	  thus	   for	  all	   future	  optimisation	  experiments	   the	  regulation	  was	   initiated	  6	  h	  post	   seeding	  and	  a	  seeding	  density	  of	  20,000	  cells/cm2	  was	  used.	  
3.3.6 Increasing	  the	  expansion	  time	  (experiment	  XP4)	  Given	  the	  improvements	  in	  cell	  density	  achieved	  by	  implementing	  regulation	  and	  applying	  it	   early	   it	  was	  decided	   to	   extend	   the	   culture	  period	  by	  a	  day	   to	  determine	  whether	   there	  was	  a	  lag	  effect	  on	  the	  growth	  on	  the	  Xpansion	  plates	  which	  could	  be	  overcome.	  So,	  again	  two	   plates	   were	   run	   in	   parallel,	   both	   against	   separate	   triplicate	   controls:	   PSC	   were	  expanded	  for	  3	  days	  (experiment	  day	  D4)	  on	  XP4.1;	  and	  expanded	  for	  4	  days	  (experiment	  day	  D5)	  on	  XP4.2.	  
From	  Figure	  3.15	  a)	  it	  can	  be	  observed	  that	  both	  plates	  struggled	  to	  maintain	  the	  pH	  at	  the	  desired	  set	  point	  of	  7.32	  during	  the	  interval	  between	  the	  media	  changes	  on	  D3	  and	  D4.	  This	  is	  despite	  the	  CO2	  in	  the	  incubator	  being	  reduced	  from	  5%	  to	  1%	  during	  this	  period	  in	  an	  effort	  to	  raise	  the	  pH	  (see	  Figure	  3.15	  b)	  caption	  for	  timings).	  At	  harvest	  XP4.1	  on	  which	  hESC	  were	  cultured	  for	  3	  days	  (4	  day	  total	  protocol	  length)	  the	  online	  pH	  was	  7.10	  (Figure	  
3.15	  a)	  and	  offline	  pH	  6.89,	  which	  was	  close	  to	  that	  of	  the	  offline	  pH	  for	  the	  control	  flasks	  of	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6.96	  (Figure	  3.16	  a).	  Critically	  during	  the	  final	  24	  hour	  period	  from	  D4	  to	  D5	  (XP4.2)	  the	  system	  only	  matches	   the	  set	  point	   for	  a	   fleeting	  period	  of	   time.	  Thus	  when	  harvested	   the	  online	  reading	  for	  XP4.2	  was	  6.54	  (Figure	  3.15	  a)	  and	  the	  offline	  reading	  was	  6.27;	  these	  are	   both	   considerably	   lower	   than	   the	   flask	   controls	  whose	   harvest	   pH	  was	   6.71	   (Figure	  
3.16	   a).	   	   Interestingly,	   an	   alternative	   trend	   with	   respect	   to	   glucose	   and	   lactate	   was	  observed	   for	   XP4.2	   compared	   to	   previous	   XP	   experiments.	   Despite	   there	   being	   far	   fewer	  cells	   per	   cm2	   in	   XP4.2	   than	   the	   control	   flasks	   the	   depletion	   in	   glucose	   and	   increases	   in	  lactate	   are	   far	   larger	   (see	   Figure	   3.16	   b).	   This	   is	   suggestive	   of	   alternative	   metabolic	  processes	   taking	   place	   on	   the	   XP	   compared	   to	   the	   flask	   culture	   due	   to	   the	   differing	  environmental	  conditions.	  	  
The	  conclusion	  from	  this	  experiment	  was	  that	  culturing	  the	  XP	  for	  an	  additional	  day	  did	  not	  improve	   the	   density	   achieved	   when	   compared	   to	   flask	   culture	   grown	   for	   an	   equivalent	  amount	  of	   time.	  With	  XP4.1	  yielding	  54.3%	  of	  controls	  and	  XP4.2	  yielding	  47.3%	  (Figure	  
3.17).	  
3.3.7 Increasing	  the	  regulatory	  flowrate	  (experiment	  XP5)	  Due	  to	  the	  inability	  of	  the	  XP	  system	  to	  maintain	  the	  pH	  at	  the	  set	  point	  value	  at	  the	  higher	  cell	  densities	  achieved	  in	  XP4	  on	  D4	  and	  D5	  it	  was	  decided	  to	   increase	  the	  flow	  rate	  from	  1mm/s	  to	  2.9	  mm/s	  for	  XP5.1	  to	  try	  and	  improve	  the	  gas	  transfer	  rate.	  	  
From	  the	  online	  pH	  readings	  for	  XP5.1	  (Figure	  3.18)	  it	  can	  be	  seen	  that	  despite	  the	  higher	  flow	  rate	  the	  pH	  still	  dropped	  significantly	  below	  the	  set	  point	  towards	  the	  end	  of	  D4.	  For	  XP5.1	  it	  was	  decided	  not	  to	  reduce	  the	  CO2	  in	  the	  incubator	  as	  was	  attempted	  in	  XP4	  as	  this	  crude	  approach	  meant	  it	  was	  very	  hard	  to	  control	  the	  outcome	  and	  actually	  generated	  great	  pH	  peaks	  when	  fresh	  media	  was	  added	  during	  the	  trial	  and	  error	  approach.	  The	  cell	  density	  achieved	  in	  XP5.1	  was	  equivalent	  to	  that	  of	  XP4.1	  which	  was	  run	  at	  the	  lower	  flow	  rate	  of	  1mm/s,	   however	   XP5.1’s	   performance	   relative	   to	   controls	   was	   better	   in	   XP5.1	   (62.15%)	  than	  for	  XP4.1	  (54.30%)	  as	  can	  be	  seen	  in	  Figure	  3.17.	  This	  apparent	  improvement	  could	  be	  attributed	  to	  a	  lower	  cell	  density	  achieved	  in	  the	  XP5.1	  control	  condition	  (Figure	  3.14	  a)	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which	  makes	   the	   percentage	   performance	   appear	   better.	   Thus,	   it	   is	   unclear	  whether	   the	  higher	  flow	  rate	  had	  a	  positive	  effect	  or	  not,	  but	  what	  is	  clear	  is	  that	  any	  effect	  is	  minimal.	  
3.3.8 Determining	  whether	  oxygen	  supply	  is	  growth	  limiting	  
(experiment	  XP6)	  From	   the	  previous	   experiments	   (XP1-­‐5)	   it	   could	  be	   seen	   that	   growth	  performance	   of	   the	  XPs	  was	  significantly	  lower	  than	  controls,	  with	  the	  best	  XP	  harvest	  densities	  being	  around	  50-­‐60%	   of	   controls	   (Figure	   3.17).	   This	   is	   somewhat	   surprising	   given	   that	   although	   the	  control	  of	  the	  environment	  was	  not	  ideal	  in	  these	  experiments	  the	  observed	  differences	  in	  the	  pH	  and	  glucose	  and	  lactate	  levels	  were	  relatively	  small.	  It	  was	  considered	  that	  a	  lack	  of	  oxygen	   supply	   that	   caused	   the	   poor	   performance	   on	   the	   XPs.	   The	   hypothesis	   being	   that	  when	  the	  system	  reaches	  the	  pH	  setpoint	  the	  pumping	  stops	  and	  there	  is	  a	  corresponding	  drop	   in	   DO.	   A	   good	   example	   of	   this	   can	   be	   seen	   in	   the	   online	   plot	   of	  Figure	   3.10	   b.	   To	  determine	  whether	   such	   a	   drop	   in	  DO	   retarded	   cell	   growth	   triplicate	   control	   flasks	  were	  run	   in	   an	   incubator	   in	   hypoxic	   conditions	   alongside	   two	   Xpansion	   plates	   namely	   XP6.1	  1mm/s	   and	   XP6.2	   2.9mm/s.	   The	   O2	   supply	   was	   manually	   reduced	   using	   the	   incubator	  controller	   settings	   (13%	  O2	  setpoint)	   to	   produce	   a	  DO	   on	   the	   XP	   of	   60%	  under	   pumping	  which	   corresponded	   to	   the	   reduced	   DO	   when	   there	   was	   no	   pump	   action	   observed	   in	  previous	  experiments.	  
From	  Figure	  3.19	  a)	  it	  can	  be	  seen	  that	  the	  regulation	  achieved	  at	  both	  the	  1	  mm/s	  and	  the	  2.9	   mm/s	   flow	   rate	   yielded	   similar	   results	   with	   the	   harvest	   pH’s	   being	   7.17	   and	   7.08	  respectively.	  The	  DO	  was	  maintained	  at	  approximately	  60%	  when	  the	  pump	  was	  initiated.	  From	  the	  offline	  pH	  it	  can	  be	  seen	  that	  the	  pH	  on	  the	  XPs	  was	  maintained	  at	  a	  slightly	  higher	  pH	  than	  the	  control	  flasks	  Figure	  3.19	  b).	  Glucose	  levels	  in	  the	  controls	  were	  also	  slightly	  lower,	  and	  lactate	  levels	  slightly	  higher,	  when	  compared	  to	  the	  XPs	  Figure	  3.19	  c).	  
The	  lowering	  of	  the	  DO	  in	  the	  incubator	  to	  13%	  to	  reduce	  the	  online	  DO	  of	  the	  XP	  to	  60%	  did	   not	   negatively	   impact	   growth	   in	   the	   control	   flasks,	   with	   the	   control	   flasks	   for	   XP6	  performing	  similar	  to	  XP5	  and	  XP	  4.1	  controls	  (Figure	  3.14	  a).	  These	  results	  of	  the	  control	  flasks	  would	  suggest	  that	  growing	  hESC	  under	  a	  lower	  oxygen	  condition	  for	  a	  single	  passage	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does	  not	  adversely	  impact	  growth.	  However,	  the	  low	  O2	  did	  seem	  to	  have	  an	  adverse	  impact	  on	   the	  XPs,	  with	   the	  1mm/s	   flowrate	   (XP6.1)	  and	   the	  2.9	  mm\s	   flowrates	   (XP6.2)	  having	  relative	   performance	   to	   controls	   of	   52%	   and	   42%	   (Figure	   3.17).	   	   The	   cell	   densities	  achieved	   under	   reduced	   O2	   on	   the	   XPs	   were	   also	   slightly	   lower	   than	   the	   equivalent	  conditions	   grown	   under	   atmospheric	   O2,	   namely	   XP4.1	   1mm/s	   and	   XP5.1	   2.9	  mm/s	   (see	  
Figure	  3.14	  a).	  Therefore,	  the	  lack	  of	  pumping	  when	  the	  setpoint	  is	  reached	  on	  the	  XPs	  and	  accompanying	  drop	  in	  DO	  does	  not	  explain	  the	  large	  40-­‐50%	  reduction	  in	  cell	  density	  when	  compared	  to	  flask	  controls.	  	  
3.3.9 Further	  analysis	  of	  the	  metabolic	  activity	  of	  the	  cells	  What	  was	  intriguing	  when	  looking	  at	  all	  the	  experimental	  data	  as	  a	  whole	  is	  that	  although	  glucose	   and	   lactate	   concentrations	   were	   very	   similar	   at	   harvest	   throughout	   all	   the	  experiments	  (both	  the	  controls	  and	  XPs),	  these	  levels	  were	  corresponding	  to	  very	  different	  cell	   densities.	   When	   these	   cell	   densities	   are	   plotted	   against	   glucose	   and	   lactate	  concentrations	  (Figure	  3.20	  a)	  and	  b),	  it	  can	  be	  seen	  that	  as	  cell	  density	  increases	  there	  is	  a	   clear	   difference	   in	   trends	   between	   the	   Xpansion	   plates	   and	   the	   control	   flasks.	   As	   cell	  density	   increases	   in	  the	  Xpansion	  plate	  there	   is	  a	  clear	   liner	  relationship	  between	  glucose	  consumption	   and	   lactate	  production	   at	   increasing	   cell	   density.	   But,	   this	   relationship	  does	  not	   hold	   true	   in	   the	   control	   flasks,	   where	   at	   higher	   cell	   densities	   far	   less	   glucose	   is	  consumed	  and	  lactate	  is	  produced	  per	  million	  cells	  per	  cm2.	  	  
Two	  possible	  explanations	  for	  this	  could	  be	  that	  the	  control	  flasks	  utilise	  alternative	  carbon	  sources	  at	  higher	  densities	  such	  as	  glutamine,	  or	   that	   the	  KLa	  of	   the	  Xpansion	  Plate	   is	  not	  greater	  than	  the	  oxygen	  uptake	  rate	  (OUR)	  of	  the	  cells	  and	  so	  the	  XP	  becomes	  hypoxic	  and	  the	  culture	  anaerobic,	  relying	  more	  on	  glycolysis	  and	  so	  producing	  more	  lactic	  acid.	  	  	  
To	   explore	   the	   first	   hypothesis	   glutamine	   consumption	   would	   ideally	   be	   measured.	  Unfortunately,	   a	   stabilised	   form	   of	   glutamine	   was	   used	   in	   these	   experiments	   (Glutamax,	  Invitrogen)	   which	   due	   to	   its	   stabilisation	   readings	   could	   not	   be	   obtained	   using	   the	  glutamine	   capable	   analyser	   available	   (Nova	   Biomedical).	   Furthermore,	   Glutamax	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degradation	  over	  time	  actually	  causes	  glutamine	  concentrations	  to	  rise	  as	  noted	  by	  Chen	  et	  al.	  (2010).	  
To	  test	  the	  second	  hypothesis	  that	  oxygen	  provision	  to	  the	  cells	  is	  rate	  limiting,	  it	  would	  be	  assumed	  that	  the	  online	  DO	  levels	  are	  inaccurate	  given	  the	  results	  of	  XP6.	  In	  fact	  this	  could	  be	  due	  to	  the	  positioning	  of	  the	  optical	  patches	  as	  they	  record	  the	  DO	  in	  the	  bulk	  media	  and	  not	   the	  close	  vicinity	  of	   the	  growing	  cells;	   this	  means	   the	  cellular	  oxygen	  partial	  pressure	  can	  be	  very	  different.	  The	  cellular	  oxygen	  partial	  pressure	  is	  impacted	  by	  high	  cell	  densities,	  high	  cellular	  oxygen	  consumption	  rates,	  and	  large	  medium	  heights,	  and	  it	  can	  be	  calculated	  mathematically	   as	   described	   by	   Millman	   et	   al.	   (2009).	   However,	   the	   data	   for	   the	  mathematical	   model	   requires	   significant	   additional	   experimentation,	   growing	   cells	   on	   a	  highly	  gas	  permeable	  surface	  so	  that	  there	  is	  minimal	  disparity	  between	  the	  oxygen	  levels	  (Powers	   et	   al.,	   2010).	   As	   an	   alternative	   to	   completing	   such	   work	   and	   modelling	   the	   XP	  system	  (which	  was	  beyond	  the	  scope	  of	  this	  feasibility	  study)	  a	  number	  of	  hypoxia	  related	  genes	   were	   explored	   via	   qPCR	   for	   the	   XP4	   experiment	   (see	   Figure	   3.21).	   These	   genes	  chosen	  cover	  a	  wide	  range	  of	  hypoxia	  pathways	   for	   instance	  HIF-­‐1α	   is	   the	   initiator	  of	   the	  cellular	   response	   to	   low	   oxygen	   conditions	   whereas	   EPAS1	   (HIF-­‐2α)	   regulates	   hES	   cell	  pluripotency	  as	  well	  as	  proliferation	  under	  hypoxic	  conditions	  (Forristal	  et	  al.,	  2010).	  Under	  hypoxic	  conditions	  HIF-­‐1α	  subunits	  translocate	  to	  the	  nucleus	  and	  activate	  transcription	  of	  target	  genes	  such	  as	  VEGF	  that	  promotes	  angiogenesis.	  
From	  the	  chart	  (Figure	  3.21)	  it	  can	  be	  seen	  that	  there	  are	  roughly	  similar	  expression	  levels	  of	  the	  hypoxia	  related	  genes	  between	  the	  flasks	  and	  the	  XPs	  for	  XP4.	  Additionally,	  ANNOVA	  analysis	  between	  triplicate	  flasks	  also	  showed	  no	  significance	  difference	  from	  allowing	  the	  cells	   to	   become	  more	   confluent	   through	   allowing	   them	   to	   grow	   another	   day.	   This	  would	  suggest	  that	  the	  cellular	  oxygen	  partial	  pressure	  environment	  is	  highly	  similar	  between	  the	  XPs	  and	  the	  controls,	  and	  that	  oxygen	  supply	  is	  not	  significantly	  growth	  limiting	  as	  was	  also	  shown	  experimentally	  in	  XP6.	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3.3.10 Maintenance	  of	  the	  pluripotent	  phenotype	  Despite	  greatly	  reduced	  growth	  in	  the	  XPs,	  the	  impact	  on	  pluripotency	  marker	  expression	  was	  relatively	  minor.	  From	  Figure	   3.22	   a)	   it	   can	  be	  seen	   that	  SSEA-­‐4	  protein	  expression	  was	  only	  slightly	  reduced	  when	  compared	  to	  the	  flask	  controls	  and	  Figure	  3.22	  b)	  shows	  that	  TRA	  1-­‐60	  expression	  either	  matched	  or	  was	  greater	   than	   the	  controls	   in	  most	  of	   the	  experiments.	  It	  was	  considered	  that	  the	  use	  of	  these	  markers	  and	  flow	  cytometry	  might	  not	  be	  sensitive	  enough	  to	  pick	  up	  changes	   in	  pluripotency,	  So,	  qPCR	  analysis	  was	  run	  on	  the	  XP4.1	  and	  XP4.2	  experiments	  for	  the	  pluripotency	  markers	  Nanog	  and	  Pou5F	  (Figure	  3.23)	  which	  showed	  a	  greater	  difference	  between	  the	  XP	  and	  the	  controls.	  What	  would	  be	  critical	  in	   determining	  whether	   the	   Xpansion	  One	   system	  has	   a	   negative	   impact	   on	   pluripotency	  marker	  expression	  would	  be	  to	  culture	  hESC	  on	  the	  XPs	  over	  a	  number	  of	  passages	  to	  allow	  time	   for	   pluripotency	   marker	   expression	   to	   change.	   In	   addition,	   the	   running	   of	   multiple	  plates	  over	  a	  number	  of	  passages	  would	  produce	  statistical	  certainty	  in	  the	  result.	  
3.4 Conclusions	  
3.4.1 Establishment	  of	  a	  working	  protocol	  to	  take	  forward	  to	  large-­‐
scale	  experimentation	  Although	  experiments	  were	  limited	  by	  the	  number	  of	  XP	  bioreactors	  available,	  it	  is	  believed	  that	   the	  work	  detailed	  here	  utilising	   the	  Xpansion	  One	   system	  enabled	   the	  exploration	  of	  key	   variables	   using	   this	   small-­‐scale	   mimic.	   Such	   work	   being	   vital	   before	   committing	   to	  large-­‐scale	   process	   development	   using	   the	   Integrity	   Xpansion	   systems	   (Table	   3.1).	   Key	  conclusions	   from	   this	  work	   are	   as	   follows.	  At	   lower	   cell	   densities	   increasing	   the	   flowrate	  did	  not	  appear	  to	  adversely	  impact	  cell	  growth	  and	  the	  pH	  could	  be	  maintained	  equivalent	  to	   flask	   culture	   (experiment	   XP1);	   the	   introduction	   of	   discontinuous	   flow	   to	   achieve	  regulation	   further	   improved	   growth	   (experiment	   XP2).	   Moreover,	   adding	   the	   regulation	  loop	   after	   6.5	   hours	   instead	   of	   24h	   increased	   cell	   growth	   (experiment	   XP3).	  However,	   in	  using	  higher	  seeding	  densities	  which	  better	  match	  those	  used	  for	  karyotypically	  normal	  cell	  lines	   the	  system	  struggled	   to	  maintain	   the	  set	  point	  pH	  and	   increasing	   the	  culture	  period	  did	   not	   increase	   performance	   relative	   to	   controls	   (experiment	   XP4).	   Finally,	   increasing	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flowrate	  at	  the	  higher	  densities	  did	  not	  appear	  to	  improve	  either	  regulation	  of	  importance	  (experiment	  XP5).	  	  
3.4.2 Is	  the	  design	  of	  the	  Xpansion	  One	  system	  suitable	  for	  high	  density	  
PSC	  culture?	  The	   XPs	   have	   a	   clear	   linear	   relationship	   between	   cell	   density	   and	   glucose	   consumption,	  whereas	   in	   flask	   culture	   less	   glucose	   is	   consumed	  and	   lactate	  produced	  at	   increasing	   cell	  density	  (Figure	   3.20).	   It	  was	  hypothesised	   that	   this	  was	  a	   result	  of	   anaerobic	   conditions	  being	   produced	   in	   the	   Xpansion	   One	   system	   due	   to	   either	   drops	   in	   DO	  when	   the	   pH	   set	  point	  was	  reached,	  or	  that	  the	  oxygen	  provision	  directly	  around	  the	  cells	  was	  low	  and	  not	  being	   picked	   up	   due	   to	   the	   positioning	   of	   the	   sensors.	   By	   running	   plates	   at	   reduced	  incubator	   O2	  (13%)	   to	   yield	   a	   DO	  max	   of	   60%,	   which	  matched	   the	  minimum	   DO	   during	  normal	  culture,	  it	  was	  seen	  that	  low	  O2	  only	  appeared	  to	  have	  a	  minimal	  negative	  impact	  on	  XPs	   and	   no	   impact	   on	   the	   control	   flasks	   (experiment	   XP6).	   Furthermore,	   hypoxia	   gene	  expression	  was	  largely	  similar	  between	  the	  XPs	  and	  flask	  controls	  suggesting	  that	  there	  is	  similar	  oxygen	  provision	  in	  the	  flasks	  and	  the	  XPs	  (Figure	  3.21).	  	  From	  this,	  it	  would	  be	  the	  conclusion	  that	  gas	  transfer	  in	  the	  XP	  system	  is	  not	  growth	  rate	  limiting.	  	  
More	   experiments	   would	   be	   needed	   at	   various	   cell	   densities	   and	   oxygen	   tensions	   to	  determine	  that	  the	  KLa	  of	  the	  XPs	  is	  greater	  than	  the	  OUR.	  For	  instance,	  there	  are	  ways	  to	  measure	  the	  KLa	  of	  bioreactors	  using	  the	  ‘gassing	  in’	  method	  in	  this	  case	  would	  require	  the	  entire	   incubator	   to	   be	   filled	  with	   nitrogen	   and	   the	   XP	   run	   to	   remove	   all	   oxygen.	   The	  KLa	  would	  be	  determined	  via	  the	  DO	  response	  of	  the	  XP	  when	  the	  incubator	  is	  re-­‐filled	  with	  O2	  gas	   mix,	   this	   rapid	   refilling	   would	   be	   technically	   difficult	   in	   practice.	   In	   traditional	  bioreactors	  the	  gassing	  in	  approach	  utilises	  a	  built	  in	  sparger.	  
The	  other	  main	  issue	  when	  growing	  these-­‐high	  density	  PSC	  cultures	  in	  the	  XP	  system	  was	  the	   poor	   ability	   to	   maintain	   pH	   at	   the	   setpoint.	   Increasing	   the	   linear	   flow	   rate	   between	  1mm/s	   to	   2.9mm/s	   showed	   no	   obvious	   benefit	   and	   raising	   the	   flowrate	   significantly	   to	  5mm/s	  caused	  protein	  precipitation	  and	  bubbles.	  Options	  for	  improving	  pH	  regulation	  and	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thereby	   performance,	   are	   better	   addressed	   using	   the	   larger	   scale	   Integrity	   Xpansion	  systems	  due	  to	  their	  more	  complex	  regulatory	  systems.	  
3.4.3 Options	  to	  improve	  performance	  when	  scaling-­‐up	  What	   is	   clear	   from	   this	   feasibility	   study	   is	   that	   the	   MEF-­‐hESC	   co-­‐culture	   system	   is	  compatible	  with	  the	  XP	  system.	  Although	  the	  best	  growth	  performance	  relative	  to	  controls	  was	  only	  62%	   the	  work	  described	  here	  narrows	   the	  discrepancy	  down	   to	   two	   causes:	   a)	  either	  growing	  PSCs	  under	  a	  fluid	  shear/dynamic	  environment;	  b)	  or	  inability	  to	  control	  pH	  accurately.	  	  
In	   terms	   of	   a)	   it	   may	   be	   that	   any	   flow	   in	   a	   PSC	   system	   reduces	   growth.	   Titmarsh	   et	   al.	  (2011)	   reported	   work	   using	   a	   continuously	   perfused	   microbioreactor	   that	   PSCs	   under	  shear	   stresses	   between	   5x10-­‐4	  to	   7.5x10-­‐4	  Pa	  matched	   static	   controls	   in	   terms	   of	   growth.	  However,	   the	   paper	   also	   reports	   that	   low	   perfusion	   rates	   caused	   the	   culture	   to	   become	  limited	  by	  mass	  transfer	  (with	  only	  11%	  yield	  compared	  to	  static	  controls	  at	  a	  shear	  stress	  8.5x10-­‐5	   Pa).	   In	   addition,	   ‘high’	   perfusion	   rates	   resulted	   in	   performance	   of	   only	   18%	   of	  static	   controls,	   with	   cells	   appearing	   to	   detach	   and	   wash	   out	   (shear	   stress	   1.1	   x10-­‐3	  Pa).	  Computational	   fluid	  dynamics	   studies	   and	  experimental	   validations	  by	  ATMI	   report	   at	   all	  their	  scales	  that	  at	  a	  linear	  velocity	  of	  2mm/s	  that	  90%	  of	  the	  culture	  experiences	  a	  shear	  stress	   of	   6	   x10-­‐3	  Pa,	  with	   a	  maximum	   shear	   stress	   at	   the	  walls	   of	   10	   x10-­‐3	  Pa	   i.e.	   a	   shear	  stress	  of	  over	  5	  times	  higher	  than	  the	  ‘high’	  flowrates	  used	  by	  Titmarsh	  et	  al.	  (2011).	  	  Even	  so,	  despite	  these	  shear	  rates	  in	  the	  XP	  being	  far	  higher	  than	  those	  reported	  by	  Titmarsh	  et	  al.	   (2011)	   the	  performance	   in	  relation	   to	   its	   static	  controls	  was	  over	  3	   times	  better	   (62%	  yield	   compared	   to	   18%).	   It	   is	   hypothesised	   that	   it	   might	   be	   the	   discontinuous	   mixing	  system,	   or	   the	   different	   geometry	   of	   the	   XPs	   that	   is	   the	   reason	   for	   the	   improved	  performance	  even	  though	  the	  shear	  rates	  are	  higher.	  	  
In	   terms	  of	   b)	   (see	   above)	   that	   it	  was	  poor	   control	   of	   pH	  or	   gas	   transfer	   that	   caused	   the	  reductions	   in	   growth	   it	   would	   be	   anticipated	   that	   the	   yields	   would	   be	   increased	   when	  scaling	  up	  to	  the	  larger	  Xpansion	  systems	  as	  they	  have	  more	  complex	  control	  systems.	  The	  previously	   described	   regulation	   system	   in	   the	   Xpansion	   One	   (Figure	   3.5)	   works	   by	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equilibrating	   the	   dissolved	   gasses	   in	   the	   silicon	   tubing	   to	   the	   background	   gas	  mix	   of	   the	  incubator.	  This	  severely	  limits	  the	  ability	  to	  control	  pH	  by	  altering	  the	  gas	  mix.	  For	  instance,	  CO2	   was	   manually	   reduced	   using	   the	   incubator	   settings	   in	   XP4	   (Figure	   3.15),	   but	   the	  results	  were	  a	  very	  crude	  and	  did	  not	  allow	  proper	  regulation	  of	  pH.	  Advantageously,	   the	  regulatory	   system	   of	   the	   full	   sized	   Xpansion	   systems	   allows	   control	   over	   the	   gas	  mix	   to	  control	  both	  pH	  and	  DO	  (Figure	  3.24)	  and	  so	  it	  is	  believed	  the	  best	  performance	  of	  62%	  in	  the	  Xpansion	  One	  could	  be	  greatly	  improved	  on	  by	  moving	  to	  the	   larger	  scale	  bioreactors.	  An	  alternate	  way	  to	  improve	  pH	  control	  would	  be	  to	  perfuse	  in	  fresh	  media.	  However	  this	  would	  increase	  the	  amount	  of	  media	  needed	  to	  grow	  each	  cell	  and	  so	  any	  improvements	  in	  yield	  would	  need	  to	  be	  balanced	  with	  the	  increased	  costs	  of	  media.	  
Finally	  one	  aspect	  which	  could	  significantly	  improve	  results	  is	  one	  of	  repeat	  passaging.	  Cells	  and	  PSCs	  in	  particular	  often	  take	  a	  few	  passages	  to	  adapt	  to	  a	  new	  culture	  method.	  While	  it	  was	   not	   tried	   here	   sequential	   passaging	   of	   cells	   using	   the	   Xpansion	   system	  may	   aid	   cell	  adaption	  and	  so	  improve	  growth	  performance.	  	  
3.5 Summary	  
3.5.1 The	  importance	  of	  environmental	  control	  
Good	  environmental	  control	  of	  pH	  is	  vital,	  it	  is	  clear	  that	  small	  variations	  in	  environmental	  conditions	   such	   as	   pH	   has	   a	   major	   impact	   on	   performance,	   with	   growth	   being	   reduced	  greater	  than	  40%.	  Comparatively	  little	  is	  known	  about	  the	  ideal	  environmental	  conditions	  for	   PSC	   cultures	   in	   dynamic	   conditions	   and	   it	   is	   highly	   likely	   that	   the	   conditions	   used	   in	  static	   flask	  culture	  non-­‐ideal.	  From	  this	   feasibility	  study	  using	  the	  Xpansion	  One	  system	  it	  can	  be	  seen	  that	  an	  understanding	  of	  a	  broad	  range	  of	  environmental	  conditions	  such	  as	  pH,	  fluid	   mixing,	   shear	   and	   nutrient	   and	   waste	   mass	   transfer	   will	   be	   vital	   if	   a	   successful	  translation	  of	  PSC	  culture	  to	  bioreactors	  is	  to	  be	  made.	  
3.5.2 Future	  work	  	  If	   the	   Xpansion	  One	   system	  was	   being	   used	   in	   a	   commercial	   setting	   a	   greater	   number	   of	  experiments	  would	  have	  been	  conducted	  using	  this	  small-­‐scale	  mimic.	  These	  results	  would	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be	   used	   to	   add	   statistical	   certainty	   to	   the	   conclusions	   made	   here	   regarding	   flow	   rate,	  maintenance	   of	   the	   pluripotent	   phenotype	   and	   the	   gas	   transfer	   capacities	   of	   the	   system.	  Furthermore,	  a	  range	  of	  set	  point	  pH	  values	  would	  be	  explored	  to	  see	  if	  the	  pH	  of	  7.32	  (the	  value	  of	  PSC	  media	  	  equilibrated	  with	  the	  temperature	  and	  5%	  CO2	  of	  a	  standard	  incubator)	  is	   indeed	   ideal.	  Future	  work	  would	  also	  use	  a	  2	  point	  calibration	  on	  the	  online	  patches	  to	  solve	  the	  discrepancy	  issues	  between	  online	  and	  offline	  readings,	  such	  a	  two	  point	  system	  is	  used	   on	   the	   large	   scale	   bioreactors.	   Also,	   a	   more	   detailed	   metabolite	   analysis	   would	   be	  useful,	  particularly	  tracking	  glutamine	  (not	  possible	  here	  due	  to	  the	  use	  of	  Glutamax),	  to	  try	  and	   understand	   the	   differing	   trends	   of	   glucose	   consumption	   and	   lactate	   production	  between	  the	  XPs	  and	  the	  flasks	  at	  increasing	  density.	  Calculation	  of	  the	  yield	  coefficients	  of	  these	  metabolites	  would	  also	  be	  useful	  for	  comparing	  environmental	  conditions	  with	  other	  systems	  as	  described	  by	  Chen	  et	  al.	  (2010),	  but	  this	  would	  require	  accurate	  measurements	  of	  cell	  density	  during	  culture.	  
What	  would	  be	  really	  interesting	  would	  be	  to	  conduct	  differentiation	  experiments	  using	  the	  Xpansion	  system	  as	  it	  could	  well	  be	  that	  the	  environmental	  conditions	  that	  are	  optimum	  for	  the	   maintenance	   of	   the	   PSC	   pluripotent	   phenotype	   are	   not	   the	   optimum	   for	   PSC	  differentiation.	   Finally	   given	   the	   large	   numbers	   of	   potential	   variables	   which	   can	   impact	  performance	  a	  statistically	   led,	  multifactorial	  screening,	  and	  optimisation	  approach	  would	  be	  beneficial.	  Such	  an	  approach	  is	  applied	  to	  PSC	  differentiation	  to	  RPE	  in	  Chapter	  4.	  
	   	  





	   	  













	   	  


















Xpansion System Structure 
The Xpansion system includes a single-use bioreactor, a docking station 
and  
a controller. 
Single-Use Bioreactor with Stacked Multiplate Design
Comprised of stacked hydrophilized polystyrene radial plates, the 
Xpansion Multiplate Bioreactor is designed to promote cell growth on the 
top of each plate. Each plate has a hole in the center. The stacking of these 
plates forms the central column which allows circulation of the medium in 
the bioreactor and gas exchange. 
The plates are covered by an outer tube, a head plate on the top and a 
base plate on the bottom. On the head plate, there are: 
ēƎ Two sensor connectors: one for pH,  
one for DO (dissolved oxygen) and  
four optional 
ēƎ Three windows for easy viewing  
under a specialized light microscopy 
ēƎ Two vent filters
ēƎ Two gas filters (in and out) for  
aeration system
ēƎ One thermowell port
ēƎ One backup port for adding  
and/or sampling
In the bottom side of the bioreactor,  
there are:
ēƎ Two fluid operation ports  
(e.g., inoculation, harvest, etc.)
ēƎ One stirring unit
Materials
1. Gas in & out 
 
 
2. Vent 1 & 2 
 
 
3. Sampling port 
4. Headplate 
5. Cell surface plates 
6. Aeration support 
6. Aeration tubing 
7. Outer tube 









Silicone tubing ID 1/4”, Sartorius Midisart 
BV 0.20µm hydrophobic filters( PTFE, 
Polyester, Polypropylene )
Silicone tubing ID 1/4”, Sartorius Midisart 
BV 0.20µm hydrophobic filters( PTFE, 
Polyester, Polypropylene )
Silicone tubing ID 1/4”, luer female connector
Clear Polystyrene
Cell culture plasma treated clear Polystyrene
Polypropylene & Polycarbonate






C-Flex Clear 374 Tubing ID 3/8”, CPC 
MPC male on which connects Silicone tubing 
ID 1/4”, luer female connector or Silicone  
tubing ID 1/4”, 0.20µm hydrophobic filters
Resin
Illustration of an Xpansion plate
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Figure'3.9:'Visual'differences'of'running'a'plate'at'a'high'Plowrate'of'5.0mm/s."Area"denoted"by"A)"shows"protein"precipitation"accumulating"in"the"centre"of"the"plate."Area"denoted"by"B)"shows"considerable"bubble"formation"around"the"?low"distributor"not"seen"at"other"?lowrates,"although"this"did"not"appear"to"impact"cell"attachment"when"viewed"under"a"microscope.""
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4.	  A	  design	  of	  experiment	  (DoE)	  approach	  to	  retinal	  pigment	  epithelium	  differentiation	  
4.1 Introduction	  and	  aims	  
4.1.1 Limitations	  of	  the	  one	  factor	  at	  a	  time	  (OFAT)	  approach	  Development	  of	  current	  differentiation	  protocols	  for	  stem	  cells	  are	  driven	  by	  a	  ‘best	  guess’	  approach	  as	  to	  what	  factor	  should	  be	  explored	  and	  varied	  to	  try	  and	  optimise	  the	  process	  to	  deliver	  the	  target	  phenotype.	  These	  choices	  are	  normally	  informed	  by	  previous	  experiences	  of	   the	   research	   group	   or	   an	   understanding	   of	   in-­‐vivo	   embryonic	   development	   combined	  with	   reviews	   of	   protocols	   published	   in	   literature.	   This	   often	   results	   in	   an	   experimental	  design	  that	  draws	  in	  on	  a	  limited	  amount	  of	  what	  are	  believed	  to	  be	  key	  factors	  which	  are	  varied	  over	  minimal	  ranges.	  However,	  very	  little	  of	  the	  design	  space	  is	  explored	  using	  this	  OFAT	  (one	  factor	  at	  a	  time)	  methodology	  (Figure	  4.1	  a),	  and	  it	  does	  little	  to	  elucidate	  the	  impact	  of	  multiple	  variables	  impacting	  on	  one	  another.	  Thus	  OFAT	  design	  can	  be	  seen	  as	  an	  inefficient	  use	  of	  resources	  and	  prone	  to	  miss	  the	  true	  optimum.	  
4.1.2 The	  statistical	  design	  of	  experiments	  (DoE)	  approach	  	  The	  alternative	  is	  to	  use	  a	  statisticaldesign	  of	  experiments	  (DoE)	  approach	  (Figure	  4.1	  b).	  Here	   experiments	   are	   conducted	   around	   the	   possible	   design	   space	   changing	   multiple	  factors	   at	   the	   same	   time.	   Different	   DoE	   designs	   vary	   the	   number	   and	   position	   of	   these	  points	  allowing	  compromises	  between	  the	  coverage	  of	  the	  design	  space	  and	  the	  number	  of	  experiments	  required.	  The	  use	  of	  statistical	  packages	  such	  as	  Design-­‐Expert	  (Stat-­‐Ease)	  can	  determine	   the	   significance	   of	   a	   factor’s	   impact	   on	   the	   desired	   response	   from	   these	  multiplexed	  conditions	  or	  ‘runs’.	  In	  addition	  such	  packages	  can	  then	  model	  the	  interactions	  of	  factors	  over	  their	  ranges	  to	  produce	  a	  computer	  model	  to	  fit	  the	  experimental	  data.	  Such	  models	   can	   then	  be	  used	   to	   give	   an	   indication	   as	   to	  where	   the	  optimum	  combinations	  of	  factors	  lie	  and	  so	  positioning	  of	  the	  design/operation	  space.	  This	  is	  often	  represented	  as	  a	  ‘heat	  map’	  or	  contour	  plot,	  which	  is	  then	  verified	  experimentally.	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This	   statistical	   approach	   to	   experimental	   design	  has	  been	   employed	   for	  many	  decades	   in	  biotechnology,	   for	   instance,	  Haaland	   (1989)	  and	  Adrion	   (1984)	  used	  a	   computer	   assisted	  approach	  to	  optimise	  in	  vivo	  monoclonal	  antibody	  production.	  DoE	  is	  now	  a	  widely	  adopted	  tool	  in	  bioprocess	  development	  being	  used	  in	  combination	  with	  high	  throughput	  screening	  technologies.	   However,	   application	   of	   DoE	   to	   optimise	   processes	   in	   the	   field	   of	   stem	   cell	  research	   is	   at	   its	   relative	   infancy	   with	   minimal,	   but	   diverse,	   uses	   in	   the	   literature.	   For	  instance	  Ratcliffe	  et	  al.	   (2013)	  and	  Hunt	  et	  al.	   (2013)	  applied	  DoE	   to	  stem	  cell	  bioreactor	  operation,	  and	  Knospel	  et	  al.	  (2010)	  used	  the	  approach	  for	  the	  serum-­‐free	  culture	  medium	  for	  mouse	  embryonic	  stem	  cells,	  whilst	  Li	  et	  al.	  (2012)	  explored	  matrix	  environment	  impact	  on	   neuronal	   differentiation	   of	   embryonic	   carcinoma	   cells	   and	   Decaris	   and	   Leach	   (2011)	  explored	   cell-­‐secreted	   matrices	   for	   directing	   osteogenic	   differentiation	   in	   mesenchymal	  stem	  cells.	  
When	   attempting	   to	   scale	   up	   a	   lab	   protocol	   for	   clinical	   trials	   or	   commercial	   production	  there	  is	  often	  a	  poor	  understanding	  of	  factors	  that	  could	  have	  an	  impact	  on	  the	  performance	  and	  economics	  of	  the	  differentiation.	  For	  example,	  initial	  seeding	  densities,	  media	  volumes	  and	  regularity	  of	  media	  changes	  are	  seldom	  reported	  in	  the	  literature	  with	  little	  evidence	  of	  any	   attempts	   to	   optimise	   or	   understand	   their	   impact.	   Although	   such	   variables	  may	   seem	  trivial,	  at	  the	  research	  scale	  they	  are	  very	  important	  when	  exploring	  the	  cost	  economics	  of	  the	   large-­‐scale	  process.	  For	   instance,	   initial	  seeding	  densities	  not	  only	  determine	  the	  seed	  chain	   requirements	   per	   batch	   but	   it	   can	   also	   impact	   the	   differentiation	   process	   itself,	   for	  example	  in	  neural	  differentiation	  of	  PSCs	  (Chambers	  et	  al.,	  2009).	  	  
4.1.3 Aims	  The	  aim	  of	  this	  chapter	  was	  to	  explore	  the	  feasibility	  of	  applying	  the	  DoE	  approach	  to	  the	  screening	  and	  optimising	  of	  the	  PSC-­‐RPE	  differentiation	  protocol.	  The	  specific	  objectives	  in	  applying	  the	  sequential	  DoE	  approach	  were:	  
• Conduct	   a	   “screening”	   experiment	   to	   determine	   which	   out	   of	   a	   large	   number	   of	  poorly	   understood	   variables	   had	   a	   significant	   impact	   on	   the	   differentiation	  efficiency.	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• Use	  knowledge	  gained	  from	  the	  screening	  experiment	  to	  pick	  the	  most	  significant	  variables	   and	   conduct	   a	   second	   “optimisation”	   experiment	   of	   higher	   statistical	  resolution	   in	   an	   attempt	   to	  model	   the	   data	   so	   as	   to	   predict	   where	   the	   optimum	  differentiation	  conditions	  lay.	  	  
4.2 Materials	  and	  methods	  	  
4.2.1 Design	  of	  experiments	  software	  
Design-­‐Expert	   6	   (Stat-­‐Ease)	   was	   used	   set	   up	   the	   runs	   based	   on	   the	   chosen	   factors	   and	  resolution	   of	   the	   design.	   The	   software	   was	   also	   used	   to	   generate	   the	   models	   to	   fit	   the	  experimental	  data	  and	  determine	  its	  statistical	  fit	  as	  well	  as	  generating	  all	  the	  plots.	  	  
4.2.2 Flow	  cytometry	  The	   anti-­‐SSEA-­‐4	   PE	   conjugate	   (Millipore)	   antibody	   was	   used	   to	   determine	   pluripotency	  expression	  prior	   to	   seeding	   cells	   in	   the	   experiments.	  A	  1%	  cut-­‐off	   gate	  was	   implemented	  based	  on	  conjugated	  isotype	  controls.	  All	  samples	  where	  analysed	  using	  a	  Beckman	  Coulter	  Epics	  XL	  MCL	  flow	  cytometer,	  and	  Summit	  software.	  
4.2.3 qPCR	  Following	   manufacturer’s	   guidelines	   (all	   reagents	   used	   were	   from	   Qiagen),	   RNA	   was	  extracted	   using	   the	   RNeasy	   mini-­‐kit	   and	   first-­‐strand	   synthesised	   using	   the	   QuantiTect	  Reverse	  Transcription	  Kit.	  Quantitative	  PCR	  was	  carried	  out	  using	  the	  SYBR	  Green	  master	  mix	   in	   the	   CFX	   Connect	   Real-­‐Time	   System	   (Bio-­‐Rad).	   Reactions	   were	   run	   using	   the	  following	   QuantiTect	   Primer	   Assays,	   OTX2	   (QT00213129),	   RAX	   (QT00212667),	   MITF	  (QT00037737),	   PMEL	   (QT00016149),	   RPE65	   (QT00001351),	   BEST1	   (QT00023282),	   TYR	  (QT00080815).	  Analysis	  of	  relative	  quantification	  used	  b-­‐ACTIN	  (QT0000	  95431),	  and	  UBC	  (QT00234430)	  to	  normalise	  expression	  against	   internal	  controls.	  Primer	  efficiencies	  were	  calculated	  using	  a	  cDNA	  dilution	  curve	  and	  analysed	  using	  Bio-­‐Rad	  software.	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4.2.4 Cell	  Culture	  Two	  different	  iPS	  lines	  were	  made	  available	  for	  study.	  The	  BJ	  line	  used	  was	  created	  by	  the	  Moorefield’s	  group	  (University	  College	  London)	  using	  the	  StemGent	  mRNA	  reprogramming	  method	   utilising	   Oct4,	   Klf4,	   Sox2,	   Lin28	   and	   c-­‐Myc	   to	   reprogram	   StemGent’s	   BJ	   human	  fibroblast	  cell	  line	  created	  from	  human	  foreskin.	  	  The	  second	  line	  ‘MSUH001’	  was	  derived	  in	  xeno-­‐free	   conditions	   from	   16	   week	   gestation	   age	   foetal	   fibroblast	   cells	   (originally	   from	  ATCC)	  using	  the	  reprogramming	  factors	  Oct4,	  Sox2,	  Nanog	  and	  Lin28	  and	  published	  as	  Ross	  et	  al.	  (2010).	  The	  line	  was	  created	  by	  the	  Cellular	  Reprogramming	  Laboratory	  at	  Michigan	  State	   University	   (USA)	   and	   deposited	   in	   the	   Banco	   Nacional	   De	   Lineas	   Celulares	  (Troncales),	   which	   is	   the	   Spanish	   stem	   cell	   bank.	   The	  MSUH001	  was	   kindly	   supplied	   by	  Professor	  Jose	  B.	  Cibelli’s	  group.	  
Both	  BJ	  and	  MSUH001	   lines	  were	  maintained	  on	  matrigel	   (BD	  bioscience)	  using	  mTeSR	  1	  media	   (Stem	   Cell	   Technologies)	   and	   mechanically	   passaged	   according	   to	   manufacturer’s	  guidelines.	   For	   the	   differentiation	   experiment	   cells	   were	   enzymatically	   detached	   using	  TrypLE	   Express	   (Life	   Technologies)	   and	   counted	   using	   a	   haemocytometer.	   Cells	   were	  seeded	  in	  mTeSR	  1	  media	  supplemented	  with	  10µM	  ROCKi	  (Cambridge	  Bioscience)	  to	  aid	  cell	   attachment.	   The	   base	   differentiation	   media	   contained	   Knockout	   DMEM,	   (Life	  Technologies)(4.5	  g	  D-­‐glucose/L,	  +	  sodium	  pyruvate,	  -­‐L-­‐glutamine),	  20	  %	  Knockout	  Serum	  Replacement	   (Life	   Technologies),	   GlutaMAX,	   (Life	   Technologies),	   0.1	   mM	   b-­‐mercaptoethanol,	   and	   1	   %	   100	   9	   MEMNEAA	   (Life	   Technologies).	   This	   base	   media	   was	  supplemented	   with	   combinations	   and	   concentrations	   of	   the	   following	   based	   on	   the	  experimental	   design:	   human	   basic	   fibroblast	   growth	   factor	   (bFGF,	   R&D	   systems),	   IWP-­‐2	  (Sigma)	  and	  nicotinamide	  (Sigma).	  All	  media	  combinations	  were	  made	  in	  bulk	  and	  stored	  at	  -­‐80oC.	  Individual	  aliquots	  were	  then	  thawed	  on	  day	  of	  use	  to	  ensure	  there	  was	  no	  variation	  between	   different	   media	   used	   on	   different	   days	   due	   to	   any	   degradation	   of	   media	  components.	  	  
	   	  
	   - 111 -	  
4.2.5 Image	  J	  analysis	  of	  percentage	  pigmentation	  The	  tissue	  culture	  plates	  were	   imaged	  using	  an	  Epson	  Perfection	  V750	  Photo	  Scanner.	  To	  account	   for	  heterogeneity	   in	  contrast	  across	   the	  wells	   images	  were	  taken	   in	   two	  different	  orientations.	   These	   images	  were	   then	   imported	   to	   Image	   J	   (National	   Institutes	   of	  Health)	  and	  converted	  to	  binary	  images	  based	  on	  a	  chosen	  threshold	  to	  select	  only	  the	  pigmented	  areas.	  This	  allows	  the	  determination	  of	  percentage	  coverage	  of	  pigmentation	  in	  a	  well.	  The	  method	   is	   similar	   to	   that	   reported	  by	   and	  validated	   against	  manual	   counts	  by	  Lane	   et	   al.	  (2014).	  	  
4.3 Results	  and	  discussion	  	  
4.3.1 Screening	  design	  
The	   application	   of	   the	   DoE	   approach	   to	   bioprocess	   optimisation	   normally	   follows	   two	  stages.	   First,	   a	   large	   number	   of	   potential	   variables	   are	   screened	   in	   a	   minimal	   set	   of	  experiments	   to	   determine	  which	   factors	   have	   the	   largest	   impact.	   Then,	   the	   interaction	   of	  factors	  is	  explored	  using	  a	  response	  surface	  design	  that	  produces	  a	  visual	  statistical	  model	  that	  can	  be	  used	  to	  determine	  the	  optimal	  operation	  space.	  	  
The	  number	  of	  factors	  chosen	  for	  the	  screen	  has	  a	  significant	  impact	  on	  the	  number	  of	  runs	  to	  be	   completed	  and	   so	   greatly	   impact	   the	   costs	   and	  practicalities	  of	   the	   experiment.	   For	  two	  level	  designs,	   i.e.	  where	  each	  variable	  is	  explored	  at	  it’s	  maxima	  and	  minima	  the	  Stat-­‐Ease	  software	  visualises	  the	  runs	  required	  in	  a	  table	  (Figure	  4.2).	  For	  example	  if	  4	  factors	  were	  to	  be	  explored	  at	  two	  levels	  16	  runs	  would	  be	  needed	  (24)	  or	  for	  8	  factors	  256	  runs	  would	  be	  needed	  (28),	  such	  designs	  are	  termed	  full	  factorial	  designs.	  The	  advantage	  of	  using	  DoE	  to	  screen	  variables	  is	  that	  these	  run	  numbers	  can	  be	  vastly	  reduced	  by	  decreasing	  the	  resolution	   of	   the	   design	   and	   so	   lowering	   the	   experimental	   effort.	   However,	   reducing	   the	  number	  of	  runs	   from	  the	   full	   factorial	  number	  also	  decreases	  the	  resolution	  which	  means	  that	   factors	   become	   aliased	   together.	   The	   lower	   the	   resolution	   the	   greater	   amount	   of	  aliasing.	  An	  example	  of	  aliasing	  for	  factors	  [A],	  [B]	  and	  [C]	  would	  be	  that	  the	  software	  would	  be	   able	   to	   say	   that	   either	   factors	   [A]	   and	   [B]	   have	   a	   significant	   impact	   on	   the	   result	   or	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factors	  [A]	  and	  [C]	  do,	  but	  it	  would	  be	  unable	  to	  discriminate	  which	  combination	  is	  having	  the	   effect.	   Therefore	   either	   past	   experience	   or	   further	   experimentation	   can	   be	   used	   to	  decide	  on	  which	  alias	  is	  correct.	  In	  lower	  resolution	  designs	  only	  2	  factor	  interactions	  will	  be	  aliased	  e.g.	  [A]	  with	  [B]	  or	  it	  could	  be	  [A]	  with	  [C]	  having	  the	  effect.	  However,	  in	  higher	  resolution	  designs	  only	  3	  or	  more	  factor	   interactions	  will	  be	  aliased	  (2	   factor	   interactions	  being	  fully	  resolved)	  e.g.	  [A]	  with	  [B]	  with	  [C]	  or	  it	  could	  be	  [A]	  with	  [B]	  with	  [D]	  having	  the	  effect.	   Such	   3	   factor	   combinations	   are	   rarely	   the	   biggest	   effectors	   on	   the	   result	   and	   so	  deemed	  acceptable	  in	  most	  screening	  designs.	  	  
Using	   the	   Stat-­‐Ease	   Software	   it	   was	   decided	   that	   an	   8	   factor	   screening	   experiment	   at	  resolution	  IV	  would	  be	  a	  good	  test	  of	  the	  applying	  a	  DoE	  approach	  to	  PSC	  differentiation	  as	  this	  would	  explore	  a	  greater	  number	  of	   factors	   than	  normally	  published	   in	   the	   literature.	  From	   Figure	   4.2,	   it	   can	   be	   seen	   that	   this	   requires	   16	   unique	   runs.	   In	   addition	   to	   this	   4	  centre	   points	  were	   used	  which	   are	   essentially	   4	   replicates	   of	   the	  middle	   values	   used	   for	  each	   factor.	   These	   centre	   points	   are	   used	   to	   determine	   the	   signal	   to	   noise	   ratio	   in	   the	  experiment	  and	  also	  determine	  curvature,	  i.e.	  where	  there	  is	  a	  non-­‐liner	  relation	  between	  a	  factor	   and	   the	   desired	   response.	   Each	   run	  was	   also	   completed	   in	   duplicate	   and	   averaged	  before	  inputting	  into	  the	  software	  meaning	  40	  runs	  were	  required	  in	  total	  for	  the	  screening	  experiment.	   The	   aliases	   of	   the	   resolution	   IV	   design	   chosen	   are	   replicated	   below	   showing	  single	   factors	   only	   aliased	   with	   3	   factors	   interactions,	   and	   2	   factor	   interactions	   are	   only	  aliased	   with	   other	   2	   factor	   interactions.	   As	   the	   purpose	   of	   screening	   experiments	   is	   to	  determine	   the	   key	   single	   factor	   impacts	   on	   the	   differentiation	   before	   a	   subsequent	  optimisation	  experiment	  this	  resolution	  IV	  design	  was	  decided	  to	  be	  the	  best	  approach.	  	  
[A]	  =	  A	  +	  BCE	  +	  BDH	  +	  BFG	  +	  CDG	  +	  CFH	  +	  DEF	  +	  EGH	  [B]	  =	  B	  +	  ACE	  +	  ADH	  +	  AFG	  +	  CDF	  +	  CGH	  +	  DEG	  +	  EFH	  [C]	  =	  C	  +	  ABE	  +	  ADG	  +	  AFH	  +	  BDF	  +	  BGH	  +	  DEH	  +	  EFG	  [D]	  =	  D	  +	  ABH	  +	  ACG	  +	  AEF	  +	  BCF	  +	  BEG	  +	  CEH	  +	  FGH	  [E]	  =	  E	  +	  ABC	  +	  ADF	  +	  AGH	  +	  BDG	  +	  BFH	  +	  CDH	  +	  CFG	  [F]	  =	  F	  +	  ABG	  +	  ACH	  +	  ADE	  +	  BCD	  +	  BEH	  +	  CEG	  +	  DGH	  [G]	  =	  G	  +	  ABF	  +	  ACD	  +	  AEH	  +	  BCH	  +	  BDE	  +	  CEF	  +	  DFH	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[H]	  =	  H	  +	  ABD	  +	  ACF	  +	  AEG	  +	  BCG	  +	  BEF	  +	  CDE	  +	  DFG	  [AB]	  =	  AB	  +	  CE	  +	  DH	  +	  FG	  [AC]	  =	  AC	  +	  BE	  +	  DG	  +	  FH	  [AD]	  =	  AD	  +	  BH	  +	  CG	  +	  EF	  [AE]	  =	  AE	  +	  BC	  +	  DF	  +	  GH	  [AF]	  =	  AF	  +	  BG	  +	  CH	  +	  DE	  [AG]	  =	  AG	  +	  BF	  +	  CD	  +	  EH	  [AH]	  =	  AH	  +	  BD	  +	  CF	  +	  EG	  
4.3.2 The	  two	  common	  methods	  of	  PSC	  to	  RPE	  differentiation	  There	   are	   a	   large	   number	   of	   published	  protocols	   for	   the	   differentiation	   of	   PSC	   to	  RPE	   as	  summarised	  in	  the	  literature	  reviews	  of	  Ramsden	  et	  al.	  (2013)	  and	  Rowland	  et	  al.	  (2012).	  These	   are	   split	   into	   two	   main	   methodologies,	   the	   first	   being	   the	   spontaneous	   adherent	  based	  method	  where	  hESC	  colonies	  are	  allowed	  to	  become	  super-­‐confluent	  and	  then	  bFGF	  is	   removed,	   with	   the	   cultures	   then	   being	   maintained	   for	   a	   number	   of	   weeks	   before	  pigmented	  foci	  of	  RPE	  are	  observed	  (Klimanskaya	  et	  al.,	  2004,	  Lund	  et	  al.,	  2006,	  Vugler	  et	  al.,	  2008).	   	  This	  is	  the	  methodology	  followed	  by	  the	  London	  Project	  to	  Cure	  Blindness	  that	  this	  thesis	   is	   in	  collaboration	  with	  and	  so	  is	  the	  basis	  of	  the	  protocol	  used	  in	  this	  Chapter.	  The	   alternate	  method	   involves	   allowing	   dissociated	   hESC	   colonies	   to	   form	   aggregates	   in	  suspension	  which	  are	  then	  maintained	  for	  similar	  time	  periods	  prior	  to	  re-­‐plating	  (Meyer	  et	  al.,	  2009).	  	  
4.3.3 Choosing	  factors	  for	  the	  PSC	  to	  RPE	  screening	  experiment	  There	   are	   a	   large	   number	   of	   potential	   factors	   that	   could	   impact	   the	   efficiency	   of	   the	  differentiation.	  A	  common	  tool	  to	  visually	  represent	  and	  categorise	  factors	  likely	  to	  impact	  on	  a	  system	  is	  the	  Ishikawa	  diagram	  (see	  Figure	  4.3).	  For	  the	  PSC-­‐RPE	  differentiation	  the	  main	   categories	   impacting	   differentiation	  were	   chosen	   to	   be	  media	   components,	   timings	  (e.g.	  differentiation	  periods),	  materials	  (e.g.	  feeder	  free	  systems),	  the	  cells	  (e.g.	  cell	  line),	  the	  environment	  (e.g.	  DO)	  and	  media	  volumes	  (e.g.	  amount	  of	  media	   fed	  to	  the	  cells).	  Further	  consideration	  of	  these	  broad	  categories	  yields	  tens	  of	  potential	  factors	  that	  could	  impact	  the	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differentiation,	   all	   of	  which	   could	   be	   varied	   over	   a	   number	   of	   levels	   in	   combination	  with	  each	  other.	  Therefore	  a	  search	  of	  the	  literature	  and	  past	  experience	  was	  used	  to	  select	  the	  8	  factors	  used	  in	  the	  screening	  experiment.	  Some	  of	  the	  factors	  were	  also	  chosen	  due	  to	  their	  impact	  on	  the	  economics	  of	  the	  process.	  
There	  have	  been	  a	  number	  of	  media	  components	  that	  have	  been	  supplemented	  or	  removed	  from	  the	  media	  to	  try	  and	  increase	  the	  differentiation	  efficiency.	  For	  instance	  Vugler	  et	  al.	  (2008)	  found	  that	  there	  was	  no	  significant	  improvement	  in	  the	  differentiation	  through	  the	  removal	   of	   bFGF.	   This	   is	   despite	   evidence	   in	   the	   embryology	   that	   the	   absence	   of	   FGF	   in	  development	   results	   in	  poor	   regionalisation	  between	  RPE	  and	  neural	   retina,	   a	   result	   that	  can	   be	   reversed	  with	   exogenous	   application	   of	   FGFs	   in	  mouse	   eye	   development	   (Nguyen	  and	   Arnheiter,	   2000).	   Given	   the	   expense	   of	   bFGF	   and	   that	   its	   removal	   is	   the	   only	  media	  component	  changed	  in	  the	  current	  clinical	  protocol	  of	  the	  Moorfields	  group	  (to	  save	  costs),	  it	   was	   decided	   to	   chose	   bFGF	   for	   the	   screening	   experiment	   to	   validate	   this	   decision.	   An	  upper	  concentration	  of	  8ng/ml	  of	  bFGF	  was	  used	   (Figure	  4.4),	  as	  this	  is	  the	  same	  used	  in	  the	  expansion	  media.	  
Other	  signalling	  molecules	  such	  as	  DKK-­‐1	  (Wnt	  inhibitor)	  and	  lefty-­‐A	  (Nodal	  inhibitor)	  have	  been	   added	   at	   the	   start	   of	   differentiation	   protocols	   (~first	   20	   days)	   to	   drive	   the	  differentiation	   towards	  eye	   field	  development,	   increasing	  expression	  of	  retinal	  progenitor	  markers	   such	   as	   RAX	   and	  MITF	  which	   is	   an	   RPE	   progenitor	   cell	  marker	   (Osakada	   et	   al.,	  2009a,	  Hirami	  et	  al.,	  2009,	  Nistor	  et	  al.,	  2010).	   	  However,	  these	  factors	  are	  very	  expensive	  and	   so	  not	  desirable	  when	   scaling	  up	   the	  process.	   Interestingly,	   the	  use	  of	   cheaper	   small	  molecules	  has	  also	  shown	  to	  increase	  RPE	  differentiation	  efficiency,	  for	  example	  Osakada	  et	  al.	   (2009b)	   used	   the	   casein	   kinase	   I	   inhibitor	   CKI-­‐7,	   the	   ALK4	   inhibitor	   SB-­‐431542	   -­‐	   to	  inhibit	   Wnt	   and	   Nodal	   signalling	   respectively.	   With	   this	   in	   mind,	   another	   Wnt	   inhibitor	  IWP-­‐2	  was	  selected	  as	  a	  factor	  for	  this	  screening	  experiment,	  as	  this	  has	  not	  been	  used	  in	  RPE	   differentiation	   before	   but	   has	   been	   used	   in	   cardiomyocyte	   differentiation	   from	  PSCs	  (Lian	  et	  al.,	  2012).	  IWP-­‐2	  Inhibits	  both	  Wnt	  processing	  and	  secretion	  by	  inactivating	  Porcn,	  a	  membrane-­‐bound	  O-­‐acyltransferase	  (MBOAT)	  which	  selectively	  inhibits	  palmitoylation	  of	  Wnt.	  A	  concentration	  of	  10µM	  IWP-­‐2	  was	  chosen	  as	  this	  would	  mean	  the	  centre	  point	  of	  the	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design	  would	  be	  5µM	  which	  matches	  published	  levels	  (Figure	  4.4).	  IWP-­‐2	  was	  only	  added	  for	  the	  first	  20	  days	  of	  the	  differentiation	  to	  match	  the	  protocols	  using	  DKK-­‐1	  and	  the	  casein	  kinase	  I	  inhibitor.	  The	  timing	  of	  the	  addition	  of	  these	  factors	  being	  critical	  as	  Nakano	  et	  al.	  (2012)	   showed	   that	   only	   the	   addition	   of	   CHIR99021	   (GSK3β	   inhibitor	   and	  Wnt	   agonist)	  later	   in	   differentiation	   from	   days	   18-­‐21	   increased	   MITF	   expression.	   Nicotinamide	   is	   the	  amide	   of	   nicotinic	   acid	   (vitamin	   B3/niacin)	   and	   us	   a	   PARP-­‐1	   inhibitor.	   It	   is	   another	  inexpensive	  small	  molecule	   that	  was	  shown	  to	  significantly	   increase	  RPE	  gene	  expression	  (Idelson	  et	  al.,	  2009),	  yet	  its	  use	  had	  produced	  variable	  results	  by	  this	  research	  group	  in	  the	  past	  and	  so	  was	  chosen	  as	  another	  factor	  to	  include	  in	  the	  media	  (Figure	  4.4).	  	  
Seeding	  density	  has	  been	  reported	  to	  have	  a	  significant	  impact	  on	  differentiation	  efficiency	  for	   instance,	   Chambers	   et	   al.	   (2009)	   reported	   that	   the	   initial	   seeding	  density	   of	   PSC	  onto	  matrigel	  determined	  the	  ratio	  of	  central	  nervous	  system	  and	  neural	  crest	  progeny	  with	  an	  ideal	   cell	   density	   being	   18,000	   cells/cm2.	   For	   the	   screening	   experiment	   a	   range	   between	  10,000	  and	  25,000	  cells/cm2	  (Figure	  4.4)	  was	  chosen	  based	  on	  past	  experience.	  	  
From	   initial	   work	   on	   the	   RPE-­‐PSC	   differentiation	   there	   appeared	   to	   be	   a	   relationship	  between	  the	  confluence	  of	  the	  culture	  at	  the	  time	  of	  switching	  to	  the	  differentiation	  media	  and	  the	  differentiation	  efficiency.	  The	  protocol	  published	  by	  Vugler	  et	  al.	  (2008)	  making	  the	  switch	  when	  the	  cultures	  had	  become	  “super”	  confluent,	  whereas	  Lane	  et	  al.	  (2014)	  made	  the	  switch	  uniformly	  at	  day	  10.	  As	  the	  degree	  of	  confluence	  is	  a	  function	  of	  both	  time	  and	  seeding	  density,	  it	  was	  decided	  to	  also	  vary	  the	  time	  at	  which	  this	  switch	  was	  made	  to	  see	  if	  there	  was	  indeed	  an	  interaction.	  High	  and	  low	  values	  were	  chosen	  of	  14	  and	  7	  days	  (Figure	  
4.4).	  
Factors	  which	  are	  often	  poorly	  reported	   in	   the	   literature	  but	  have	  a	  significant	   impact	  on	  the	   economics	   of	   the	   process,	   are	   the	   volumes	   and	   regularities	   of	  media	   changes;	  media	  being	   a	   significant	   cost	   of	   goods	   component	   in	   these	   therapies.	   Furthermore,	   discussion	  with	  those	  working	  on	  the	  PSC-­‐RPE	  protocol	  led	  to	  the	  discovery	  that	  various	  researchers	  at	  the	  London	  project	  were	  using	  a	  wide	  variation	  in	  media	  volumes	  and	  regularity	  of	  media	  changing.	   A	   common	   rationale	   was	   that	   when	   differentiating	   the	   PSC	   culture	   the	   media	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should	  be	   changed	   infrequently	   to	   stress	   the	   cells	   into	  differentiating,	   and	   to	   concentrate	  any	   signalling	   factors.	   To	   explore	  whether	  media	   volume	   or	   frequency	   of	  media	   changes	  had	  an	  impact	  these	  were	  also	  varied	  in	  the	  screening	  experiment.	  The	  volume	  of	  media	  per	  change	  was	  varied	  between	  4	  and	  3	  mL	  in	  a	  single	  well	  of	  a	  6	  well	  plate,	  and	  the	  frequency	  varied	  between	  every	  day	  feeding	  and	  every	  third	  day	  feeding	  (Figure	  4.4).	  
Finally,	  two	  separate	  cell	  lines	  were	  used	  to	  see	  if	  the	  same	  factors	  had	  a	  significant	  impact	  for	   both	   lines.	   The	   lines	   used	   were	   both	   iPS	   lines,	   namely	   BJ	   and	   MSUH001.	   They	   were	  maintained	   in	   a	   feeder	   free	   culture	   using	   the	   mTeSR	   material	   system	   in	   an	   attempt	   to	  reduce	   potential	   variation	   from	   the	   MEF-­‐PSC	   co-­‐culture	   system	   used	   elsewhere	   in	   this	  thesis.	  The	   total	  protocol	  was	   run	   for	  49	  days	   to	  allow	  sufficient	   time	   for	  pigmented	  RPE	  foci	  to	  appear	  even	  in	  conditions	  where	  efficiency	  might	  be	  low	  or	  subject	  to	  an	  initial	   lag	  phase	  due	  to	  a	  later	  switch	  to	  differentiation	  media.	  	  
To	   complete	   the	   screening	   experiment	   as	   described	   20	   runs	   were	   conducted	   in	  experimental	   duplicate	   (40	   runs	   in	   total)	   and	   inputted	   into	   the	   Design	   Expert	   software	  
(Figure	   4.5).	   Triplicate	   data	   points	   were	   considered	   but	   this	   was	   not	   considered	   to	   be	  practically	  feasible.	  	  This	  design	  was	  on	  the	  limits	  of	  what	  was	  practically	  possible	  to	  handle	  as	  a	  single	   individual	  working	  in	  a	   lab.	   It	  required	  14	  different	  types	  of	  media	  to	  be	  made	  and	  delivered	  to	  different	  wells,	  on	  different	  6	  well	  plates,	  in	  different	  volumes	  on	  different	  days,	  over	  a	  49	  day	  protocol.	  The	  well	  plan	  for	  the	  experimental	  protocol	  is	  represented	  in	  
Figure	  4.6.	  
4.3.4 Results	  and	  discussion	  of	  the	  PSC	  to	  RPE	  screening	  experiment	  Both	   the	  BJ	  and	  MSUH001	   lines	  were	   tested	   for	   the	  SSEA-­‐4	  pluripotency	  marker	  via	   flow	  cytometry	   when	   seeded	   and	   were	   found	   to	   have	   expression	   levels	   of	   95%	   and	   94%	  respectively,	  demonstrating	  a	  high	  degree	  of	  pluripotency.	  Both	   lines	  had	  been	  previously	  maintained	   using	   manual	   colony	   dissection	   but	   showed	   good	   replating	   efficiency	   after	  enzymatic	   dissociation	   with	   the	   TrypLE	   Express	   (life	   technologies)	   enzyme	   and	  supplementing	  the	  media	  with	  ROCK	  inhibitor.	  The	  earliest	  point	  at	  which	  the	  switch	  was	  made	   from	   the	  mTeSR	  pluripotency	  media	   to	   the	  differentiation	  media	  was	  7	  days.	  From	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Figure	  4.7	   a)	   and	  b)	   it	   can	  be	   seen	   that	  both	   lines	  were	  highly	   confluent	   at	   the	  D7	   time	  point,	  however	  the	  BJ	  line	  appeared	  to	  have	  slightly	  quicker	  growth	  judging	  by	  the	  D4	  time	  point.	  
A	   large	   amount	   of	   data	  was	   obtained	   for	   the	   20	   duplicate	   runs	   (40	   experimental	   runs	   in	  total).	  Gene	  analysis	  focused	  on	  the	  RPE	  related	  genes	  BEST-­‐1,	  MIT	  F,	  PMEL	  17,	  TYR,	  RPE	  65	  and	   the	   eye	   field	   related	   genes	   OTX	   2	   and	   RAX.	   This	   data	   was	   inputted	   into	   the	   Design	  Expert	  software	  and	  initially	  tested	  using	  the	  Half	  Normal	  Plot	  and	  Pareto	  Charts.	  The	  Half	  Normal	  Plot	  involves	  selecting	  factors	  which	  have	  the	  greatest	  impact	  on	  the	  response	  gene	  e.g.	  OTX	  2	   (See	  Figure	   4.8)	   to	   leave	   those	  which	  do	  not	   have	   a	   significant	   impact	   on	   the	  response	   clustered	   along	   the	   remaining	   straight	   line	   (which	   is	   a	   representation	   of	  experimental	   noise).	   The	   Pareto	   Chart	   (See	  Figure	   4.9)	   is	   an	   alternate	   representation	   of	  this	  same	  selection	  process	  to	  confirm	  the	  factors	  chosen	  are	  above	  the	  statistical	  limits	  of	  significance.	  Unfortunately,	  despite	  obtaining	  data	   for	  all	  7	  genes	   in	   the	  20	  duplicate	  runs	  (40	   in	   total)	   only	  OTX	  2	   and	  TYR	   passed	   these	   first	   tests	   in	   the	   Design	   Expert	   software.	  There	   was	   no	   describable	   expression	   for	   RPE	   65	   gene	   response	   to	   be	   entered	   into	   the	  screening	  model.	  The	  F	  values	  for	  these	  genes	  which	  passed	  the	  significance	  levels	  from	  the	  Pareto	   Chart	   are	   displayed	   in	  Figure	   4.10.	   The	   F	   values	   are	   colour	   coded	   depending	   on	  whether	   they	   were	   greater	   than	   the	   t-­‐limit	   or	   greater	   than	   the	   Bonferroni	   limit.	   The	  Bonferroni	   limits	   controls	   for	   family	   wise	   error	   rate	   which	   is	   an	   issue	   when	   multiple	  hypothesis	  are	  in	  a	  single	  test.	  From	  a	  desired	  outcome	  perspective,	  TYR	  expression	  is	  more	  important	   than	   OTX	   2	   as	   it	   represents	   a	   gene	   involved	   in	   melanin	   synthesis	   and	   so	  indicative	   of	   RPE	   formation.	   Whereas,	   OTX	   2	   is	   an	   eye	   field	   marker	   involved	   in	   RPE	  development	   but	   is	   also	   expressed	   in	   a	   number	   of	   forebrain	   derivatives	   and	   so	   not	   as	  specific	   for	   RPE	   (Larsen	   et	   al.,	   2009).	   Eye	   filed	   genes	   such	   as	   OTX	   2	   and	   RAX	   had	   been	  included	   in	   the	  analysis	   to	   see	   if	   any	   inverse	   trends	  with	   the	  RPE	  specific	  genes	   could	  be	  determined.	  
From	  Figure	  4.10	  it	  would	  appear	  that	  seeding	  density	  has	  a	  positive	  impact	  on	  both	  OTX	  2	  and	  TYR,	  and	  that	  nicotinamide	  could	  potentially	  have	  a	  positive	  impact	  on	  TYR.	  There	  also	  appears	   to	   be	   some	   support	   for	   the	   hypothesis	   that	   feeding	   cells	   less	   often	   increases	   the	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differentiation	   efficiency,	   judging	   by	   the	   response	   for	   differentiation	   media	   volume	   and	  regularity	  of	  media	   change	  on	  TYR	   expression.	   Spent	  media	  was	  analysed	   for	  pH,	  glucose	  and	  lactate	  at	  several	  time	  points	  (using	  a	  YSI	  2700	  media	  analyser)	  and	  fed	  into	  the	  Design	  Expert	   software	   to	   see	   if	   any	   other	   information	   with	   respect	   to	   media	   volumes	   and	  regularity	   of	   media	   volume	   could	   be	   elucidated,	   however	   all	   this	   data	   also	   failed	   the	  statistical	   tests.	   The	   use	   of	   IWP-­‐2	   had	   a	   negative	   impact	   on	   OTX	   2	   and	   TYR,	   with	   these	  cultures	   also	   producing	   a	   large	   amount	   of	   spontaneously	   beating	   cardiomyocytes	  suggesting	   the	   cultures	   had	   not	   been	   efficiently	   driven	   down	   the	   neuroectoderm	   lineage.	  The	  growth	  of	  cardiomyocytes	  was	  understandable	  as	  IWP-­‐2	  has	  been	  shown	  previously	  to	  optimize	  cardiomyocyte	  differentiation	  in	  PSCs	  (Lian	  et	  al.,	  2012).	  It	  could	  therefore	  be	  that	  this	  small	  molecule	  has	  other	  effects	  in	  addition	  to	  being	  a	  Wnt	  inhibitor	  which	  makes	  it	  an	  unsuitable	   replacement	   for	   expensive	   factors	   such	   as	   DKK-­‐1	   in	   RPE	   differentiation	  protocols.	  
The	  results	  of	  the	  percentage	  pigmentation	  analysis	  are	  shown	  in	  (Figure	  4.11).	  When	  this	  data	  was	   imported	   into	   the	  Design	  Expert	   software	   it	   could	   be	   seen	   that	   increasing	   both	  seeding	   density	   and	   increasing	   bFGF	   both	   had	   a	   negative	   impact	   on	   percentage	  pigmentation	  (analysis	  performed	  using	  Software’s	  user	  guides).	  This	  is	  an	  important	  result	  as	   it	   was	   previously	   unclear	   whether	   the	   removal	   of	   bFGF	   had	   any	   clear	   impact	   on	   the	  differentiation	  efficiency,	  it	  being	  removed	  from	  the	  differentiation	  media	  on	  primarily	  cost	  grounds.	  With	   bFGF	  being	   the	  most	   expensive	  part	   of	   the	   culture	  media	   showing	   that	   its	  inclusion	  has	  a	  deleterious	  impact	  on	  differentiation	  could	  mean	  significant	  savings	  as	  the	  process	  is	  scaled	  up.	  
The	  chosen	  factors	  for	  each	  specific	  response	  were	  then	  imported	  into	  the	  ANOVA	  analysis	  section	  of	   the	   software	  analysis	   tool.	  The	  aim	  of	   this	  part	  of	   the	   tool	   is	   to	  match	   the	  data	  with	  a	  computational	  model.	  Unfortunately	  for	  the	  data	  highlighted	  in	  Figure	  4.10,	  none	  of	  the	  proposed	  models	  passed	  the	  software’s	  tests	  for	  significance.	  The	  only	  response	  which	  did	  pass	  the	  tests	  and	  could	  be	  modelled	  was	  the	  OTX	  2	  response.	  However	  as	  this	  gene	  is	  not-­‐RPE	  specific	  to	  the	  desired	  mature	  RPE	  phenotype	  the	  results	  are	  not	  discussed	  here.	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As	   only	   the	   3	   responses	   of	   i)	   percentage	   pigmentation,	   ii)	   OTX	   2	   and	   iii)	   TYR	   were	  compatible	   with	   the	   DoE	   software	   the	   raw	   data	   for	   all	   responses	   was	   also	   plotted	   (see	  
Figures	  4.11,	  4.12,	  4.13).	  From	  these	  plots	  it	  is	  clear	  that	  Run/condition	  4	  was	  clearly	  the	  superior	   condition	   with	   high	   expression	   of	   the	   RPE	   markers	   particularly	   those	   markers	  representative	  of	  the	  mature	  RPE	  phenotype	  such	  as	  BEST-­‐1.	  The	  condition	  for	  Run	  4	  used	  the	  MSUH001	  line,	  without	  bFGF,	  and	  differentiation	  was	  started	  at	  the	  shortest	  time	  point	  of	   7	   days	   but	   at	   the	   highest	   seeding	   density	   of	   25,000	   cells/cm2.	   The	   condition	  was	   also	  supplemented	   with	   the	   highest	   amount	   of	   nicatinamide	   (20µM)	   and	   without	   IWP-­‐2.	  Interestingly,	  if	  only	  the	  Design	  Expert	  software	  had	  been	  relied	  upon	  in	  isolation	  this	  Run	  4	  condition,	   which	   showed	   the	   best	   result,	   would	   not	   have	   been	   flagged	   for	   further	  investigation.	   	  This	  is	  because	  the	  software	  takes	  a	  holistic	  approach	  to	  analysing	  the	  data	  looking	  for	  trends,	  this	  means	  single	  point	  outliers	  are	  not	  immediately	  obvious.	  Especially	  if	  the	  response	  was	  excluded	  from	  the	  analysis	  as	  it	  failed	  to	  meet	  expectance	  criteria	  for	  to	  be	  modelled.	  For	  instance	  the	  response	  could	  be	  very	  low	  and	  so	  fail	  the	  signal	  noise	  ratio	  in	  most	  of	  the	  runs,	  yet	  due	  to	  serendipity	  of	  the	  conditions	  chosen	  a	  very	  high	  response	  might	  be	  seen	  in	  just	  one	  condition.	  	  
4.3.5 Lessons	  learned	  from	  the	  PSC	  to	  RPE	  screening	  experiment	  	  Applying	   the	   DoE	   approach	   to	   screen	   a	   large	   amount	   of	   variables	   for	   the	   PSC-­‐RPE	  differentiation	   proved	   to	   be	   problematic,	   not	   just	   in	   generating	   data	   that	   passed	   the	  software’s	   statistical	   tests	   but	   also	   the	   practicalities	   of	   completing	   the	   experiment.	   The	  complexity	   of	   using	   14	   different	   types	   of	   media	   in	   40	   different	   conditions,	   being	   fed	   on	  different	   days,	   different	   volumes	   of	   media	   over	   a	   49	   day	   protocol	   was	   perhaps	  underestimated.	  It	  was	  disappointing	  that	  a	  large	  amount	  of	  the	  data	  could	  not	  be	  used	  in	  the	  analysis	  software,	   this	   included	  not	  only	  the	  majority	  of	   the	  RPE	  genes	  of	   interest	  but	  also	   the	   spent	   media	   analysis.	   However,	   considerable	   insight	   was	   gleaned	   into	   factors	  influencing	  the	  differentiation	  process.	  
The	  inability	  of	  the	  data	  to	  satisfy	  the	  requirements	  for	  a	  statistical	  model	  could	  be	  due	  to	  a	  number	  of	   reasons.	  The	  most	  probable	   reason	   is	   the	   signal	   noise	   ratio	   of	   the	   experiment	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was	   too	   low.	   The	   centrepoints	   are	   essentially	   technical	   repeats	   of	   the	   same	   condition	   to	  access	  the	  “noise”	  of	  the	  experiment.	  This	  noise	   is	  then	  compared	  to	  the	  “signal”	  obtained	  from	  one	  of	   the	   experimental	   conditions.	   If	   the	  noise	   is	   high	   for	   example	  due	   to	   the	  high	  amounts	  of	  variability	  in	  PSC	  differentiation	  or	  if	  the	  signal	  is	  low	  e.g.	  the	  gene	  expression	  varies	   little,	   there	   will	   be	   a	   low	   signal	   noise	   ratio	   and	   the	   data	   will	   therefore	   fail	   the	  significance	  tests.	  	  
It	  was	  the	  original	  intention	  to	  use	  the	  screening	  experiment	  to	  select	  the	  factors	  of	  greatest	  impact	  on	  the	  PSC-­‐RPE	  differentiation	  to	  inform	  the	  design	  of	  the	  optimisation	  experiment.	  Even	  though	  the	  data	  generated	  from	  the	  screen	  could	  not	  be	  used	  to	  create	  a	  statistically	  valid	  model	  to	  fit	  the	  data	  it	  did	  confirm	  that	  the	  seeding	  density,	  time	  to	  differentiation	  and	  nicotinamide	  may	  have	  an	  impact	  on	  differentiation	  efficiency.	  Therefore,	  these	  were	  the	  3	  factors	  chosen	  and	  taken	  forward	  to	  the	  optimization	  experiment	  as	  planned.	  
4.3.6 Central	  composite	  design	  for	  the	  PSC-­‐RPE	  differentiation	  
experiment	  	  	  For	  the	  optimization	  experiment	  a	  central	  composite	  design	  (see	  Figure	  4.1	  b)	  was	  chosen	  to	  carry	  out	  a	  full	  factorial	  experiment	  to	  allow	  the	  estimation	  of	  second	  order	  relationships	  between	  the	  factors	  and	  target	  result	  as	  part	  of	  response	  surface	  methodology	  (RSM).	  This	  is	  similar	  in	  many	  ways	  to	  the	  screening	  design	  used	  in	  that	  a	  number	  of	  centre	  points	  are	  used	  to	  determine	  the	  noise	  of	  the	  experiment,	  then	  each	  factor	  is	  varied	  at	  both	  high	  and	  low	  iterations.	  However,	  axial	  points	  are	  also	  used.	  These	  points	  essentially	  sit	  outside	  the	  box	  (Figure	  4.1	  b)	  and	  are	  identical	  to	  the	  centre	  points	  except	  for	  1	  of	  the	  factors	  that	  is	  varied	   to	   a	   value	   sitting	  outside	  of	   the	  high	   to	   low	   range.	  This	  high/low	   range	   is	   visually	  represented	  as	  the	  sides	  of	  the	  box,	  and	  the	  axial	  points	  sitting	  off	  these	  faces	  (Figure	  4.1	  
b).	  For	  this	  response	  surface	  design,	  a	  full	  factorial	  experiment	  was	  used	  which	  means	  that	  every	   combination	   of	   factor	   is	   experimentally	   tested	  meaning	   there	   is	   no	   aliasing	   of	   the	  data.	  	  
For	   the	   optimisation	   experiment	   Run	   4	   from	   the	   screening	   experiment	   was	   used	   as	   a	  baseline.	   Also	   to	   reduce	   the	   experimental	   effort	   only	   the	  MSUH001	   line	  was	   used.	   It	  was	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decided	   to	   feed	   the	  cells	  3mL	  of	  media	  every	   third	  day	  as	   the	  screen	  showed	  this	  did	  not	  have	  a	  negative	   impact	  on	   the	  differentiation	   (compared	   to	   feeding	   cells	  4mL	  every	  day).	  Such	   a	   feeding	   regime	   would	   lead	   to	   savings	   if	   the	   process	   was	   scaled	   up.	   Further	  decreasing	  media	  volumes,	  or	  decreasing	  feeding	  regularity	  in	  the	  optimisation	  experiment	  was	  not	  explored	  as	  there	  was	  already	  a	  very	  high	  amount	  of	  cell	  death	  and	  very	  low	  pH’s	  produced	   in	   the	   screen	   (as	   low	   as	   6.5).	   Thus	   reducing	   the	   amount	   of	   media	   fed	   to	   the	  cultures	  any	  further	  could	  lead	  to	  total	  cell	  death	  in	  the	  Run(s)	  which	  would	  lead	  to	  missing	  data	  points.	  	  
In	  the	  screening	  experiment,	  nicotinamide	  was	  varied	  between	  0-­‐20	  mM	  which	  appeared	  to	  have	   some	  positive	   impact	   on	  OTX	  2	   and	  TYR	  (Figure	   4.10).	   It	  was	   thought	   that	   greater	  concentration	   of	   nicotinamide	   could	   increase	   this	   further	   and	   so	   in	   the	   optimisation	  experiment	  a	  range	  of	  10-­‐30mM	  nicotinamide	  was	  used	  (Figure	  4.14	  a).	  Altering	  seeding	  density	  also	  impacted	  the	  expression	  of	  OTX	  and	  TYR.	  Yet,	  somewhat	  counter	  intuitively,	  it	  appeared	  to	  have	  a	  negative	  impact	  on	  percentage	  pigmentation	  (Figure	  4.10).	  	  The	  paper	  by	   Lane	   et	   al.	   (2014)	   reports	   findings	   based	   on	   single	   cell	   seeding	   of	   PSCs	   at	   various	  densities	   for	   the	   PSC-­‐PRE	  differentiation	   in	   a	   feeder	   free	   system.	   They	   reported	   not	   only	  that	  single	  cell	  seeding	  produced	  better	  yields	  than	  traditional	  manual	  passaging	  of	  colony	  clumps,	   but	   in	   addition	   increasing	   seeding	   density	   from	   17,000	   cells/cm2	   to	   35,000	  cells/cm2	   increased	   the	   pigmented	   surface	   area	   five-­‐fold.	   However,	   at	   seeding	   densities	  greater	   than	   35,000	   cells/cm2	   RPE	   differentiation	   was	   arrested.	   Therefore,	   for	   the	  optimisation	  experiment	  the	  seeding	  density	  range	  was	  widened	  from	  the	  13,000	  cells/cm2	  to	  25,000	  cells/cm2	  used	  in	  the	  screen	  	  (Figure	  4.5)	  to	  13,000	  cells	  to	  37,000	  cells/cm2	  for	  the	  optimisation	  experiment	  (Figure	  4.14	  a).	  Finally,	  the	  range	  of	  time	  passed	  prior	  to	  the	  switch	   to	   differentiation	  media	  was	   also	   changed	   for	   the	   optimisation	   experiment.	   In	   the	  original	   screening	   experiment	   the	   earliest	   change	   to	   differentiation	  media	   was	   day	   7,	   at	  which	  point	  all	   the	  conditions	  were	   fully	  confluent	  (Figure	   4.7).	  Based	  on	  previous	  work	  (data	  not	  shown)	  interesting	  results	  had	  been	  obtained	  when	  the	  switch	  was	  made	  prior	  to	  confluency.	   Therefore,	   the	   range	  was	   changed	   from	   the	   high	   and	   low	   values	   of	   7	   and	   15	  used	   in	   the	   screen	   (Figure	   4.4)	   to	   3	   days	   (72	   hours)	   and	   11	   days	   (264	   hours)	   in	   the	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optimisation	   experiment	   (Figure	   4.14	   a).	  The	  upper	   limit	  was	   reduced	   from	  15	   to	  11	   as	  from	  looking	  at	  the	  raw	  data	  the	  15	  day	  cultures	  had	  no	  clear	  improvement	  over	  the	  others	  and	  11	  days	  is	  closer	  to	  the	  standard	  protocol	  used	  with	  success	  in	  the	  Moorfields	  group.	  	  
Using	   the	   Stat	   Ease	   software	   the	   3	   factors	   of	   i)	   time	   to	   differentiation,	   ii)	   nicotinamide	  concentration	   and	   iii)	   seeding	   density	   were	   inputted	   into	   the	   Central	   Composite	   design	  builder	  (Figure	  4.14).	  As	  the	  alpha	  values	  sit	  below	  the	  lower	  and	  upper	  range	  of	  the	  values	  chosen	  the	  true	  range	  of	  the	  experiment	  is	  actually	  larger.	  For	  instance	  the	  chosen	  range	  of	  seeding	  density	  was	  13,000	  cells	  to	  37,000	  cells/cm2,	  however,	  due	  to	  the	  alpha	  values	  the	  lowest	   seeding	   density	   to	   be	   experimented	   with	   was	   4,819	   (-­‐alpha)	   and	   highest	   45,182	  (+alpha).	  For	  the	  time	  to	  differentiation	  factor	  the	  –alpha	  was	  only	  6.55	  hours,	  this	  meant	  that	  the	  media	  mTeSR	  media	  containing	  ROCK	  inhibitor	   in	  which	  the	  cells	  were	  seeded	  in	  was	   swapped	   for	   the	   differentiation	   media	   after	   only	   6.55	   hours.	   Each	   experimental	  condition	  was	  repeated	  twice	  as	  technical	  repeats	  (Figure	  4.14	  b).	  Through	  consultation	  of	  the	   Design	   Expert	   help	   function	   tutorials	   a	   total	   of	   5	   centre	   points	   were	   used	   and	   a	  “rotatable”	   alpha	   applied	   (Figure	   4.14	   b).	   Finally	   by	   selecting	   a	   full	   factorial	   design	   (to	  remove	  aliasing)	  a	  total	  of	  33	  runs	  were	  required	  (Figure	  4.14	  c).	  The	  description	  of	  each	  of	  these	  Runs	  is	  presented	  in	  Figure	  4.15.	  	  
4.3.7 Results	  and	  discussion	  of	  the	  central	  composite	  PSC-­‐RPE	  
differentiation	  experiment	  As	  for	  the	  screening	  experiment,	  the	  pluripotency	  of	  the	  seeded	  population	  of	  the	  MSUH001	  was	  tested	  for	  the	  SSEA-­‐4	  market	  via	  flow	  cytometry	  with	  93%	  of	  cells	  proving	  positive	  (for	  the	   screening	   experiment	   94%	  of	   the	   cells	  were	   positive).	   The	   growth	   of	   the	   cells	   at	   the	  13,000	   and	   25,000	   cells/cm2	   were	   also	   very	   similar	   to	   that	   seen	   in	   the	   screening	  experiment	  (Figure	   4.16	   compared	  to	  Figure	   4.7	   b).	  Even	  at	   the	   lowest	  density	  of	  4,818	  cells/cm2	   a	   good	  degree	  of	   confluency	  was	   achieved	   (Figure	   4.16).	   In	   addition,	   changing	  the	  media	  only	  6.55	  hours	  after	  seeding	  (as	  was	  required	  in	  some	  of	  the	  conditions)	  did	  not	  negatively	  impact	  this	  conditions	  ability	  to	  achieve	  good	  confluence	  by	  day	  7.	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One	   clearly	   observable	   difference	   from	   the	   screening	   experiment	  was	   the	   high	   degree	   of	  pigmentation	   seen	   in	   the	   cultures,	  with	   a	  maximum	  pigmentation	  of	  8.2%	  compared	   to	   a	  maximal	  value	  of	  only	  0.32%	  in	  the	  screening	  experiment.	  A	  range	  of	  pigmentations	   from	  0.4%	   to	   6.9%	   is	   shown	   in	   Figure	   4.17,	   to	   illustrate	   this	   difference	   and	   the	   raw	  pigmentation	   data	   at	   D49	   is	   presented	   in	   the	   chart	   of	   Figure	   4.18.	   The	   improved	  performance	  was	  assumed	  to	  be	  a	  result	  of	  taking	  the	  best	  performing	  run	  from	  the	  screen	  (Run	  4)	  as	  a	  baseline	   for	  conditions	   to	  be	  used	   in	   the	  optimization	  experiment.	  When	  the	  percentage	   pigmentation	   data	   was	   imported	   into	   the	   Design	   Expert	   software	   the	   data	  passed	  the	  various	  inbuilt	  validation	  tests,	  such	  as	  the	  normal	  plot	  of	  residues	  all	  sitting	  on	  the	   same	   line	   (data	   not	   shown),	   this	   allowed	   the	   data	   to	   be	   successfully	  modelled.	   The	   F	  value	   for	   the	  model	  was	  40.62	  which	  meant	   that	   there	  was	  only	  a	  0.01%	  chance	  that	   this	  could	  be	  due	  to	  noise.	  The	  F	  value	  being	  used	  as	  a	  measure	  of	  whether	  the	  expected	  values	  of	   a	   quantitative	   variable	   within	   several	   pre-­‐defined	   groups	   differ	   from	   each	   other.	   The	  significant	  model	  terms	  at	  a	  5%	  confidence	  interval	  were	  A,	  B,	  C,	  AB,	  AC,	  BC,	  B2,	  C2,	  where	  A	  =	  Seeding	  Density,	  	  B	  =	  Time	  to	  differentiation,	  C	  =	  nicotinamide	  concentration.	  This	  meant	  that	  not	  only	  do	   the	   factors	  chosen	  have	  a	   significant	   impact	  on	  percentage	  pigmentation	  but	   that	   there	   are	   a	   number	   of	   two	   factor	   interactions	   involved.	   These	  would	   have	   been	  very	  hard	  to	  elucidate	  using	  traditional	  experimental	  approaches	  as	  can	  been	  seen	  from	  the	  model’s	  equation	  below.	  
Percentage	  Pigmentation	   	  =	  2.48	   	  -­‐8.44E-­‐05	   	  *	  Seeding	  Density	  -­‐0.00086	   	  *	  Time	  to	  differentiation	  0.16	   	  *	  Nicotinamide	  1.6E-­‐07	   	  *	  Seeding	  Density	  *	  Time	  to	  differentiation	  1.36E-­‐06	   	  *	  Seeding	  Density	  *	  Nicotinamide	  0.00025	   	  *	  Time	  to	  differentiation	  *	  Nicotinamide	  2.02E-­‐10	   	  *	  Seeding	  Density^2	  -­‐3.30E-­‐05	   	  *	  Time	  to	  differentiation^2	  -­‐0.0064	   	  *	  Nicotinamide^2	  	  
The	  model	  created	  using	  the	  significant	  terms	  is	  then	  employed	  to	  create	  contour	  plots	  to	  analyse	  trends	  in	  the	  data.	  Plots	  of	  seeding	  density	  versus	  time	  to	  differentiation	  at	  varying	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concentrations	  of	  nicotinamide	  are	  represented	  in	  Figure	  4.19.	  From	  these	  plots,	  its	  clear	  that	  an	  increase	  from	  10mM	  nicotinamide	  to	  20mM	  increases	  the	  percentage	  pigmentation	  across	   the	   ranges	   chosen	   for	   seeding	   density	   and	   time	   to	   differentiation.	   Visually	   this	   is	  seen	   as	   a	   “warming”	   of	   the	  plots	   and	   the	  percentage	  pigmentation	   values	   on	   the	   contour	  lines.	  However,	  an	   increase	   to	  30mM	  nicotinamide	  has	  a	  deleterious	   impact	  (Figure	   4.19	  
c).	   An	   alternate	   way	   of	   representing	   this	   same	   data	   is	   to	   plot	   seeding	   density	   Vs	  nicotinamide	  concentration	  and	  then	  generate	  unique	  plots	  for	  the	  range	  of	  values	  chosen	  for	   time	   to	   differentiation	   (Figure	   4.20).	   From	   these	   contour	   plots,	   it	   can	   be	   seen	   that	  increasing	  the	  time	  before	  the	  swap	  to	  differentiation	  media	  is	  made	  from	  72	  to	  120h,	  the	  optimum	  operating	  space	   is	  reduced	   (Figure	   4.20	   a)	   and	  b).	  Further	   increasing	   the	   time	  period	  to	  168h	  has	  a	  further	  negative	  effect	  on	  percentage	  pigmentation	  Figure	  4.20	  c).	  In	  addition	   from	   these	   plots	   (Figure	   4.19	   and	   Figure	   4.20)	   it	   can	   be	   observed	   that	   the	  optimum	   condition	   for	   the	   differentiation	   to	   optimise	   percentage	   pigmentation	   occurs	   at	  lower	   values	   of	   time	   to	   differentiation	   and	   seeding	   density,	   than	   that	   were	   used	   in	   the	  design.	   Using	   the	   built	   in	   optimisation	   algorithm	   of	   the	   Design	   Expert	   software	   the	   best	  conditions	   to	   maximise	   percentage	   pigmentation	   were	   found	   to	   be	   a	   nicotinamide	  concentration	  of	  15mM,	  seeding	  density	  and	  13,000	  cells/cm2	  and	  time	  to	  differentiation	  of	  75	   hours	   (Figure	   4.21).	   Such	   settings	   are	   predicted	   by	   the	   model	   to	   yield	   an	   optimum	  percentage	  pigmentation	  of	  7.82%.	  The	  seeding	  density	  value	  is	  right	  on	  the	  edge	  of	  the	  plot	  which	  further	  suggests	  that	  the	  lower	  seeding	  densities	  would	  produce	  even	  better	  results	  and	  so	  that	  the	  design	  space	  has	  missed	  the	  optimum.	  	  
As	   with	   the	   screening	   experiment,	   the	   data	   for	   gene	   expression	   mostly	   failed	   the	  significance	   tests	   of	   the	   Design	   Expert	   software	   and	   so	   could	   not	   be	   used	   to	   generate	  models	   and	   contour	   plots	   which	   would	   allow	   the	   optimisation	   algorithm	   to	   be	   run	   and	  visualised.	  The	  exception	  was	  PMEL	  that	  did	  pass	  these	  tests.	  This	  was	  fortuitous	  as	  PMEL-­‐
17	   is	  a	  key	  RPE	  associated	  gene	   involved	  in	  the	  melanosome	  and	  is	  controlled	  by	  another	  highly	  RPE	  associated	  gene	  MIT	  F	  (Baxter	  and	  Pavan,	  2003).	  MIT	  F	  was	  also	  included	  in	  the	  analysis	  but	   failed	  data	  validation	  tests.	  This	  could	  be	  due	  to	  the	  PMEL17	   transcript	  being	  expressed	   highly	   in	   absolute	   numbers	   (copies	   of	   mRNA)	   therefore	   the	   fold	   changes	   or	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signal	   are	   larger	   compared	   to	   the	   experimental	   noise.	   Whereas	  MITF	   as	   a	   transcription	  factor	   only	   varies	   over	   a	   small	   range	   in	   mRNA	   numbers	   but	   has	   a	   big	   impact	   on	  downstream	   transcripts.	   To	   fit	   the	   validation	   requirements	   of	   the	   data,	   the	   software	  recommended	   the	   data	   underwent	   a	   square	   root	   transformation	   hence	   the	   label	  sqrt(PMEL)	  in	  the	  Figures.	  This	  also	  means	  that	  the	  values	  from	  the	  contour	  plots	  require	  squaring	  for	  them	  to	  be	  transformed	  back	  to	  normalized	  fold	  expression	  data.	  As	  with	  the	  percentage	  pigmentation	  data,	  the	  F	  value	  (21.01)	  for	  the	  pigmentation	  data	  was	  significant	  with	   there	   being	   only	   a	   0.01%	   chance	   that	   this	  was	   due	   to	   noise.	   The	   “lack	   of	   fit”	   of	   the	  model	   was	   also	   determined	   by	   the	   software	   to	   be	   insignificant.	   The	   significant	   factors	  having	   an	   impact	   on	   the	   PMEL	   expression	   at	   the	   5%	   confidence	   interval	   were	   slightly	  narrower	   than	   that	   were	   found	   for	   the	   percentage	   pigmentation	   response	  with	   only	   the	  terms	   A,	   B,	   C,	   AB,	   AC,	   C2	   having	   an	   impact.	   As	   these	   terms	   are	   significant	   the	   software	  includes	  them	  as	  part	  of	  the	  PMEL	  response	  model,	  for	  which	  the	  equation	  is	  below.	  
Sqrt(PMEL)	   	  =	  1.59	   	  -­‐3.85E-­‐05	   	  *	  Seeding	  Density	  -­‐0.0065	   	  *	  Time	  to	  differentiation	  0.079	   	  *	  Nicotinamide	  9.78E-­‐08	   	  *	  Seeding	  Density	  *	  Time	  to	  differentiation	  9.54E-­‐07	   	  *	  Seeding	  Density	  *	  Nicotinamide	  7.17E-­‐05	   	  *	  Time	  to	  differentiation	  *	  Nicotinamide	  -­‐2.045E-­‐10	   	  *	  Seeding	  Density^2	  2.56E-­‐06	   	  *	  Time	  to	  differentiation^2	  -­‐0.0031	   	  *	  Nicotinamide^2	  Using	  these	  terms	  the	  Design	  Expert	  software	  outputs	  the	  contour	  plots	  in	  Figure	  4.22	  and	  
4.23.	   For	   plots	   of	   seeding	   density	   Vs	   time	   to	   differentiation	   at	   increasing	   nicotinamide	  concentration	  (Figure	  4.22	  a)	  10mM,	  b)	  20mM,	  c)	  30mM)	  the	  trend	  for	  PMEL	  expression	  is	  very	  similar	  as	  that	  which	  was	  seen	  for	  percentage	  pigmentation	  (Figure	  4.19).	  The	  PMEL	  plots	  of	  seeding	  density	  Vs	  nicotinamide	  concentration	  at	  different	  time	  points	  prior	  to	  the	  swap	   to	   differentiation	   media	   are	   also	   highly	   similar	   to	   those	   observed	   for	   percentage	  pigmentation	  (comparison	  of	  Figure	  4.23	  to	  4.20).	  These	  correlations	  are	  understandable	  due	  to	  the	  link	  between	  the	  PMEL	  gene	  and	  the	  pigmented	  phenotype.	  Using	  the	  software	  to	  predict	   the	   optimum	   condition	   based	   on	   PMEL	   alone	   produced	   a	   slightly	   different	   result	  than	  when	  an	  optimisation	  was	  performed	  on	  percentage	  pigmentation	  alone	  (comparison	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of	   Figure	   4.24	   to	   Figure	   4.21).	   The	   difference	   being	   for	   PMEL	   optimization	   a	   slightly	  higher	  nicotinamide	   concentration	  of	   15.13mM	   is	   required	   (compared	   to	  15mM)	  and	   the	  seeding	  density	  and	  time	  to	  differentiation	  parameters	  sit	  in	  the	  bottom	  corner	  at	  72	  hours	  (compared	  to	  75h),	  and	  13,000	  cells/cm2.	  This	  PMEL	  optimization	  data	  further	  suggests	  the	  optimum	  conditions	  lay	  outside	  the	  design	  space.	   	  The	  Design	  Expert	  software	  also	  allows	  optimization	  based	  on	  more	  than	  one	  response,	  and	  a	  weighting	  to	  be	  given	  to	  the	  preferred	  response.	  Based	  on	  an	  equal	  rating	  of	  PMEL	  and	  percentage	  pigmentation	  the	  plot	  in	  Figure	  
4.25,	  was	  generated	  which	  essentially	  recommends	  the	  same	  parameters	  as	  for	  the	  PMEL	  expression	   optimization,	   again	   confirming	   the	   actual	   optimum	   is	   likely	   to	   be	   outside	   the	  design	  space.	  	  
The	  gene	  expression	  data	  which	  failed	  to	  produce	  significant	  models	   in	  the	  Design	  Expert	  software	  was	  plotted	  against	  PMEL	  to	  see	  if	  any	  clustering	  could	  be	  observed	  (Figure	  4.26).	  Understandably,	  PMEL,	  MIT	  F	  and	  TYR	  all	  showed	  similar	  clustering	  as	  they	  are	  all	  involved	  in	  pigmentation	  pathways.	  Interestingly	  two	  key	  RPE	  genes	  which	  are	  representative	  of	  the	  most	   mature	   phenotype	   BEST	   and	   RPE	   65	   (Idelson	   et	   al.,	   2009)	   show	   slightly	   different	  trends	  .	  These	  genes	  are	  not	  directly	  part	  of	  the	  pigmentation	  pathways	  with	  the	  bestrophin	  protein	  being	  present	  on	  the	  basolateral	  plasma	  membrane	  of	  mature	  RPE	  cells	  and	  RPE	  65	  being	   involved	   in	   the	   vision	   cycle	   (Marmorstein	   et	   al.,	   2000).	   In	  particular	  RPE	  65	   shows	  some	  strong	  expression	  at	  some	  of	  the	  very	  lower	  concentrations	  of	  nicotinamide	  (3.18mM)	  where	   all	   the	   other	   pigmentation	   genes	   show	   weak	   expression	   (Figure	   4.26).	   This	   is	  confirmed	  when	  plots	  are	  made	  of	  gene	  expression	  Vs	  nicotinamide	  concentrations	  (Figure	  
4.27	  and	  Figure	  4.28)	  which	  shows	  RPE	  65	  expression	  is	  unique	  in	  that	  it	  is	  highest	  at	  the	  lowest	  nicotinamide	  concentration.	  Furthermore,	  RPE	  65	  displays	  the	  opposite	  relationship	  to	   seeding	   density	   when	   plots	   of	   gene	   expression	   Vs	   seeding	   density	   are	   made	   (Figure	  
4.29,	  Figure	   4.30),	  with	  a	  higher	   seeding	  density	  producing	  a	  higher	  RPE	  65	  expression.	  This	  could	  be	  suggestive	  of	  there	  being	  two	  subtypes	  of	  RPE	  being	  present	  e.g.	  an	  immature	  and	  a	  more	  mature	  phenotype,	   it	  also	   indicates	   that	  perhaps	  nicotinamide	  should	  only	  be	  supplemented	  to	  the	  media	  during	  a	  particular	  window	  if	  there	  is	  an	  inhibitory	  effect.	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4.4 Conclusions	  
4.3.8 The	  feasibility	  of	  applying	  DoE	  methodology	  to	  the	  PSC-­‐RPE	  
differentiation	  The	  aim	  of	  this	  chapter	  was	  to	  explore	  the	  feasibility	  of	  applying	  the	  DoE	  approach	  to	  the	  PSC-­‐RPE	  differentiation,	   as	   it	  was	   the	  hope	   that	   the	  methodology	  would	  not	  only	   identify	  new	  significant	  factors	  but	  also	  generate	  an	  understanding	  of	  any	  complex	  interactions.	  By	  first	  completing	  a	  screening	  experiment	  of	  a	  large	  number	  of	  factors	  it	  was	  hoped	  that	  using	  this	   approach	   the	   factors	  with	   the	   largest	   impact	   could	   be	   easily	   identified	  with	  minimal	  effort	   through	  use	  of	   a	   rationalised	  design	   involving	  aliasing.	   In	  practice,	  due	   to	   the	   large	  number	  of	   experimental	   conditions	   and	  variations	  of	  media	   it	  was	  practically	   complex	   to	  complete	  the	  experiment	  as	  planed	  over	  the	  49	  day	  protocol.	  The	  experiment	  did	  however	  give	  good	  confidence	   that	  seeding	  density,	   time	  before	  switching	   to	  differentiation	  media,	  and	  nicotinamide	  concentration	  were	  important	  to	  improving	  the	  differentiation	  efficiency,	  even	   if	   the	   effects	   could	   not	   be	   quantitatively	   modelled.	   The	   screen	   also	   showed	   that	  reducing	  media	  feeding	  from	  every	  day	  to	  every	  3rd	  day	  and	  reducing	  the	  media	  volumes	  by	  25%	  actually	  had	  a	  positive	   impact.	  At	   the	  extreme	  this	  means	  a	  reduction	   in	   total	  media	  used	   of	   75%	   and	   so	   would	   have	   a	   significant	   impact	   on	   the	   process	   economics	   as	   this	  process	  scales.	  	  
Using	  the	  key	  factors	   identified	  from	  the	  screen	  the	  central	  composite	  design	  was	  used	  to	  better	  understand	   the	   interactions	  between	   the	  key	   factors	   so	  as	   to	  be	  able	   to	  predict	   an	  optimum.	  From	  the	  raw	  data	  points	  plotted	   in	  Figure	   4.25	   to	  Figure	   4.28	   it	   can	  be	  seen	  just	   how	   noisy	   some	   of	   the	   raw	   data	   is	   for	  what	   are	   technical	   repeats.	   Such	   variation	   is	  common	  issue	  in	  PSC	  differentiation	  where	  protocols	  are	  highly	  manual,	  and	  given	  the	  long	  length	   of	   this	   protocol	   in	   particular	   (49	   days)	   there	   is	   plenty	   of	   time	   for	   any	   small	  differences	   to	   be	   magnified.	   So,	   although	   qPCR	   is	   a	   very	   sensitive	   analytical	   test	   in	  determining	  small	  differences	   in	  gene	  expression	  between	  similar	   conditions	  perhaps	   the	  “signal”	  of	  the	  test	  is	  not	  sufficient	  to	  be	  used	  in	  a	  robust	  manner	  in	  software	  packages	  such	  as	  Design	  Expert	  as	  part	  of	  DoE	  approaches.	   It	   should	  also	  be	  noted	   that	  gene	  expression	  does	   not	   equal	   protein	   expression,	   and	   there	   are	   likely	   to	   be	   a	   number	   of	   post
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transcriptional	   processes	   as	   well	   as	   post	   translational	   processes	   involved	   in	   the	  differentiation.	  The	  good	  correlation	  between	  PMEL	  and	  percentage	  pigmentation	  does	  give	  confidence	  that	  such	  factors	  are	  not	  having	  a	  significant	  impact	  in	  this	  differentiation	  .The	  ANNOVA	  analysis	   tests	   this	  using	   a	   term	  called	   “adequate	  precision”	  which	  measures	   the	  signal	   to	   noise	   ratio	   where	   a	   ratio	   of	   greater	   than	   4	   is	   described	   as	   “desirable”.	   For	   the	  optimisation	   experiment,	   the	   two	   responses	   which	   passed	   all	   the	   tests	   had	   adequate	  precision	  ratio	  of	  22	  for	  percentage	  pigmentation	  and	  for	  PMEL	  it	  was	  over	  16.	  	  
The	  question	  then	  has	  to	  be	  asked	  what	  marker/output	  should	  be	  optimised	  for?	  For	  this	  stage	  of	  the	  process	  the	  aim	  is	  to	  gain	  as	  much	  pigmentation	  in	  the	  cultures	  as	  possible	  so	  that	  they	  can	  be	  visually	  identified	  and	  dissected.	  Therefore,	  using	  percentage	  pigmentation	  as	  the	  critical	  quality	  attribute	  is	  probably	  most	  desirable.	  Even	  though	  the	  gene	  expression	  for	  RPE	  65	  and	  BEST	  might	  not	  directly	  correlate	  with	  the	  conditions	  that	  provide	  maximum	  percentage	   pigmentation	   at	   this	   stage	   in	   the	   process,	   it	   could	   be	   hypothesized	   that	   once	  these	   pigmented	   areas	   are	   successfully	   replated	   and	   allowed	   to	   mature	   a	   positive	  correlation	  would	  occur.	  	  
From	  a	  feasibility	  perspective,	  where	  the	  DoE	  approach	  was	  particularly	  successful	  was	  in	  the	   identification	   and	   modelling	   of	   a	   particularly	   complex	   interaction	   between	   seeding	  density,	   time	   to	   differentiation	   and	   nicotinamide	   concentration.	   One	   issue	   was	   that	   the	  predicted	   optimum	   lay	   at	   the	   very	   lowest	   position	   of	   the	   seeding	   density	   and	   time	   to	  differentiation	  time	  points	  used,	  and	  so	  there	  is	  a	  high	  likelihood	  that	  the	  true	  optimum	  was	  missed.	   It	   is	   not	   believed	   that	   this	   could	   have	   been	   anticipated	   when	   planning	   the	  experiment	   as	   the	   finding	  was	   contrary	   to	   the	   past	   experience	   of	   the	   research	   team.	  The	  current	   protocol	   involves	   prolonged	   feeding	   of	   PSC	   cultures	   to	   allow	   them	   to	   become	  “super	  confluent”	  before	   the	  switch	   to	  differentiation	  media	   is	  made	  (Vugler	  et	  al.,	  2008).	  Therefore	  making	  the	  switch	  after	  only	  6.55	  hours	  in	  the	  –alpha	  condition	  was	  considered	  to	  be	  a	  high	  risk	   in	   the	  planning	  stage,	  as	   it	  was	   feared	   that	  all	   the	  cells	   could	  be	  washed	  away	  if	  they	  had	  not	  successfully	  seeded	  or	  that	  growth	  would	  be	  so	  poor	  no	  RPE	  would	  be	  produced.	  For	  future	  work	  it	  would	  be	  interesting	  to	  see	  what	  the	  impact	  of	  seeding	  straight	  into	  differentiation	  media	  would	  be.	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With	  regards	  to	   the	  optimisation	  plots	  showing	  that	   lowest	  seeding	  densities	  produce	  the	  best	  differentiation	   conditions,	   this	  was	  a	   good	   result	   in	   that	   it	   confirmed	  what	  was	   seen	  from	   the	   screening	   experiment	   F	   values	   (Figure	   4.10).	   However,	   these	   results	   are	   very	  different	  from	  the	  conclusions	  drawn	  from	  Lane	  et	  al.	  (2014)	  who	  reported	  that	  an	  increase	  of	   seeding	   density	   from	   17,000	   cells/cm2	   to	   35,000	   cells/cm2	   increased	   the	   pigmented	  surface	  area	  five-­‐fold.	  This	  data	  was	  the	  reason	  why	  the	  upper	  seeding	  density	  used	  in	  the	  screen	   (25,000	   cells/cm2)	  was	   increased	   for	   the	   optimisation	   experiment	   to	   37,000	   cells	  /cm2.	  There	  are	  a	  number	  of	  factors	  that	  could	  explain	  this	  observed	  discrepancy.	  The	  first	  is	   that	  not	  only	   that	  different	  PSC	   lines	  were	  used,	  which	  often	   lead	   to	  discrepancies,	  but	  also	  that	  the	  cells	  used	  in	  this	  work	  were	  iPS	  cells	  were	  rather	  than	  hESC	  lines	  used	  by	  Lane	  et	   al.	   (2014).	   But,	   perhaps	  more	   importantly	  was	   the	  use	   of	  ROCK	   inhibitor	   in	   this	   study	  which	  increases	  PSC	  survival	  during	  replating	  (Claassen	  et	  al.,	  2009)	  and	  supplementing	  the	  various	   conditions	  with	  nicotinamide	  has	   also	  been	   reported	   to	   improve	  neural	   stem	  cell	  survival	   in	   vitro	   (Li	   et	   al.,	   2006,	   Shen	   et	   al.,	   2004).	   Therefore	   both	   these	   agents	   could	   be	  responsible	   in	   part	   for	   a	   shift	   in	   the	   location	   of	   the	   optimum	   seeding	   density	   below	   the	  range	  chosen	  for	  optimisation	  design.	  	  
It	   would	   also	   be	   normal	   to	   confirm	   the	   optimum	   predicted	   from	   the	   data	   with	   a	   final	  experiment.	  However,	  in	  this	  case	  as	  appears	  that	  the	  true	  optimum	  was	  slightly	  missed	  due	  to	   the	  ranges	  used,	  and	  that	   the	  protocol	   takes	  several	  months	   from	  start	   to	   finish,	   it	  was	  believed	  this	  was	  not	  the	  best	  use	  of	  time	  and	  resources.	  A	  large	  amount	  of	  other	  data	  was	  also	   recorded	   for	   the	   optimization	   experiment	   such	   as	   percentage	   pigmentation	   image	  analysis	  at	  other	   time	  points	  and	  also	  analysing	  spent	  media.	  A	  number	  of	   these	   tests	  did	  produce	  data	  that	  did	  pass	  the	  validation	  requirements	  of	  the	  software	  to	  produce	  models,	  but	  were	  not	  discussed	  here	  for	  the	  sake	  of	  brevity	  as	  they	  were	  not	  directly	  related	  to	  the	  RPE	  phenotype.	  	  It	  would	  be	  hoped	  that	  if	  this	  non-­‐destructive	  and	  quick	  to	  obtain	  data	  was	  collected	  over	  a	  number	  of	  experiments	  it	  could	  be	  used	  as	  proxy	  measurements	  to	  predict	  quality	  attributes	  such	  as	  gene	  expression.	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4.3.9 Summary	  Where	  there	  is	  a	  need	  to	  understand	  a	  complex	  relationship	  of	  a	  limited	  number	  of	  factors	  which	   impact	  a	  differentiation	  processes’	  critical	  attributes	  the	  DoE	  approach	  is	  a	   feasible	  and	  powerful	  tool	  to	  give	  real	  insights.	  For	  example,	  the	  data	  here	  has	  shown	  evidence	  that	  the	   media	   consumption	   can	   be	   reduced	   by	   75%	   without	   any	   adverse	   effect	   on	   the	  differentiation,	   the	   lowest	   seeding	   densities	   give	   the	   best	   results	   which	   will	   improve	  economics	  by	  reducing	  the	  seed	  chain	  requirements.	  Furthermore,	  differentiation	  efficiency	  was	  shown	  to	  be	  improved	  by	  the	  addition	  of	  a	  very	  cheap	  small	  molecule	  (nicotinamide)	  but	   that	   there	   is	   an	   optimum	   that	   needs	   to	   be	   understood	   which	   is	   impacted	   by	   a	  combination	   of	   seeding	   density	   and	   time	   to	   differentiation.	   This	  might	   explain	   the	  mixed	  results	  this	  lab	  has	  achieved	  with	  nicotinamide	  before.	  	  However,	  the	  application	  of	  DoE	  as	  a	   screening	   tool	   for	   PSC	   differentiation	   really	   requires	   high	   throughput	   automation	  methods	   to	   both	   culture	   the	   cells	   but	   also	   mix	   the	   media	   components.	   Combining	   such	  methods	   with	   technologies	   that	   allow	   close	   control	   of	   the	   environment	   should	   not	   only	  reduce	  variation,	  and	  so	  solve	  the	  signal	  to	  noise	  ratio	  issues,	  but	  also	  allow	  conditions	  such	  as	  hypoxia	  during	  differentiation	   to	  be	  explored.	  For	  example,	  hypoxia	  has	  been	   found	   to	  increase	  RPE	  related	  pathways	  such	  as	  PEDF	  secretion	   in	  Müller	   cells	   (Yang	  et	  al.,	  2012).	  Ideally,	  if	  this	  could	  be	  coupled	  up	  to	  online	  image	  analysis	  of	  percentage	  pigmentation	  the	  process	   would	   not	   only	   be	   better	   understood	   but	   interventions	   could	   be	   made	   to	   both	  optimize	  the	  end	  result	  and	  increase	  process	  robustness.	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Figure'4.2:'Design'Expert'visual'representation'of'number'of'runs'required'for'2'level'
designs.'As#the#number#of#factors#are#increased#for#a#2Llevel#design#the#number#of#runs#required#also#increases#in#a#2n#fashion.#Reducing#the#number#of#runs#for#a#given#number#of#factors#reduces#the#resolution#of#the#design,#as#indicated#by#the#Roman#numerals#and#colours.#The#lower#the#Roman#numeral#the#lower#the#resolution#and#so#the#greater#the#risk#of#misidentifying#a#factor#(or#combination#of)#as#having#a#particular#impact.#The#black#square#highlights#the#design#chosen#for#the#screening#experiment#an#8#factor#resolution#IV#design.##
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Name) Units) Type) Low) Med) High)
Cell)line)[CL]) Categoric) MSUH001) BJ)iPS)
Seeding)Density))[SD]) cell/cm2) Numeric) 13,000) 19,000) 25,000)
bFGF) ng/ml) Numeric) 0) 4) 8)
Time)to)diﬀeren#a#on)[diﬀ)#me]) days) Numeric) 7) 11) 15)
Diﬀeren#a#on)media)volume) ml) Numeric) 3) 3.5) 4)
Time)between)media)changes)[med.)
#me]) days) Numeric) 1) 2) 3)
Nico#namide)[nic]) mM) Numeric) 0) 10) 20)






































































































) (cell/cm2)) (days)) (days)) (ml)) (ng/ml)) (mM)) (µ/M))
MSUH001) 13,000) 15) 1) 3) 8) 20) 0)
MSUH001) 25,000) 15) 1) 3) 0) 0) 10)
MSUH001) 25,000) 15) 3) 4) 8) 20) 10)
MSUH001) 13,000) 15) 3) 4) 0) 0) 0)
MSUH001) 19,000) 11) 2) 3.5) 4) 10) 5)
MSUH001) 19,000) 11) 2) 3.5) 4) 10) 5)
MSUH001) 13,000) 7) 3) 3) 8) 0) 10)
MSUH001) 25,000) 7) 1) 4) 8) 0) 0)
MSUH001) 13,000) 7) 1) 4) 0) 20) 10)
MSUH001) 25,000) 7) 3) 3) 0) 20) 0)
BJ) 25,000) 15) 1) 4) 0) 20) 0)
BJ) 13,000) 15) 1) 4) 8) 0) 10)
BJ) 25,000) 15) 3) 3) 8) 0) 0)
BJ) 13,000) 15) 3) 3) 0) 20) 10)
BJ) 19,000) 11) 2) 3.5) 4) 10) 5)
BJ) 19,000) 11) 2) 3.5) 4) 10) 5)
BJ) 13,000) 7) 1) 3) 0) 0) 0)
BJ) 25,000) 7) 1) 3) 8) 20) 10)
BJ) 15,000) 7) 3) 4) 8) 20) 0)
BJ) 25,000) 7) 3) 4) 0) 0) 10)
	   	  


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































) 1) 7) 5) 3)
	   	  










	   	  








































D: Time to differentiation
E: Differentiation media volume








































	   	  









GYNico#namide) )) 0.0021) 0.0372)
HYIWPY2) 0.0347) 0.0004) 0.0061)
AB) )) ))
AC,)BE,)DG,)FH) 0.0267) 0.0082)
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Run Type Seeding Density (cells/cm2) Time to differentiation (d) Nicotinamide (mM) 
1 Axial 25000.00 7.00 36.82 
2 Factorial 37000.00 3.00 10.00 
3 Factorial 37000.00 3.00 30.00 
4 Factorial 13000.00 3.00 10.00 
5 Center 25000.00 7.00 20.00 
6 Axial 45181.51 7.00 20.00 
7 Axial 25000.00 7.00 36.82 
8 Factorial 13000.00 3.00 30.00 
9 Factorial 13000.00 11.00 10.00 
10 Factorial 13000.00 11.00 30.00 
11 Factorial 13000.00 3.00 30.00 
12 Factorial 37000.00 11.00 10.00 
13 Factorial 13000.00 11.00 10.00 
14 Center 25000.00 7.00 20.00 
15 Center 25000.00 7.00 20.00 
16 Factorial 37000.00 11.00 10.00 
17 Factorial 37000.00 11.00 30.00 
18 Axial 25000.00 7.00 3.18 
19 Factorial 37000.00 3.00 10.00 
20 Factorial 37000.00 3.00 30.00 
21 Center 25000.00 7.00 20.00 
22 Axial 4818.49 7.00 20.00 
23 Axial 25000.00 0.27 20.00 
24 Axial 25000.00 7.00 3.18 
25 Factorial 13000.00 11.00 30.00 
26 Axial 4818.49 7.00 20.00 
27 Factorial 13000.00 3.00 10.00 
28 Axial 45181.51 7.00 20.00 
29 Factorial 37000.00 11.00 30.00 
30 Axial 25000.00 0.27 20.00 
31 Axial 25000.00 13.73 20.00 
32 Axial 25000.00 13.73 20.00 
33 Center 25000.00 7.00 20.00 
Figure'4.15:'Run'descriptions'of'the'optimisation'experiment:'In#all#33#Runs#were#needed#to#generate#data#for#the#Central#Composite#design.#Where#timings#were#a#fraction#of#a#day#these#were#converted#to#hours#post#seeding#to#follow#the#design#precisely.##
	   	  
















































	   	  



























	   	  








X1 = B: Time to differentiation
X2 = A: Seeding Density
Actual Factor
C: Nicotinamide = 10.00













































X1 = B: Time to differentiation
X2 = A: Seeding Density
Actual Factor
C: Nicotinamide = 20.00









































X1 = B: Time to differentiation
X2 = A: Seeding Density
Actual Factor
C: Nicotinamide = 30.00










































	   	  








X1 = C: Nicotinamide
X2 = A: Seeding Density
Actual Factor
B: Time to differentiation = 72.00












































X1 = C: Nicotinamide
X2 = A: Seeding Density
Actual Factor
B: Time to differentiation = 120.00









































X1 = C: Nicotinamide
X2 = A: Seeding Density
Actual Factor
B: Time to differentiation = 168.00







































	   	  







X1 = A: Seeding Density
X2 = B: Time to differentiation
Actual Factor
C: Nicotinamide = 15.00







































	   	  







	   	  







	   	  







X1 = A: Seeding Density
X2 = B: Time to differentiation
Actual Factor

























A: Seeding Density (cells/cm2)




	   	  









(mM) BEST MITF OTX 2 PMEL RAX RPE 65 TYR
1 25,000 7.00 36.82 0.0004 0.0361 0.0048 0.0003 0.0147 0.1531 0.0002
7 25,000 7.00 36.82 0.0001 0.0407 0.0058 0.0004 0.0131 0.1537 0.0003
17 37,000 11.00 30.00 0.1412 0.2395 0.2888 0.0935 0.1452 0.2845 0.2068
29 37,000 11.00 30.00 0.2280 0.2463 0.2337 0.2734 0.1118 0.3529 0.1962
10 13,000 11.00 30.00 0.3478 0.3004 0.3346 0.1395 0.2111 0.2018 0.3302
25 13,000 11.00 30.00 0.1899 0.1626 0.1872 0.2241 0.2305 0.1865 0.0759
3 37,000 3.00 30.00 0.3453 0.3379 0.3344 0.1886 0.1097 0.2590 0.2561
20 37,000 3.00 30.00 0.7559 0.4535 0.5014 0.4112 0.2213 0.3537 0.5149
11 13,000 3.00 30.00 0.7573 0.4898 0.3435 0.3660 0.1238 0.2562 0.3337
8 13,000 3.00 30.00 0.7056 0.5860 0.3920 0.6174 0.2537 0.3291 0.4539
15 25,000 7.00 20.00 0.4504 0.7757 1.1331 0.9113 0.1562 0.5139 1.2779
33 25,000 7.00 20.00 0.4767 0.9919 1.4448 1.7543 0.1342 0.8676 1.3210
14 25,000 7.00 20.00 0.6778 0.7091 0.9997 0.7076 0.1204 0.8406 1.0099
21 25,000 7.00 20.00 0.8804 0.5542 0.9708 0.5789 0.2049 0.6586 1.0938
5 25,000 7.00 20.00 0.9764 0.6887 1.0466 0.7920 0.1545 0.8409 0.9668
32 25,000 13.73 20.00 0.1653 0.5242 0.8021 0.5625 0.1318 0.5070 1.0022
31 25,000 13.73 20.00 0.2457 0.6002 1.0194 0.7444 0.1075 0.5404 1.2122
30 25,000 0.27 20.00 2.4810 1.4691 1.8821 2.4810 2.4810 1.2907 1.6081
23 25,000 0.27 20.00 3.9831 1.0854 1.7209 1.3733 0.6310 1.3005 1.4612
6 45,182 7.00 20.00 0.3399 0.7230 1.1073 0.3601 0.1575 0.8553 0.9967
28 45,182 7.00 20.00 0.2433 0.5386 1.0441 0.5326 0.1466 0.7811 0.5408
22 4,818 7.00 20.00 1.1299 1.6511 2.4044 1.6968 0.4248 0.4052 2.2720
26 4,818 7.00 20.00 0.6529 1.6895 1.6320 1.2694 0.1764 0.5721 1.8000
16 37,000 11.00 10.00 0.1063 0.4317 0.6372 0.2110 0.1031 0.5100 0.2523
12 37,000 11.00 10.00 0.0547 0.6531 0.9064 0.0842 0.1731 0.4915 0.5259
13 13,000 11.00 10.00 0.1711 0.4480 0.8371 0.2965 0.1280 0.3264 0.4170
9 13,000 11.00 10.00 0.1026 0.4209 0.7208 0.2864 0.0942 0.3617 0.4438
2 37,000 3.00 10.00 0.0605 0.8628 1.2520 0.1827 0.0777 1.5244 0.4329
19 37,000 3.00 10.00 0.0522 0.9938 1.4292 0.2660 0.0933 1.3558 0.4282
27 13,000 3.00 10.00 0.1735 2.0380 2.6379 1.9874 0.6534 0.8094 2.3347
4 13,000 3.00 10.00 0.2672 2.1464 2.1464 1.8738 0.4039 0.7245 2.1464
18 25,000 7.00 3.18 0.0282 0.5755 0.9362 0.1026 0.0653 1.2895 0.1590
24 25,000 7.00 3.18 0.0130 0.6810 0.9659 0.0636 0.0651 1.3020 0.1312
0 1.99155 3.9831
Figure'4.26:'Gene'Expression'data'for'the'optimisation'experiment.'The#normalised#expression#data#for#all#the#genes#investigated#in#the#central#composite#design#were#plotted#to#see#if#any#clustering#could#be#observed.#The#colour#coding#is#based#on#the#key#at#the#bottom#which#displays#the#range#of#data#obtained#for#gene#expression#data#normalised#on#UBC#and#B%ACTIN)internal#housekeeping#gene#controls.#'
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5.	  Isolation	  of	  retinal	  pigment	  epithelium	  cells	  from	  differentiating	  pluripotent	  stem	  cell	  monolayers	  
5.1 Introduction	  and	  aims	  
5.1.1 The	  bottleneck	  of	  manual	  pigmented	  foci	  separation	  Key	   to	   transforming	   the	   current	   lab	   based	   protocol	   to	   a	   commercialisable	   bioprocess	   is	  addressing	  the	  separation	  bottleneck	  of	  removing	  the	  pigmented	  RPE	  from	  the	  other	  non-­‐RPE	   contaminants	   in	   the	   differentiating	   monolayer.	   The	   current	   method	   is	   described	   as	  follows	  and	  is	  replicated	  from	  Vugler	  et	  al.	  (2008)	  “pigmented	  foci	  are	  excised	  mechanically	  
using	   the	   tip	  of	   a	  glass	  Pasteur	  pipette	  and	  microsurgical	   blades	  –	   this	   only	  being	  practical	  
when	   foci	   had	   reached	   at	   least	   1	   mm	   in	   diameter.	   Efforts	   are	   made	   to	   dissect	   away	  
surrounding,	  non-­‐pigmented	  material.	  The	  excised	  foci	  are	  then	  directly	  plated	  onto	  matrigel	  
coated	   plates	   to	   expand	  as	   a	  monolayer”.	   Clearly	   this	  method	   is	   undesirable	   because	   it	   is	  highly	  manual	   and	   operator	   dependent.	   The	   purity	   and	   quality	   of	   the	   excised	   foci	   is	   also	  subjective	   as	   the	   protocol	   prescribes	   that	   “best	   efforts”	   are	   made	   to	   dissect	   away	  contaminant	   material.	   Thus	   determining	   any	   critical	   quality	   attributes	   or	   achieving	  reproducibility	  in	  commercial	  production	  is	  very	  unlikely.	  	  It	  is	  also	  exceptionally	  hard	  to	  do	  in	   practice	   taking	   around	   30	   min	   for	   a	   single	   T25	   flask.	   Consequently,	   alternative	  approaches	  need	  to	  be	  explored.	  
5.1.2 Technologies	  for	  the	  separation	  of	  live	  cells	  There	  are	  a	  number	  of	  technologies	  for	  the	  identification	  and	  separation	  of	  sub	  populations	  of	  cells	  that	  could	  be	  used	  as	  alternatives	  to	  the	  manual	  method	  currently	  employed.	  Such	  methods	   have	   traditionally	   been	   utilised	   for	   analytical	   purposes	   e.g.	   disease	   diagnosis.	  Apheresis	   machines	   and	   other	   technologies,	   such	   as	   density	   based	   centrifugation	   are	  commonly	   used	   to	   enrich	   blood	   for	   a	   particular	   sub	   population,	   for	   instance,	  monocytes,	  based	  on	  the	  differing	  physical	  characteristics	  of	   the	  cells.	  However,	  such	  systems	  are	  not	  well	  suited	  to	  the	  purification	  of	  PSC	  derived	  differentiation	  products	  where	  the	  differences	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between	  the	  cells	  are	  more	  nuanced	  and	  higher	  purities	  are	  a	  requirement.	  Here	  the	  most	  common	  methods	   suggested	   are	   fluorescence-­‐activated	   cell	   sorting	   (FACs)	   and	  magnetic-­‐activated	   cell	   sorting	   (MACs)	   which	   are	   currently	   applied	   in	   single	   patient	   therapies	   for	  instance	   the	   separation	   of	   CD34+	   cells	   for	   hematopoietic	   stem	   cell	   transplants	   after	  radiotherapy.	  	  
5.1.3 Fluorescence-­‐activated	  cell	  sorting	  (FACs)	  
Flow	  Cytometry	   (Figure	   5.1	   a)	   involves	   the	  passing	  of	  a	   single	  cell	   suspension	   through	  a	  small	   capillary	   where	   it	   is	   interrogated	   with	   a	   laser.	   Analysis	   of	   the	   cells	   is	   based	   on	  computational	   identification	   from	   the	   relative	   light-­‐scattering	   and	   colour-­‐discriminated	  fluorescence.	  Typically	   cells	   are	   labelled	   to	   aid	   identification	  by	  using	  primary	   antibodies	  raised	   against	   specific	   cell	   markers	   in	   or/on	   target	   cells.	   Then	   a	   fluorophore	   labelled	  secondary	  antibody	  attaches	  to	  the	  primary	  antibody,	  labelling	  the	  cell.	  FACs	  sorts	  cells	  by	  putting	  the	  stream	  of	  cells	   into	  droplets	  of	   liquid	  with	  each	  drop	  containing	  only	  one	  cell.	  Target	  cells	  which	  are	  identified	  and	  ‘gated’	  by	  the	  computer	  software	  have	  their	  droplets	  labelled	  with	  an	  electric	  charge,	  this	  physically	  alters	  their	  trajectory	  as	  they	  pass	  deflector	  plates,	  causing	  the	  cell	  to	  be	  deposited	  in	  a	  specific	  collection	  tube	  (Figure	  5.1	  a).	  
Although	   capable	   of	   highly	   selective	   separations	   the	   capacity	   of	   the	   technology	   as	   a	  commercial	   purification	   system	   for	   allogeneic	   therapies	   is	   limited.	   For	   instance	   the	  manufacturers	  data	  for	  the	  BD	  FACSAria	  III	  reports	  a	  throughput	  of	  70,000	  events	  for	  cell	  sorting	  can	  be	  achieved	  without	  affecting	  purity,	  however,	   this	   ‘high’	  speed	  greatly	  affects	  yield.	  This	  is	  because	  in	  order	  for	  the	  system	  to	  achieve	  high	  purity	  a	  compromise	  needs	  to	  be	  made	  against	  yield.	  When	  the	  machine	  detects	  two	  drops	  as	  being	  too	  close	  together	  to	  be	  physically	  separated	  as	  determined	  by	   the	  software	   	  a	   separation	  attempt	   is	  not	  made	  and	  so	  both	  drops	  go	  to	  waste.	  Experimental	  analysis	  and	  modelling	  of	  this	  trade-­‐off	  using	  PSCs	   could	  not	  be	   found	  on	   the	  manufacturer’s	   site	  or	   in	   the	   literature.	  The	  performance	  robustness	  of	  FACS	  in	  a	  commercial	  bioprocess	  also	  represents	  something	  of	  an	  unknown	  as	  key	  performance	   indicators	   such	  as	  purity,	  viability	  and	  yield	  are	  highly	  dependent	  on	  the	  cell	  type	  used,	  the	  population	  being	  isolated,	  and	  the	  protocols	  applied	  as	  discussed	  in	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depth	  in	  the	  review	  by	  Weil	  and	  Veraitch	  (2014).	  Overall	  the	  inherent	  problem	  in	  scaling	  up	  FACs	   technology	   in	   that	   it	   only	   interrogates	  one	   cell	   at	  a	   time,	   and	  with	   the	  high	   costs	  of	  each	  machine	   ‘scale	   out’	   is	   not	   an	   option.	   This	   limited	   throughput	   also	  means	   very	   long	  processing	   times	   if	   FACS	  was	   applied	   to	   the	   separation	   of	   pigmented	  RPE	   at	   commercial	  scale	   where	   it	   is	   likely	   many	   billions	   of	   cells	   would	   need	   to	   be	   processed	   as	   part	   of	   an	  allogeneic	  bioprocess.	  However	  it	  remains	  a	  highly	  powerful	  tool	  for	  the	  specific	  isolation	  of	  cells	  prior	  to	  expansion	  at	  the	  start	  of	  a	  process.	  
As	  the	  RPE	  cells	  are	  highly	  pigmented	  it	  was	  expected	  that	  the	  cells	  would	  have	  a	  greater	  side	   scatter	   and	   lower	   forward	   scatter	   on	   a	   flow	   cytometry	   dot	   plot	   than	   the	   other	   non-­‐pigmented	  cells	  in	  the	  heterogeneous	  differentiating	  culture,	  as	  is	  the	  case	  with	  pigmented	  melanocytes	  (Dupin	  et	  al.,	  2000).	  In	  fact	  Shi	  and	  Clegg	  (2008)	  used	  FACS	  on	  the	  expanding	  PSC-­‐RPE	  monolayer	  (after	  manual	  separation	  and	  re-­‐plating)	  to	  enrich	  what	  they	  termed	  as	  “darkly	  pigmented”	   cells	   from	  30.4%	  before	   the	   sort	   to	  90.6%	  after	   the	   sort.	   Some	   initial	  work	   was	   undertaken	   in	   pursuit	   of	   this	   thesis	   to	   determine	   if	   a	   pigmented	   population	  within	   the	   differentiating	   monolayer	   could	   be	   identified	   using	   flow	   cytometer	   (data	   not	  shown),	  however	  without	  a	  second	  fluorescence	  marker	  to	  compare	  against	  it	  was	  virtually	  impossible	   to	   define	   a	   subpopulation	   on	   pigmentation	   alone,	   particularly	   given	   the	   low	  efficiency	  of	  the	  differentiation	  protocol	  used	  (a	  few	  per	  cent).	  
5.1.4 Magnetic	  activated	  cell	  sorting	  (MACs)	  Magnetic	  activated	  cell	  sorted	  MACs	  has	  far	  better	  prospects	  from	  a	  viewpoint	  of	  scale-­‐up	  with	   the	   throughput	   being	   limited	   to	   the	   size	   of	   the	   column	   and	   the	   number	   of	   labelled	  magnetic	  beads	  available	  for	  binding,	  an	  overview	  of	  its	  operation	  is	  reproduced	  in	  Figure	  
5.1	  b).	  This	  affinity	  chromatography	  system	  could	  also	  benefit	  from	  knowledge	  transferred	  from	   the	   scale-­‐up	   of	   traditional	   biopharmaceuticals	   in	   which	   chromatography	   is	   a	   key	  purification	   technology.	   The	   autoMACS	   platform	   which	   is	   the	   trade	   name	   of	   the	  electronically	  controlled	  automatic	  MACS	  systems	   from	  Miltenyi	  has	  a	  column	  capacity	   to	  bind	  up	  to	  2×108	  magnetically	  labelled	  cells	  from	  a	  total	  cell	  population	  of	  4×109	  cells	  (50ml	  tubes)	   “in	   about	   5	   minutes”	   (personal	   communication).	   	   Throughputs	   in	   the	   technical	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specification	   (based	   on	   1ml)	   is	   107	   cells/sec	   with	   a	   total	   program	   time	   of	   2-­‐15mins	  (dependent	  on	   the	   separation	  program	  selected),	   so	   even	  at	   this	   small	   scale	  MACs	  would	  appear	   to	   have	   a	   far	   higher	   throughput	   than	   FACs.	   In	   addition	   the	  MACs	   technology	   has	  already	  been	  used	  in	  the	  clinic	  with	  the	  ‘cliniMACs’	  machine	  used	  in	  the	  isolation	  of	  CD34+	  cells	  from	  blood.	  	  
Unfortunately	  no	  papers	  were	  found	  in	  the	  literature	  that	  adequately	  compared	  the	  purity	  and	  throughput	  achieved	  with	  the	  two	  different	  technologies	  where	  multiple	  variables	  were	  investigated	  for	  an	  optimised	  system.	  If	  would	  be	  assumed	  that	  as	  the	  MACs	  system	  scales	  by	   increasing	   the	   column	   size	   that	   this	   is	   inherently	   more	   scalable.	   Importantly	   both	  systems	  make	  use	  of	  the	  antibody	  labelling	  of	  the	  cells,	  which	  is	  both	  highly	  expensive,	  and	  a	   regulatory	   concern.	   The	   latter	   is	   due	   to	   the	   safety	   considerations	   of	   introducing	  antibodies	   raised	   in	   a	   different	   species	   (typically	   rabbit,	   goat	   or	  mouse)	   into	   therapeutic	  process	   as	   they	   present	   the	   risk	   of	   zoonoses.	   The	   alternative	   would	   be	   to	   produce	   the	  antibodies	  through	  recombinant	  technologies,	   for	  example,	  using	  a	  CHO	  (Chinese	  hamster	  ovary)	  expression	  system.	  However	  this	  would	  be	  far	  from	  trivial	  and	  likely	  to	  be	  expensive.	  Additionally,	   the	  work	  needed	  to	  prove	  no	  transmissible	  agents	  were	   introduced	  and	  that	  the	  antibodies	  and	  their	  attached	  fluorophores/magnetic	  beads	  were	  absent	  from	  the	  end	  product	  would	  be	  considerable.	  But	  perhaps	  the	  main	  criticism	  of	  using	  antibody	  labelling	  in	  a	  therapeutic	  bioprocess	  in	  this	  PSC-­‐RPE	  application	  is	  that	  no	  definitive	  RPE	  marker	  was	  available	  to	  this	  project.	  
5.1.5 Dielectrophoresis	  	  An	   alternative	   to	   MACs	   and	   FACs	   postulated	   in	   the	   literature,	   which	   does	   not	   involve	  antibody	   labelling	   is	   dielectrophoresis	   (DEP).	   Here,	   electrical	   stimulation	   induces	   a	  frequency-­‐dependent	  dipole	  in	  the	  cells	  which	  traps/migrates	  them	  towards	  or	  away	  from	  the	   electrodes.	   The	   effect	   is	   dependent	   on	   the	   cells’	   composition,	   morphology	   and	  phenotype	   (Doh	   and	   Cho,	   2005).	   For	   example,	   Flanagan	   et	   al.	   (2008)	   showed	   that	  populations	  of	  mouse	  neural	  stem/precursor	  cells	  (NSPCs)	  harvested	  from	  mice	  at	  different	  stages	   of	   embryonic	   development	   displayed	   different	   differentiation	   propensities,	   the	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NSPCs	  from	  different	  stages	  could	  not	  be	  characterized	  using	  FACs	  but	  could	  be	  by	  using	  a	  DEP	  device.	  This	  demonstrates	  the	  DEP	  technology	  as	  a	  useful	  characterization	  tool	  where	  suitable	  markers	  are	  unavailable.	  At	  the	  microfluidic	  scale	  such	  devices	  have	  been	  modified	  to	   operate	   under	   a	   continuous	   flow	   regime	   to	   separate	   viable	   and	   dead	   yeast	   cells	   at	   a	  flowrate	  of	  4.8million	  cells	  an	  hour	  (Doh	  and	  Cho,	  2005)	   this	   compares	   favourably	   to	   the	  separation	   of	   PSC	   from	   PSC	   derived	   neurons	   using	   a	   FACS	   machine,	   operating	   at	   a	  throughput	   of	   3.6-­‐10.8	  million	   cells	   and	   hour	   (1K-­‐3K	   per	   second)	   (Pruszak	   et	   al.,	   2007).	  There	   are	   examples	   of	   many	   other	   DEP	   sorting	   devices	   in	   the	   literature	   (Korohoda	   and	  Wilk,	   2008,	   Wang	   et	   al.,	   2009,	   Alazzam	   et	   al.,	   2008).	   The	   low	   cost	   of	   these	   microfluidic	  devices	   mean	   they	   can	   be	   a	   disposable	   technology	   which	   helps	   with	   batch-­‐to-­‐batch	  validation	  and	  thereby	  making	  them	  cost	  effective	  for	   ‘scale	  out’.	   It	  would	  be	  assumed	  the	  technology	  would	  be	  readily	  applicable	  to	  the	  RPE	  separation	  due	  to	  the	  high	  concentration	  of	   charged	  melanosomes	   in	   the	  RPE	   (Testorf	   et	   al.,	   2001).	  The	  expectation	  being	   that	   the	  melanosome	   charge	   would	   result	   in	   a	   vastly	   different	   experience	   of	   the	   RPE	   to	   the	   DEP	  effect	   compared	   to	   the	   non-­‐pigmented	   contaminates,	   thereby	   creating	   a	   basis	   for	  separation.	  However,	  without	  a	  commercially	  available	  device	  the	  technology	  is	  unlikely	  to	  be	  applied	  to	  any	  cell	  therapy	  in	  the	  immediate	  future	  and	  so	  not	  pursued	  in	  this	  thesis.	  
5.1.6 Laser-­‐enabled	  analysis	  and	  processing	  system	  	  Due	  to	  the	  pigmented	  nature	  of	   the	  cells	  allowing	  the	   identification	  of	   the	  RPE	  phenotype	  via	   bright	   field	   imaging,	   some	   preliminary	   work	   was	   conducted	   using	   the	   laser-­‐enabled	  analysis	   and	   processing	   system	   (LEAP),	   from	   a	   company	   called	   Cyntellect	   which	   is	   no	  longer	   in	   existence.	   The	   system	   combines	   a	   rapid	   whole	   well	   imaging	   system	   with	   a	  selective	  laser	  to	  purify	  colonies	  based	  ablation	  of	  contaminants.	  The	  device	  was	  marketed	  as	  a	  method	  to	  passage	  PSC	  colonies	  or	  to	  remove	  cells	  which	  had	  failed	  to	  reprogram	  in	  iPS	  protocols.	  A	  number	  wells	  containing	  pigmented	  foci	  were	  tested	  on	  the	  system	  (Figure	  5.1	  
c),	  which	  allowed	  pigmented	  areas	   to	  be	  manually	   “circled”	  using	   the	   software.	  The	   laser	  then	  ablated	  the	  surrounding	  cells	  with	  the	  aim	  that	  the	  pigmented	  foci	  would	  be	  released.	  The	   early	   results	   from	   the	   system	   demonstrated	   it	   might	   have	   some	   promise	   if	   applied	  earlier	   in	   the	   differentiation	   protocol,	   but	   as	   with	   the	   aforementioned	   build	   up	   of	   extra	  
	   	  
	   - 161 -	  
cellular	  matrix	  the	   laser	  cutting	  was	  inconsistent	  across	  the	  well.	  A	  hypothesised	  protocol	  would	  involve	  repeated	  removal	  of	  non-­‐pigmented	  cells	  surrounding	  the	  foci	  allowing	  room	  for	   the	   foci	   to	   expand	   into	   a	  monolayer	  without	   the	   need	   for	   replating.	  However,	   due	   to	  circumstances	   beyond	   the	   control	   of	   this	   thesis	   further	   work	   on	   the	  machine	   to	   test	   his	  protocol	  on	  the	  machine	  was	  not	  possible	  (the	  company	  is	  now	  no	  longer	  in	  existence).	  	  
5.1.7 The	  required	  purity	  of	  a	  separation	  technology	  
As	  discussed	  in	  the	  Introduction	  to	  this	  thesis	  the	  final	  therapy	  could	  be	  contaminated	  with	  undifferentiated	  PSCs,	  cells	  with	  abnormal	  karyotype,	  or	  non-­‐RPE	  contaminant	  cells.	  Thus,	  when	   evaluating	   and	   eventually	   deciding	   on	   a	   separation	   technology	   the	   required	   purity	  needs	  to	  be	  considered.	  
Crucially	  when	  considering	  PSCs	  in	  the	  final	  therapy	  it	  is	  unknown	  whether	  all	  contaminant	  PSCs	   need	   be	   removed	   from	   a	   therapy	   or	   whether	   a	   certain	   amount	   is	   acceptable.	   For	  instance	  Lawrenz	  et	  al.	  (2004)	  found	  that	  injections	  of	  as	  few	  as	  2	  mouse	  embryonic	  stem	  cells	   (mESC)	   into	  BALB/c	   nude	   (inhibited	   immune	   system)	  mice	   produced	   teratomas	   yet	  the	   study	   of	   Shih	   et	   al.	   (2007)	   showed	   it	   took	   a	   minimum	   of	   5000	   PSC	   injected	   into	  engrafted	   human	   foetal	   tissue	   (lung	   and	   thymus)	   into	   severe	   combined	   immunodeficient	  mice	  (SCID)	  mice,	  to	  cause	  teratomas,	  yet	  a	  level	  of	  50	  PSC	  contaminants	  did	  not.	  The	  site	  of	  implantation	   of	   the	   cells	   also	   seems	   to	   play	   an	   important	   role,	  when	  PSC	  were	   engrafted	  into	   the	   liver	   of	   nude	   mice	   large	   tumours	   (teratomas)	   formed	   containing	   a	   majority	   of	  ‘immature’	   cells,	   yet	   masses	   from	   subcutaneous	   implantations	   grew	   slower	   eventually	  containing	  differentiated	  cells	  (Cooke	  et	  al.,	  2006).	  The	  result	  being	  an	  unclear	  view	  into	  the	  amount	  of	  PSC	  which	  would	  be	  considered	  safe	  in	  a	  therapy.	  
Using	  the	  findings	  of	  Lawrenz	  et	  al.	  (2004)	  where	  only	  2	  mESC	  caused	  tumours	  a	  paper	  by	  Schriebl	   et	   al.	   (2010)	   experimentally	   characterised	   a	   MACs	   sort	   based	   the	   separation	   of	  mouse	   stem	   cells.	   Applying	   a	  model	   calculation	   they	   estimated	   the	   number	   of	   separation	  stages	   needed	   to	   achieve	   a	   purity	   of	   less	   than	   10–1	   stem	   cells	   per	   109	   cells	   in	   a	   single	  treatment.	  With	  an	  initial	  purity	  of	  60%	  they	  equated	  it	  would	  take	  31	  stages	  to	  achieve	  this	  tolerance.	   This	   lead	   them	   to	   conclude	   that	   with	   a	   target	   log	   clearance	   rate	   of	   10	   for	   a	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hypothetical	   clinical	   product	   that	   the	   MACs	   technology	   as	   it	   stands	   was	   not	   suitable.	  However,	   the	  situation	   is	   far	  more	  complex	   than	   this	  as	   the	  Lawrenz	  et	  al.	   (2004)	  data	   is	  based	  on	  putting	  mESC	  into	  immunosupressed	  mice	  rather	  than	  human	  PSCs	  as	  xenografts	  into	   immunosupressed	  mice.	   So	   these	  papers	  present	  a	  poor	  model	   for	  a	  human	   therapy,	  and	  thus	  requirements	  of	  a	  separation	  technology.	  	  
Fortuitously,	  with	   respect	   to	   the	  PSC-­‐RPE	  clinical	  protocol	  PSC	  contamination	   in	   the	   final	  product	  does	  not	  seem	  to	  be	  an	  issue.	  The	  rationale	  being	  the	  length	  of	  the	  differentiation	  protocol	  is	  so	  long	  that	  the	  pluripotent	  phenotype	  is	  lost	  completely	  as	  determined	  by	  QPCR	  analysis	   (data	   not	   shown).	   This	   is	   also	   seen	   in	   the	   literature	  with	  Anisimov	   et	   al.	   (2010)	  reporting	   that	   in	   animal	   studies	   long	  differentiation	  protocols	   removed	   the	   risk	   of	   tumor	  formation	  for	  stem	  cell	  transplants.	  	  
Of	   other	   importance	   is	   contamination	   from	   non	   PSC-­‐RPE	   cells	   in	   the	   final	   therapy.	   The	  current	   crude	   manual	   separation	   which	   involves	   best	   efforts	   to	   remove	   non-­‐pigmented	  cells	  has	  actually	  been	  shown	   to	  be	  highly	   robust	   in	  animal	   studies	  as	  part	  of	  pre-­‐clinical	  development	   (personal	   communication	   with	   Professor	   Pete	   Coffey,	   data	   not	   publically	  available).	   With	   no	   graft	   overgrowth	   of	   contaminant	   cells	   on	   the	   implanted	   patches.	  Therefore	   for	   the	   planned	   initial	   human	   trials	   the	   patches	   for	   implantation	   are	   released	  based	   on	   viability,	   cell	   coverage,	   morphology	   and	   pigmentation.	   With	   a	   QC	   patched	  interrogated	  for	  TRA-­‐1-­‐60	  (pluripotency	  marker),	  Ki67	  (a	  proliferation	  marker,	  RPE	  being	  post	  mitotic),	  PMEL-­‐17	  (RPE	  marker)	  and	  MERTK	  (RPE	  marker).	  
5.1.8 Aims	  With	  the	  potential	  cell	  separation	  methods	  described	  above	  not	  well	  suited	  to	  a	  commercial	  PSC	   RPE	   purification	   it	   was	   important	   to	   explore	   alternate	   approaches.	   During	  experimental	  work	  on	  the	  cells	  it	  was	  noticed	  that	  the	  in	  the	  spontaneously	  differentiating	  monolayers	   that	   the	   RPE	   cells	   and	   bulk	   monolayer	   have	   a	   differing	   susceptibility	   to	  dissociation	   agents.	   This	   observation	   became	   the	   basis	   of	   developing	   a	   novel	   filter	   based	  separation	  method.	  Specifically	  the	  aims	  were:	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• Characterise	   the	   spontaneous	   formation	   of	   pigmented	   RPE	   foci	   in	   monolayer	  culture	   and	   evaluate	   the	   current	   manual	   method	   of	   isolation	   and	   subsequent	  expansion.	  
• Exploration	   of	   a	   novel	   alternate	   enzymatic	   and	   filter	   based	   separation	   method	  which	  was	  discovered	  serendipitously	  through	  working	  with	  the	  cultures.	  
5.2 Materials	  and	  methods	  
5.2.1 Cell	  culture	  and	  differentiation	  into	  PSC-­‐RPE	  
The	  Shef	  3	  hESC	  line	  was	  passaged	  manually	  twice	  weekly	  using	  the	  tip	  of	  a	  Pasteur	  pipette	  and	   co-­‐cultured	   on	   mitomycin	   c	   inactivated	   mouse	   embryonic	   fibroblasts	   (MEFs).	   MEFs	  were	   originally	   grown	   in	   Dulbecco’s	   Modified	   Eagle	   Medium	   (DMEM,	   Life	   Technologies)	  with	  10	  %	  (v/v)	  heat	  inactivated	  fetal	  bovine	  serum	  (FBS,	  Sera	  Laboratories	  International)	  and	  1	  %	  (v/v)	  100x	  alpha	  MEM	  non-­‐essential	  amino	  acids	  (NEAA,	  Life	  Technologies).	  PSC	  were	  grown	  in	  Knockout	  DMEM,	  (Life	  Technologies)(4.5	  g	  D-­‐glucose/L,	  sodium	  pyruvate,	  -­‐L-­‐glutamine),	   20	   %	   Knockout	   Serum	   Replacement	   (Life	   Technologies),	   GlutaMAX,	   (Life	  Technologies),	  0.1	  mM	  b-­‐mercaptoethanol,	  human	  basic	   fibroblast	  growth	   factor,	  4	  ng/ml	  (bFGF,	  R&D	  systems),	  and	  1	  %	  100	  alpha	  MEMNEAA	  (Life	  Technologies).	  
5.2.2 Filter	  separation	  method	  T-­‐25	   flasks	   which	   had	   been	   left	   to	   differentiate	   for	   at	   least	   8	   weeks	   to	   the	   point	   which	  pigmented	  foci	  were	  observed	  were	  rinsed	  3x	  with	  dPBS	  and	  2	  mg/ml	  Collagenase	  IV	  was	  added.	  These	  flasks	  were	  left	  overnight	  on	  a	  shaker	  platform	  set	  to	  its	  highest	  setting	  in	  an	  incubator	  (5%	  CO2,	  370C).	  These	  cultures	  were	  than	  pelleted	  at	  300	  rcf	   for	  3	  min,	  and	  re-­‐suspended	   in	  PBS	  and	  passed	   through	  a	  70µM	   filter.	  The	  non-­‐pigmented	   run	   though	  was	  also	  pelleted	  to	  determine	  if	  any	  pigmented	  clusters	  had	  made	  it	  though	  the	  filter	  or	  if	  the	  pellet	  itself	  was	  discoloured.	  
The	  pigmented	   foci	   retained	  on	   the	   surface	  of	   the	  70µM	   filter	  were	   rinsed	   from	   the	   filter	  using	  0.25%	  trypsin	  (Invitrogen).	  This	   foci-­‐trypsin	  suspension	  was	  then	  incubated	  for	  30-­‐
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45m	  until	  the	  foci	  visually	  ‘fell	  apart’.	  Repeat	  pipetting	  of	  the	  solution	  was	  then	  used	  to	  try	  and	  obtain	  a	  single	  cell	  suspension.	  	  This	  suspension	  was	  then	  transferred	  to	  a	  fresh	  70µM	  filter	  and	  inactivation	  media	  (PSC	  media	  -­‐bFGF)	  was	  used	  to	  rinse	  the	  filter	  into	  a	  collection	  tube.	  The	  resultant	  suspension	  was	  then	  pelleted	  at	  300	  rcf	  for	  3	  min	  and	  re-­‐suspended	  in	  PSC	  media	  –bFGF	  and	  counted	  using	  a	  haemocytometer.	  
5.2.3 PSC-­‐RPE	  expansion	  
After	  the	  PSC-­‐RPE	  were	  separated	  from	  the	  contaminant	  cells	  they	  were	  replated	  onto	  wells	  coated	  with	  Matrigel	  (BD	  bioscience)	  and	  the	  media	  was	  changed	  twice	  weekly	  using	  PSC	  media	  as	  previously	  described	  but	  without	  bFGF.	  
5.2.4 Image	  J	  analysis	  The	   percentage	   of	   pigmented	   cells	   in	   the	   seeded	   population	  was	   determined	   via	  manual	  counting	  of	  the	  pigmented	  cells.	  	  Images	  from	  3	  fields	  of	  view	  taken	  using	  the	  Nikon	  Eclipse	  2000	   inverted	   microscope	   and	   the	   NIS-­‐elements	   software.	   These	   images	   were	   then	  imported	   into	   Image	   J	   (National	   Institute	   of	  Health)	   and	   the	   software’s	   cell	   counting	   and	  annotating	  tools	  were	  used.	  
The	   relative	   coverage	   of	   pigmented	   area	   for	   the	   expanded	   RPE	  was	   also	   determined	   via	  Image	  J	  analysis.	   Images	  taken	  using	  the	  Nikon	  Eclipse	  2000	   inverted	  microscope	  and	  the	  NIS-­‐elements	   software	   were	   first	   cropped	   to	   remove	   any	   areas	   of	   shadow	   and	   then	  imported	  into	  Image	  J	  and	  converted	  to	  binary	  form	  via	  setting	  of	  a	  threshold	  value	  where	  all	  pigmented	  cells	  were	  accounted	  for.	  The	  percentage	  area	  covered	  was	  measured	  using	  Image	  J’s	  built	  in	  analysis	  tool.	  	  
5.2.5 Immunocytochemistry	  Cells	  were	  fixed	  in	  a	  1.33	  M	  PFA	  solution	  and	  0.25	  %v/v	  Triton	  X	  was	  used	  to	  permeabilise	  cells.	  Primary	  antibodies	  used	  were	  as	  follows	  Bestrophin	  (1:1000	  dilution,	  Millipore),	  OTX	  2	   (1:500	   dilution,	   Millipore),	   ZO1	   (1:50	   dilution,	   Zymed).	   The	   following	   secondary	  antibodies	  were	  used	  at	  1:200	  dilutions:	  Alexa	   fluor	  488	  goat	  anti-­‐mouse	   IgG,	  Alexa	   fluor	  488	   goat	   anti-­‐rabbit	   IgG	   and	   Alexa	   fluor	   594	   goat	   anti-­‐rabbit	   IgG	   (all	   from	   Life	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Technologies).	   Images	   were	   taken	   with	   an	   epifluorescence	   Nikon	   Eclipse	   2000	   inverted	  microscope	  and	  the	  NIS-­‐elements	  software.	  Where	  applicable,	  isotype	  controls	  were	  run	  in	  parallel.	  
5.3 Results	  and	  discussion	  	  
5.3.1 RPE	  form	  spontaneously	  in	  differentiating	  RPE	  monolayers	  
The	   pigmented	   foci	   which	   form	   spontaneously	   in	   differentiating	   monolayers	   are	   very	  heterogonous	   in	  both	   shape	  and	  subsequent	  expansion	  within	   the	   culture.	  An	  example	  of	  two	  common	  morphologies	  is	  highlighted	  in	  Figure	  5.2.	  a)	  which	  shows	  areas	  of	  foci	  which	  have	   clear	   boundaries	   and	   others	   which	   appear	   to	   be	   ‘smeared’.	   Interestingly	   these	  ‘smeared’	  areas	  increase	  in	  pigmentation	  overtime	  and	  become	  more	  defined	  as	  illustrated	  in	  Figure	   5.2.	   b).	   It	   is	   important	   to	  note	   that	   the	  other	  dark	  areas	  not	  highlighted	  by	   the	  arrow	  or	  asterisk	   in	  Figure	   5.2.	   b)	   are	  not	  pigmented	  RPE	  and	  rather	   represent	  areas	  of	  monolayer	  build-­‐up.	  Distinction	  between	   true	  pigmentation	   and	   this	   build-­‐up	   is	   easier	   to	  discern	  with	  by	  eye	  then	  using	  a	  microscope.	  	  
5.3.2 Evaluation	  of	  the	  manual	  excision	  method	  Over	   the	   prolonged	   differentiation	   period,	   which	   can	   be	   up	   to	   up	   to	   12	   weeks,	   large	  amounts	  of	   extra	   cellular	  matrix	   (ECM)	  build-­‐up	   in	   the	   cultures.	  Therefore	  when	   the	  RPE	  are	  to	  be	  excised	  the	  whole	  culture	  can	  be	  pulled	  out	  as	  a	  single	  sheet	  that	  curls	  up	  into	  a	  ‘slimy’	  ball	  Figure	  5.2.	  c).	  This	  ball	  is	  highly	  elastic	  and	  hard	  to	  dissect	  making	  the	  release	  of	   the	   pigmented	   RPE	   harder,	   however	   foci	   are	   typically	   released	   as	   a	   distinct	   cluster	   of	  cells.	   Particular	   difficulties	   arise	   when	   the	   foci	   are	   very	   small	   and	   so	   cannot	   be	   easily	  dissected	   from	   contaminants	   and	   so	   are	   lost.	   Once	   transferred	   to	   fresh	   matrigel	   coated	  plates	   the	   expansion	   of	   the	   RPE	  monolayer	  was	   also	   seen	   to	   be	   highly	   variable.	   In	   some	  instances	  there	  was	  clear	  expansion	  of	  a	  pigmented	  monolayer	  from	  the	  explant	  Figure	  5.2.	  
d).	  However,	  in	  other	  cases	  the	  foci	  appeared	  to	  just	  attach	  and	  not	  expand,	  it	  being	  unclear	  whether	  this	  was	  due	  to	  a	  lack	  of	  viability	  or	  other	  cause	  Figure	  5.2.	  e).	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5.3.3 Immunocytochemistry	  determination	  of	  the	  RPE	  phenotype	  The	  expanding	  RPE	  monolayers	  were	   interrogated	   for	  markers	   representative	  of	   the	  RPE	  phenotype.	  Bestrophin	  is	  found	  on	  the	  basolateral	  plasma	  membrane	  of	  differentiated	  RPE	  cells	   in	   vivo	   (Marmorstein	   et	   al.,	   2000)	   Figure	   5.3.	   a),	   OTX	   2	   is	   involved	   in	   RPE	   cell	  development	   and	   is	   localised	   to	   the	   nucleus	   Figure	   5.3.	   b),	   and	   Z01	   is	   located	   on	   the	  cytoplasmic	  membranes	   surface	   of	   intracellular	   tight	   functions,	   found	   in	   both	   developing	  and	  mature	  RPE	  cells	  (Vugler	  et	  al.,	  2008)	  (see	  Figure	  5.4).	  This	  immunocytochemistry	  of	  the	   explanted	   foci	   shows	   a	   clear	   correlation	   between	   the	   pigmented	   foci	   in	   the	  differentiating	   cultures	   Figure	   5.2	   a),	   b)	   and	   the	   characteristic	   pigmented	   cobblestone	  morphology	   and	   the	   expression	   of	   RPE	   markers	   (Figure	   5.3	   and	   Figure	   5.4).	   	   The	  inference	   from	   this	   correlation	   being	   that	   the	   pigmented	   foci	   which	   spontaneously	   form	  will	   (if	   excised	   and	   replated	   on	   matrigel)	   expand	   into	   an	   RPE	   monolayer.	   Thus	   these	  spontaneously	  forming	  pigmented	  foci	  are	  RPE	  and	  not	  another	  pigmented	  cell	  type	  such	  as	  dopaminergic	  neurons	  of	  the	  substantia	  nigra.	  The	  ultimate	  way	  to	  confirm	  these	  cells	  are	  true	   RPE	   cells	  would	   be	   to	   determine	   their	   ability	   to	   rescue	   sight	   in	   the	   royal	   college	   of	  surgeons	   rat	   model	   of	   RPE	   (Sauve	   et	   al.,	   1998),	   or	   to	   test	   their	   ability	   to	   internalise	  fluorescently	   labelled	   rod	   and	   cone	   outer	   segments	   (Carr	   et	   al.,	   2009).	   However,	   such	  additional	   confirmatory	   testing	   was	   considered	   to	   be	   beyond	   the	   scope	   of	   this	   thesis,	  especially	   given	   the	  well-­‐reported	   and	   clear	   correlation	   between	   pigmented	   foci	   and	   the	  RPE	  phenotype.	  
5.3.4 Single	  cell	  seeding	  improves	  RPE	  monolayer	  expansion	  post	  
replating	  As	  previously	  described	  and	   illustrated	  the	  subsequent	  expansion	   from	  the	  explanted	   foci	  isolated	  through	  the	  manual	  excision	  method	  was	  variable	  to	  the	  eye	  (Figure	  5.2	  d)	  and	  e).	  These	  differences	  were	  further	  explored	  over	  a	  time	  course	  using	  microscopy	  Figure	  5.5	  a)	  and	  c).	  The	  series	  of	  pictures	  shown	  in	  Figure	  5.5	  a)	  shows	  a	  mixed	  morphology	  expanded	  from	   the	   explant	   foci;	   initially	   one	   cell	   type	   expands	   from	   the	   boundary	   and	   becomes	  confluent	  and	  then	  a	  second	  more	  pigmented	  cell	  type	  emanates/matures	  in	  spikes	  or	  tubes	  with	   defined	   boundary	   like	   those	   displayed	   previously	   in	   Figure	   5.2	   b).	   In	   contrast	   the	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series	  of	  images	  of	  Figure	  5.5	  b)	  show	  what	  appears	  to	  be	  the	  explanting	  foci	  reducing	  in	  size	  and	  pigmentation	  as	  time	  progresses	  and	  non-­‐pigmented	  cells	  expand.	  It	  is	  unclear	  that	  if	   the	  experiment	  was	  run	  for	   longer	  whether	  this	  culture	  will	  re-­‐pigment	  as	  described	  by	  Vugler	  et	  al.	  (2008).	  Finally	  the	  third	  series	  of	  images	  (Figure	  5.5	  c)	  shows	  clear	  expansion	  of	   a	   pigmented	   cobblestone	   morphology.	   Critically	   maintaining	   this	   cobblestone	  morphology	  has	  a	  clear	  relationship	  with	   the	  expression	  of	  markers	  representative	  of	   the	  target	   RPE	   phenotype.	   In	   Figure	   5.6	   it	   can	   be	   seen	   that	   in	   areas	   where	   this	   target	  morphology	  is	  lost	  during	  expansion	  that	  the	  RPE	  marker	  Bestrophin	  is	  also	  lost.	  
To	  improve	  the	  expansion	  of	  the	  excised	  foci	  instead	  of	  plating	  whole	  foci	  onto	  matrigel	  the	  manually	  excised	  foci	  were	  first	  enzymatically	  dissociated	  using	  0.25%	  trypsin	  (Invitrogen).	  When	   this	   single	   cell	   suspension	  was	   replated	   the	  expansion	   characteristics	  where	  vastly	  improved	  (see	  Figure	  5.7	  a),	  b),	  and	  C).	  Furthermore	  the	  seeding	  efficiency	  was	  very	  high	  and	  the	  cells	  quickly	  expanded	  to	  form	  a	  monolayer,	  which	  as	  it	  matured	  over	  a	  number	  of	  weeks	  became	  highly	  pigmented.	  What	  was	  of	  particular	   interest	  was	   that	   these	  qualities	  were	  not	  adversely	  impacted	  by	  very	  long	  incubation	  times	  (up	  to	  45	  minutes)	  with	  0.25%	  trypsin	  to	  obtain	  the	  single	  cell	  suspension.	  An	  examination	  of	  the	  whole	  well	  scan	  (Figure	  
5.8)	   demonstrates	   a	   heterogeneous	   spread	   of	   pigmentation,	   a	   likely	   result	   of	   PSC-­‐RPE	  colonies	   expanding	   to	  meet	   each	   other	   at	   different	   rates.	   Images	   i)	   and	   ii)	   in	  Figure	   5.8	  show	  areas	  of	  very	  good	  RPE	  morphology	  but	  poor	  pigmentation,	  whether	  these	  areas	  will	  eventually	  pigment	  or	  if	  they	  are	  not	  optimal	  for	  use	  in	  a	  therapy	  is	  an	  unknown.	  Images	  iii)	  and	  iv)	  in	  Figure	  5.8	  depict	  what	  could	  be	  described	  as	  the	  opposite	  to	  the	  former	  images	  i.e.	   poor	   cobblestone	  morphology	   yet	   high	   amounts	   of	   pigmentation.	  Whereas	   images	   v)	  and	   vi)	   shows	   cells	   which	   have	   high	   amounts	   of	   pigmentation	   and	   what	   could	   be	   good	  cobblestone	   morphology	   but	   it	   is	   hard	   to	   visualise	   due	   to	   the	   pigmentation.	   It	   was	  hypothesised	   that	   a	   more	   heterogeneous	   expansion	   could	   be	   achieved	   by	   varying	   the	  seeding	   density	   as	   from	   the	   whole	   well	   image	   it	   appears	   that	   a	   number	   of	   individual	  colonies	   have	   expanded	   and	   collided	   and	   then	   pigmented	   at	   differing	   rate.	   Such	  experimentation	  on	  the	  seeding	  density	  is	  explored	  later	  in	  this	  Chapter.	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5.3.5 A	  novel	  enzymatic	  PSC-­‐RPE	  purification	  method	  While	   attempting	   to	   dissociate	   the	   spontaneously	   differentiating	   PSC	   monolayer	   it	   was	  noted	  that	  the	  pigmented	  foci	  were	  preferentially	  released	  from	  the	  thick	  monolayer	  when	  collagenase	  was	  used	  rather	  than	  trypsin.	  These	  foci	  remained	  whole	  and	  intact	  and	  would	  not	   further	   dissociate	   using	   longer	   incubation	  periods	  with	   collagenase	   (see	  Figure	   5.9).	  After	   some	   initial	   experimentation	   it	   was	   determined	   that	   the	   foci	   could	   be	   successfully	  removed	  from	  the	  contaminant	  monolayer	  by	  overnight	  incubation	  in	  2	  mg/ml	  collagenase	  on	  a	   shaker	  platform	  set	   at	   its	  highest	   setting.	  The	   foci	   could	   then	  be	   separated	   from	   the	  resultant	   suspension	   via	   filtration	   through	   a	   70µm	   filter	   that	   retained	   the	   foci.	   The	   non-­‐pigmented	  contaminant	  filtrate	  was	  then	  centrifuged	  to	  identify	  if	  any	  pigmented	  cells	  had	  passed	  through	  the	  filter.	  From	  visual	  observation	  there	  was	  no	  discernable	  pigmentation	  suggesting	  yield	  is	  high,	  however	  further	  experimentation	  would	  be	  needed	  to	  quantify	  this.	  PCR	   might	   be	   a	   useful	   assay	   to	   quantify	   this.	   As	   described	   in	   the	   methods	   section	   the	  retained	   foci	   where	   then	   dissociated	   into	   a	   single	   cell	   suspension	   through	   extended	  incubation	  with	  0.25%	   trypsin	   (up	   to	  45	  minutes)	   and	  pipetting	   of	   the	   same	  and	   filtered	  again	   through	   a	   70µm	   filter.	  When	   these	   cells	   were	   replated	   and	   compared	   to	  manually	  excised	   foci	   which	   were	   plated	   onto	   matrigel	   without	   dissociation	   there	   was	   a	   clear	  improvement	  in	  RPE	  expansion	  after	  4	  weeks	  (Figure	  5.9	  b).	  Additionally	  it	  can	  be	  seen	  in	  
Figure	  5.9	  b	  that	  in	  the	  wells	  where	  the	  foci	  were	  manually	  excised	  that	  a	  non-­‐pigmented	  cell	  type	  has	  proliferated	  across	  the	  well	  and	  caused	  the	  cell	  sheet	  to	  peel	  at	  the	  edges	  (as	  denoted	  by	  arrows).	  Although	  it	  is	  unclear	  where	  this	  second	  type	  is	  a	  contaminant	  of	  not,	  such	  peeling	  is	  undesirable	  in	  culture.	  	  
Using	  this	  enzymatic	  and	  filtration	  method	  as	  described	  above	  it	  was	  then	  explored	  to	  see	  if	  there	  was	  an	  optimum	  seeding	  density	  which	  would	  allow	  expansion	  of	  the	  PSC-­‐RPE	  whilst	  maintaining	   the	  RPE	  phenotype	   (Figure	   5.10).	   It	   can	  be	   seen	   that	   the	  best	   result	   from	  a	  morphology	  perspective	  were	   achieved	  at	   the	  highest	   seeding	  density	  of	  67,000	   cells	  per	  cm2.	  This	  culture	  was	  fully	  confluent	  at	  only	  3	  days	  post	  seeding	  and	  at	  D22	  had	  the	  highest	  percentage	   of	   pigmentation	   at	   69%.	   At	   the	   lower	   seeding	   densities	   more	   swirl-­‐like	  morphology	   was	   observed	   and	   the	   resultant	   pigmentation	   was	   lower.	   When	   the	   whole	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wells	  were	  scanned	  using	  a	  flat	  bead	  scanner	  at	  the	  highest	  density	  of	  67,000	  cells	  per	  cm2	  
(Figure	  5.11	  a)	   there	  were	  a	  couple	  of	  areas	  in	  which	  aggregates	  had	  been	  transferred	  to	  the	  well,	  possibly	  a	  result	  of	  over-­‐pipetting	  the	  sample	  after	  it	  was	  passed	  through	  the	  final	  filter.	  Yet	  overall	  the	  well	  had	  clear	  homogeneity	  of	  pigmentation.	  For	  50,000	  cells	  per	  cm2	  
(Figure	  5.11	  b)	  there	  was	  a	  denser	  ‘streak’	  of	  cells	  at	  the	  centre	  of	  the	  well	  where	  the	  cells	  had	  accumulated.	  Such	  a	  distribution	  has	  been	  seen	  using	  other	  cell	   types	   in	  smaller	  well	  formats	  (e.g.	  48	  well),	   it	  would	  be	  assumed	  this	  phenomenon	  could	  be	  avoided	  by	  moving	  up	  to	  a	   larger	  well	   format.	  Further	  work	  is	  needed	  to	  characterise	  this	  successful	  proof	  of	  concept	  separation	  method	  quantitatively	  using	  a	  range	  of	  phenotypic	  markers	  to	  explore	  purity,	  yield	  and	  devise	  a	  way	  to	  scope	  the	  target	  morphology.	  	  
5.4 Conclusions	  RPE	   adopt	   a	   number	   of	   morphologies	   as	   they	   appear	   as	   foci	   in	   PSC	   monolayer	  differentiation	  experiments,	  why	  exactly	   there	   is	  heterogeneity	   is	  an	  unknown	  but	   for	   the	  current	  manual	  excision	  method	  foci	  less	  than	  1mm	  cannot	  be	  successfully	  harvested.	  The	  manual	   method	   is	   very	   hard	   to	   perform	   and	   time	   consuming	   and	   without	   subsequent	  dissociation	  of	  the	  foci	  poor	  expansion	  of	  the	  PSC-­‐RPE	  culture	  is	  seen.	  As	  has	  been	  widely	  reported	   in	   the	   literature	   these	  pigmented	   foci	  once	  replated	  quickly	  expand	  and	  adopt	  a	  highly	  distinct	  pigmented	  monolayer	  which	  is	  positive	  for	  RPE	  specific	  markers	  (where	  the	  morphology	   is	   maintained),	   this	   validates	   the	   approach	   of	   tracking	   percentage	  pigmentation	  -­‐	  to	  track	  the	  differentiation	  in	  a	  non-­‐invasive	  way.	  In	  addition	  this	  adds	  to	  the	  confidence	  that	  it	  is	  not	  another	  pigmented	  cell	  type	  that	  has	  been	  obtained.	  	  	  
There	   are	   a	   number	   of	   separation	   technologies	   that	   could	  be	  used	   to	   replace	   the	  manual	  method,	   such	   as	   FACs,	   MACs,	   and	   potentially	   dielectrophoresis.	   As	   these	   technologies	  currently	   stand	   they	   are	   not	   well	   suited	   to	   the	   mass	   manufacture	   of	   an	   allogeneic	   cell	  therapy.	   The	   exception	   being	   MACs	   where	   there	   is	   precedent	   for	   the	   scaling	   of	   affinity	  chromatography	  in	  recombinant	  protein	  purification.	  However,	  without	  a	  definitive	  surface	  marker	   to	   base	   the	   sort	   on,	   the	   costs	   involved,	   and	   validation	   effort	   involved	   in	   sorting	  using	  antibodies	  the	  approach	  is	  not	  without	  significant	  issues.	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Although	   the	   current	   manual	   separation	   approach	   makes	   best	   efforts	   to	   only	   take	  pigmented	  cells	   the	  approach	  clearly	  cannot	  produce	  100%	  purity,	  however	   in	  numerous	  animal	  studies	   there	  has	  been	  no	   issue	  arising	   from	  a	  contaminant	  cell	   type	  causing	  graft	  overgrowth	  etc.	  Thus	  without	  a	  need	  for	  a	  high	  purity	  separation	  stage	  the	  antibody	  based	  separation	  methods	   of	  MACs	   and	  FACs	   are	   probably	   not	   required	   to	   ensure	   the	   safety	   of	  this	  particular	  PSC-­‐RPE	  therapy.	  	  	  
In	  fact,	  it	  would	  appear	  that	  there	  is	  no	  requirement	  for	  a	  separation	  stage	  at	  all.	  After	  the	  work	   reported	   in	   this	   Chapter	   was	   completed,	   a	   paper	   was	   published	   by	  Maruotti	   et	   al.	  (2013)	  which	   serially	  passaged	   the	  entire	  differentiating	   sheet	   to	  produce	   the	   target	  RPE	  monolayer.	   The	   difference	   to	   the	  method	   described	   in	   this	   Chapter	   is	   the	  Maruotti	   et	   al.	  (2013)	  method	  does	  not	  have	  the	  first	  filtration	  step	  to	  separate	  away	  the	  dissociated	  non-­‐pigmented	   cells	   from	   the	   non-­‐dissociated	   foci,	   but	   instead	   it	   passages	   the	  whole	   culture.	  Specifically	   in	   the	  Maruotti	   et	   al.	   (2013)	  approach	   the	  differentiating	   culture	   is	   incubated	  for	   4	   hours	   under	   collagenase,	   then	   under	   Accumax	   (Sigma-­‐Aldrich)	   for	   45mins,	   and	  through	  the	  use	  of	  “vigorous”	  pipetting	  and	  passing	  the	  suspension	  through	  a	  40µm	  filter,	  a	  single	   cell	   suspension	  was	  obtained	  and	  seeded	  at	  100,000	  cells/cm2.	  This	   is	   a	   far	  higher	  seeding	   density	   than	   that	   explored	   here	   (67,000	   cells	   cm2),	   however	   based	   on	   the	   trend	  observed	   it	   would	   be	   assumed	   that	   the	   higher	   density	   would	   result	   in	   an	   improved	  morphology	  and	   in	   the	  current	  clinical	  protocol	  a	  seeding	  density	  of	  116,000	  cells/cm2	  at	  the	  final	  stage	  onto	  the	  membrane	  for	  implantation.	  
5.5 Summary	  The	  current	  manual	  separation	  method	  is	  totally	  unsuited	  to	  commercial	  manufacture	  and	  needs	   to	   be	   replaced.	   The	   enzymatic	   based	   method	   described	   here	   and	   the	   similar	   one	  described	   by	  Maruotti	   et	   al.	   (2013)	   demonstrate	   there	   are	   enzymatic	   alternatives	   which	  provide	   a	   proof	   of	   concept	   for	   further	   optimisation	   for	   adoption	   into	   a	   commercial	  bioprocess.	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5.5.1 Future	  work	  Ideally	  the	  method	  described	  here	  would	  be	  compared	  to	  the	  method	  described	  by	  Maruotti	  et	  al.	  (2013),	  however	  due	  to	  a	  lack	  of	  clinical	  understanding	  there	  is	  no	  quantifiable	  target	  product	   profile	   to	   optimise	   either	  method	   and	   compare	   them.	   For	   instance	   although	   the	  cobblestone	  morphology	  with	  tight	  junctions	  is	  the	  target	  attribute	  of	  the	  monolayer	  there	  is	   no	   easy	   way	   to	   quantifiably	   score	   it	   for	   a	   whole	   well,	   here	   some	   kind	   of	   automated	  imaging	   combined	   with	   algorithmic	   analyses	   of	   the	   morphology	   like	   that	   described	   in	  Vugler	   et	   al.	   (2008)	   and	   Boatright	   et	   al.	   (2015)	   could	   be	   useful.	   Another	  way	   to	   test	   the	  integrity	  of	  the	  PSC-­‐RPE	  sheet	  in	  transwell	  plates	  is	  to	  test	  for	  impedance	  and	  permeability,	  with	  the	  sheets	  with	  the	  highest	  impedance	  and	  lowest	  permeability	  representing	  the	  more	  mature	  phenotype	  (Savolainen	  et	  al.,	  2011).	  Both	  tests	  are	  non-­‐destructive	  and	  so	  would	  be	  ideal	  lot	  release	  tests	  if	  they	  could	  be	  validated	  to	  relate	  to	  functional	  tests	  such	  as	  rod	  and	  code	  phagocytosis	  in	  vitro	  and	  expected	  clinical	  efficacy.	  Finally,	  no	  matter	  which	  enzymatic	  method	   is	   pursued	   the	   method	   needs	   to	   be	   scaled	   up	   so	   that	   the	   changes	   between	  dissociation	  agents,	  wash	  media	  and	  inactivation	  media	  can	  be	  completed	  in	  an	  automated	  fashion.	  There	  are	  a	  large	  number	  of	  filtration	  units	  and	  purification	  rigs	  currently	  applied	  to	  whole	  cell	  separation	  and	  protein	  purification	  that	  could	  be	  modified	  to	  the	  task	  to	  create	  a	  robust,	  controllable	  and	  so	  validatable	  separation	  solution.	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The! RPE! associated! markers! in! Table! 7! were! investigated! through!
Immunocytochemistry! (images! displayed! in!Figure! 22! through!Figure! 29).! CRABP!





Figure 21: Foci Exhibit Different Expansion Characteristics Post re-plating. A-H: 4X brightfield, 
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6. Conclusions	  and	  future	  work	  	  
6.1 Summary	  and	  overall	  conclusions	  
6.1.1 Meeting	  of	  thesis	  aims	  and	  objectives	  	  
The	   aim	   of	   this	   thesis	   was	   to	   explore	   the	   feasibility	   of	   applying	   methodologies	   and	  technologies	   from	   traditional	   biotherapeutic	   production	   to	   cell	   therapy	   manufacturing,	  specifically	  the	  creation	  of	  a	  PSC-­‐RPE	  therapy	  to	  treat	  AMD.	  	  The	  overall	  focus	  of	  the	  thesis	  being	  the	  development	  of	  a	  scalable	  and	  robust	  cell	  therapy	  manufacturing	  process	  to	  treat	  blindness	  	  
Key	  to	  the	  scaling	  of	  any	  cell	  culture	  process	  is	  to	  realise	  economies	  of	  scale	  and	  to	  do	  this	  in	  a	  robust	  and	  predictable	  manner.	  This	  traditionally	  involves	  either	  automation	  (common	  in	  a	  “scale	  out”	  approach)	  or	  the	  use	  of	  larger	  production	  units	  (in	  a	  “scale	  out”)	  approach.	  In	  
Chapter	  2	  the	  Quantum	  Cell	  Expansion	  system	  was	  used	  to	  scale	  up	  cell	  culture.	  Using	  the	  system	  60	  million	  human	  embryonic	  stem	  cells	  were	  expanded	  to	  708	  million	  cells	  over	  5	  days.	   High	   levels	   of	   pluripotency	  marker	   expression	   were	  maintained	   on	   the	   bioreactor,	  with	  97.7%	  of	  cells	  expressing	  SSEA-­‐4	  when	  harvested.	  	  However,	  the	  cell	  density	  achieved	  per	  cm2	  was	  18%	  of	  traditional	  2D	  flask	  controls.	  The	  likely	  source	  of	  this	  variation	  was	  the	  inability	  to	  control	   the	  provision	  of	  an	   ideal	  environment	   for	  cell	  growth	  in	  this	  perfusion	  system	  as	  there	  was	  a	  lack	  of	  online	  monitoring	  or	  control.	  	  
As	  the	  Quantum	  System	  lacks	  the	  following:	  i)	  a	  small-­‐scale	  mimic	  for	  process	  development	  ii)	  a	  range	  of	  product	  sizes	  to	  be	  used	  in	  a	  seed	  chain	  and	  iii)	  and	  no	  online	  monitoring	  or	  control	  besides	   temperature,	   in	   its	   current	   state	   it	   is	  not	   suitable	   for	  use	   in	   an	  allogeneic	  PSC	  derived	  RPE	  therapy.	  It	  is	  important	  to	  note	  that	  this	  conclusion	  is	  specific	  for	  the	  PSC	  application	   as	   the	   Quantum	   system	   clearly	   has	   a	   number	   of	   key	   processing	   advantages	  when	   it	   is	   used	   with	   mesenchymal	   stem	   cells	   and	   similar	   cell	   types,	   for	   which	   it	   was	  originally	  designed.	  A	  particularly	  interesting	  application	  is	  the	  expansion	  of	  adherent	  cells	  from	  whole	  bone	  marrow	  aspirate.	  As	  the	  device	   is	  a	   functionally	  closed	  unit	  with	  a	   large	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amount	  of	  automated	  functions	  for	  the	  isolation	  and	  expansion	  of	  bone	  marrow	  aspirate,	  it	  could	  potentially	  be	  used	  as	  a	  “point	  of	  care”	  device.	  	  
From	   the	   work	   with	   the	   Quantum	   Cell	   Expansion	   System	   it	   was	   clear	   that	   for	   a	   mass-­‐produced	   allogeneic	   PSC-­‐RPE	   therapy	   online	   monitoring	   and	   control	   were	   needed	   to	  optimise	   production	   and	   realise	   economies	   of	   scale.	   The	   collaboration	  with	   Artelis	   (who	  became	   part	   of	   ATMI	   and	   now	   Pall)	   gave	   access	   to	   the	   Xpansion	   One	   system,	   a	   128cm2	  mimic	   of	   their	   larger	   production	   reactors	   (Chapter	   3).	   This	   device	   allowed	   the	  investigation	   of	   online	   monitoring	   and	   control	   of	   pH	   and	   dissolved	   oxygen.	   The	   best	  performance	  relative	  to	  flask	  controls	  was	  62%.	  It	  was	  observed	  that	  even	  small	  changes	  in	  pH	   had	   a	   large	   impact	   on	   growth	   and	   that	   the	   highly	   metabolic	   nature	   of	   PSCs	   at	   high	  density	   put	   great	   demands	   on	   systems	   originally	   developed	   for	   mesenchymal	   stem	   cell	  culture.	  Better	  results	  would	  be	  expected	  if	  the	  gas	  mix	  of	  the	  system	  could	  be	  controlled,	  i.e.	   increase	  of	  O2	  and	  reduction	  of	  CO2	  at	  these	  higher	  cell	  densities.	  Control	  of	  gas	  mix	   is	  achievable	  on	  the	  production	  scale	  units	  but	  not	  the	  Xpansion	  One	  development	  scale	  used	  in	  this	  thesis.	  
What	  was	  particularly	  interesting	  about	  the	  Xpansion	  system	  is	  that	  the	  manufacturer	  had	  intentionally	  tried	  to	  intensify	  traditional	  2D	  culture	  systems	  rather	  than	  move	  to	  a	  fully	  3D	  environment.	   The	   aim	   being	   to	  minimise	   the	   process	   development	   required	   to	   scale	   the	  process	   and	   minimise	   any	   impact	   on	   the	   target	   phenotype	   that	   might	   necessitate	   the	  replication	  of	  pre-­‐clinical	  or	  clinical	  work.	  	  Through	  the	  removal	  of	  the	  gas	  headspace	  in	  the	  Xpansion	   systems	   a	   greater	   volumetric	   productivity	   can	   be	   achieved	   when	   compared	   to	  flasks	  (cm2	  available	  per	  cm3	  of	  bioreactor	  volume).	  However,	  by	  removing	  this	  headspace	  the	  gas	  transfer	  needs	  to	  be	  driven	  in	  a	  dynamic	  manner.	  This	  can	  cause	  issues	  due	  shear	  or	  other	  effects	  on	  the	  cells	  or	  if	  the	  rector	  design	  can	  not	  match	  the	  oxygen	  uptake	  rate	  of	  the	  cells,	   as	   described	   in	   the	  KLa	   equation.	   A	   comparison	   of	   a	   number	   of	  metrics	   for	   various	  flask/stack	  based	  methods	  to	  adherent	  bioreactor	  culture	  are	  replicated	  in	  Figures	  6.1	  and	  
6.2	   (these	   were	   originally	   presented	   as	   part	   of	   a	   poster	   at	   the	   Engineering	   Conferences	  International	  conference	  on	  Cell	  Therapy	  Manufacturing	  in	  2013).	  	  As	  can	  be	  seen	  in	  Figure	  
6.1	  a	  traditional	  T-­‐flask	  has	  a	  volumetric	  productivity	  of	  0.26	  (cm2/cm3),	  and	  a	  HYPERStack	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has	  a	  ratio	  of	  4.62,	  the	  Xpansion	  system	  improves	  on	  the	  latter	  slightly	  to	  5.59	  (Figure	  6.2).	  The	  Xpansion	  system	   is	   limited	   to	  any	   further	   increases	   in	  volumetric	  productivity	  as	   the	  media	  volume	  per	  cm2	  was	  chosen	  to	  match	  traditional	  flask	  culture	  as	  close	  as	  possible	  and	  so	  the	  vessel	  volume	  can	  not	  be	  reduced	  any	  further.	  With	  experience	  of	  using	  the	  Xpansion	  system	   and	   using	   the	   data	   from	   Figure	   6.1	   and	   6.2	   it	   would	   be	   interesting	   to	   run	   a	  comparison	  of	  the	  larger	  Xpansion	  reactors	  against	  the	  HYPER	  system	  to	  see	  which	  is	  better	  suited	  to	  commercial	  production	  of	  a	  PSC-­‐RPE	  therapy.	  Key	  to	  this	  would	  be	  to	  determine	  how	  the	  highly	  metabolic	  nature	  of	  the	  PSC	  impacts	  the	  gas	  and	  mass	  transfer	  capabilities	  of	  the	  respective	  systems.	  
In	   summary,	   the	   work	   with	   the	   Quantum	   Cell	   Xpansion	   System	   and	   Xpansion	   One	  bioreactors	   meant	   that	   the	   feasibility	   of	   growing	   PSCs	   in	   very	   different	   dynamic	  environments	  for	  the	  first	  time.	  Clearly,	   the	  work	  conducted	  in	  the	  thesis	  did	  not	  produce	  optimised	   protocols	   to	   take	   into	   clinical	   manufacturing	   but	   the	   work	   was	   successful	   in	  identifying	   a	   number	   of	   technical	   and	   practical	   questions	   which	   need	   to	   be	   asked	   when	  scaling	  such	  systems.	  The	  results	  of	  this	  work	  were	  fed	  back	  to	  the	  manufacturers	  and	  it	  is	  hoped	   that	   they	  will	   inform	   the	   design	   of	   their	   respective	   product	   ranges	   if	   they	   seek	   to	  grow	  PSCs	  for	  allogeneic	  therapies.	  	  	  
No	   evidence	   could	   be	   found	   in	   the	   literature	   of	   applying	   the	   DoE	   approach	   to	   PSC	  differentiation	   in	  either	  a	   screening	  design	  or	  an	  optimisation	  design.	  So,	  given	   the	  heavy	  use	   of	   the	   approach	   in	   biotherapeutic	   production	   it	  was	   seen	   as	   a	   key	   tool	   to	   attempt	   to	  apply	  to	  PSC	  differentiation	  to	  develop	  a	  scalable	  and	  robust	  PSC-­‐RPE	  process	  (Chapter	  4).	  Initially	  a	  screening	  run	  of	  8	   factors	  was	  completed	   to	   identify	  key	  variables.	  From	  this	   it	  was	   identified	   that	   reducing	   media	   changes	   from	   every	   day	   to	   once	   every	   3	   days,	   and	  reducing	  media	  volume	  by	  half	  did	  not	  have	  an	  adverse	  impact	  on	  pigmentation	  yield	  -­‐	  this	  is	  vital	  when	  considering	  process	  economics.	  	  The	  screen	  also	  suggested	  that	  the	  outputs	  of	  percentage	   pigmentation	   and	   the	   RPE	   related	   gene	   TYR	  were	   significantly	   impacted	   by	  seeding	  density,	   the	   time	   to	  differentiation	  and	  nicotinamide	  concentration.	  However,	   the	  validity	  of	  the	  data	  recorded	  was	  such	  that	  Stat	  Ease	  software	  could	  not	  create	  a	  statistically	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valid	  model	  of	  these	  inputs	  to	  be	  able	  to	  quantifiably	  predict	  the	  outcomes	  for	  the	  screening	  experiment.	  	  
This	   screening	   experiment	  was	   followed	   by	   a	   central	   composite	   design	   in	   a	   full	   factorial	  experiment	  to	  determine	  the	  process	  optimum	  with	  replicates	  of	  each	  of	  the	  33	  chosen	  data	  points	   for	   the	   49	   day	   protocol.	   	   The	   outputs	   measured	   for	   each	   data	   point	   included	  quantitative	  PCR	  of	  7	  RPE	  related	  genes,	  pH,	  media	  composition	  (glucose	  and	  lactate),	  and	  percentage	  pigmentation	  (a	  proxy	  measurement	  of	  RPE	  differentiation)	  all	  at	  several	  time	  points.	  For	  the	  optimisation	  experiment	  the	  factors	  explored	  were:	  i)	  time	  prior	  to	  switch	  to	  differentiation	  media,	  ii)	  nicotinamide	  concentration	  and	  iii)	  initial	  seeding	  density.	  Due	  to	  the	  variability	  of	  manual	  PSC	  culture	  many	  of	   the	  observations	   from	  these	  measurements	  were	   not	   significant	  when	   analysed	   in	   the	  Design	  Expert	   software	   (Stat-­‐Ease).	   	  However,	  Pmel17	   (a	   key	   RPE	   development	   marker)	   and	   percentage	   pigmentation	   allowed	   the	  creation	   of	   a	   computational	   model	   that	   statistically	   matched	   the	   experimental	   data.	  Exploration	   of	   this	   experimental	   space	   identified	   optimum	   conditions	   of:	   15.3mM	  nicotinamide,	   an	   initial	   seeding	   density	   13,000	   cells/cm2	   and	   allowing	   72	   hours	   post	  seeding	  before	  making	  a	  change	  to	  differentiation	  media	  from	  PSC	  media.	  But,	  the	  contour	  plots	   suggested	   that	   the	   range	   explored	   in	   the	   design	   laid	   outside	   of	   the	   true	   optimal	  conditions.	   The	   model	   indicating	   that	   yet	   better	   results	   achievable	   at	   lower	   seeding	  densities	  and	  shorter	  periods	  before	  a	  switch	  to	  differentiation	  media	  is	  made.	  
There	  were	  clear	  practical	  issues	  in	  applying	  the	  DoE	  approach	  to	  PSC	  differentiation,	  due	  to	   the	   highly	   manual	   nature	   of	   the	   protocols	   and	   variability	   of	   the	   results	   from	   long	  differentiation	  protocols.	  Yet,	  the	  approach	  did	  yield	  interesting	  and	  useful	  results	  and	  has	  given	   a	   far	   better	   understanding	   of	   complex	   interactions	   of	   processing	   variables,	   such	   as	  seeding	   density,	   time	   to	   differentiation	   and	   nicotinamide	   concentration.	   It	   is	   expected	   as	  new	   technological	   methods	   and	   automated	   platforms	   are	   developed	   which	   allow	   high	  throughput	  screening	  of	  culture	  parameters	  that	  the	  DoE	  approach	  will	  be	  become	  standard	  practice.	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The	   key	   limiting	   step	   of	   the	   current	   protocol	   is	   clearly	   the	   manual	   separation	   of	   the	  pigmented	  RPE	  from	  the	  rest	  of	  the	  differentiation	  culture.	  A	  novel	  separation	  stage	  using	  two	  different	  types	  of	  enzyme	  and	  a	  number	  of	  filtration	  stages	  was	  found	  to	  produce	  RPE	  monolayers	  of	  the	  target	  morphology	  (Chapter	  5).	  This	  method	  is	  inherently	  more	  scalable	  than	  the	  manual	  method	  and	  it	  would	  be	  relatively	  simple	  through	  the	  use	  of	  commercially	  available	   filtration	  units,	  pumps	  and	  values	   to	  build	  a	  proof	  of	   concept	  device	   that	  would	  remove	  much	  of	  the	  manual	  handling.	  What	  halts	  the	  progression	  of	  such	  work	  is	  a	  lack	  of	  understanding	   what	   the	   target	   product	   profile	   of	   the	   final	   monolayer	   actually	   is.	   From	  analysis	  of	  the	  expanding	  monolayer	  there	  is	  clear	  variation	  in	  the	  cell	  size	  and	  cobblestone	  morphology,	  and	  that	  this	  has	  an	  impact	  on	  RPE	  protein	  expression.	  There	  are	  a	  number	  of	  ways	   in	   which	   this	   and	   other	   metrics	   such	   as	   trans-­‐membrane	   electrical	   potential,	   or	  protein	  secretions	  could	  be	  scored	  non-­‐destructively,	  yet	  without	  an	  understanding	  of	  how	  these	   impact	   the	   potency	   of	   the	   final	   product	   the	   exercise	  would	   essentially	   be	   fruitless.	  What	   was	   critical	   in	   deciding	   not	   to	   take	   this	   work	   further,	   which	   would	   entail	  characterising	  and	  optimising	  the	  process,	   is	  that	   it	  appeared	  it	  might	  not	  be	  necessary	  to	  sort	  the	  cells	  at	  all.	  The	  manual	  method	  of	  using	  “best	  efforts”	  to	  remove	  any	  contaminant	  cells	   obviously	   does	   not	   create	   a	   pure	   population	   of	   cells,	   yet	   this	   has	   not	   caused	   any	  adverse	   incidents	   of	   graft	   overgrowth	   in	   any	   of	   the	   animal	   models.	   Furthermore,	   a	   new	  protocol	   published	   by	   Maruotti	   et	   al.	   (2013)	   obtains	   a	   high	   yield	   of	   RPE	   in	   a	   short	  timeframe	  by	  dissociating	  the	  entire	  differentiating	  culture,	  and	  then	  serially	  passaging	  the	  culture	  and	  so	  making	  no	  effort	  to	  “purify”	  the	  cells	  at	  all.	  If	  such	  an	  enzymatic	  method	  can	  show	  safety	  to	  the	  regulators	  from	  a	  cell	  contaminant	  perspective	  it	  would	  be	  a	  very	  simple	  method	  to	  scale	  successfully,	  negating	  the	  need	  for	  the	  current	  manual	  dissection	  method.	  
6.1.2 Practical	  and	  resource	  issues	  Attempting	   to	   apply	   standard	   biomanufacturing	   technologies,	   such	   as	   bioreactors	   and	  approaches	   like	   DoE	   to	   PSC	   culture	   and	   differentiation,	   produced	   a	   large	   number	   of	  practical	  and	  resourcing	  issues.	  These	  presented	  a	  significant	  challenge	  in	  trying	  to	  develop	  a	  scalable	  and	  robust	  manufacturing	  process.	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A	  key	   issue	   from	   the	   start	   of	   the	  work	  was	   the	  need	   for	   single	   cell	   passaging	  methods	  of	  PSCs.	   Typically	   PSCs	   are	  manually	   passaging	   through	   the	   selection	   of	   PSC	   colonies	   via	   a	  plastic	  pipette	  under	  a	  dissecting	  microscope.	  Such	  methods	  are	  extremely	  time	  consuming	  and	   insufficient	   to	   produce	   the	   number	   of	   cells	   required	   to	   complete	   the	   work	  with	   the	  bioreactors	   used	   in	   this	   thesis	   (60million	   cells	   were	   needed	   to	   seed	   each	   run	   of	   the	  Quantum	   system,	   and	   the	   Xpansion	   One	   unit	   has	   a	   128cm2	   growth	   area).	   A	   number	   of	  attempts	   were	   made	   within	   the	   research	   group	   at	   UCL	   to	   adapt	   cell	   lines	   to	   enzymatic	  passaging	   methods	   however	   these	   always	   yielded	   cell	   line	   with	   stable,	   yet	   abnormal,	  karyotypes.	  Such	  a	  line	  was	  used	  in	  Chapters	  2	  and	  3,	  which	  although	  deemed	  suitable	  for	  these	  feasibility	  studies	  when	  developing	  a	  new	  process	  it	  would	  have	  been	  better	  to	  have	  used	  karyotypically	  normal	   lines	  to	  ensure	  the	  data	  produced	  was	  directly	  transferable	  to	  the	  clinical	  work.	  The	  DoE	  work	  (Chapter	  4)	  used	  karyotypically	  normal	  iPS	  lines	  and	  the	  (Stem	   Cell	   Technologies)	   feeder	   free	   system	   which	   through	   use	   of	   rock	   inhibitor	   could	  remain	  kayotypically	  stable	  after	  passaging	  with	  enzymatic	  methods.	  But,	  such	  systems	  are	  far	   too	   expensive	   for	   an	   academic	   lab	   to	   be	   used	   in	   process	   development	   work	   in	   the	  Quantum	  System	  or	  the	  Xpansion	  One	  system.	  	  
Even	   using	   the	   cheaper	  mouse	   feeder	   based	   system	   the	  Quantum	  Cell	   Expansion	   System	  was	  very	  expensive.	  Each	  run	  involved	  the	  coating	  of	  the	  21,000	  cm2	  of	  the	  bioreactor	  with	  fibronectin.	  Additionally,	   if	  media	   consumption	  had	  of	  been	  matched	   to	   the	   same	  mL	  per	  cm2	  ratio	  as	  used	  in	  flasks	  4.2L	  of	  media	  would	  have	  been	  required	  per	  day.	  So,	  even	  though	  the	  poorer	   growth	   in	   the	  Quantum	  System	   compared	   to	   flask	   culture	   is	   believed	   to	  be	   in	  part	  because	  of	  an	  undersupply	  in	  media,	  to	  “oversupply”	  media	  at	  the	  start	  of	  the	  culture	  when	  the	  cell	  number	  is	  comparably	  low	  was	  simply	  unaffordable	  in	  an	  academic	  setting.	  In	  all	  7	  runs	  were	  completed	  on	  Quantum	  System	  using	  a	  variety	  of	  cell	  lines	  before	  the	  runs	  described	  in	  Chapter	  2	  were	  performed	  (each	  run	  taking	  weeks	  to	  months	  to	  complete	  and	  analyse).	   Experimenting	   at	   such	   a	   large	   scale	   proved	   to	   not	   just	   be	   highly	   expensive,	   but	  also	   impractical	   in	   having	   to	   grow	   up	   10’s	   millions	   of	   cells	   per	   run	   to	   conduct	   a	   simple	  experiment	   such	   as	   seeding	   efficiency.	   Therefore	   it	   is	   clear	   that	   any	   bioreactor	   system	  
	   	  
	   - 189 -	  
needs	  to	  be	  available	  in	  a	  full	  range	  of	  small	  scale	  testing	  forms	  and	  large-­‐scale	  production	  units.	  	  
Variability	   was	   also	   a	   constant	   issue	   with	   the	   work.	   Among	   other	   factors	   the	   RPE	  differentiation	   is	   adversely	   effected	   by	   passage	   number	   Lane	   et	   al.	   (2014)	   which	   causes	  reproducibility	   issues.	   To	   address	   this	   experiments	  were	   always	   set	   up	   at	   the	   same	   time	  and	   from	  the	  same	  passage.	  However,	   this	  creates	  significant	   labour	  demands	   for	  a	  single	  operator	   as	   it	   requires	   the	   culturing	   of	   a	   large	   number	   of	   cells	   before	   starting	   any	  experimental	  work.	  The	  differentiation	  protocol	  used	  in	  this	  thesis	  was	  also	  extremely	  long.	  After	  the	  first	  PSC	  expansion	  phase	  the	  differentiation	  stage	  to	  produce	  the	  pigmented	  foci	  can	  be	  run	  for	  12	  weeks.	  The	  excised	  foci	  are	  then	  expanded	  for	  up	  to	  another	  7	  weeks	  in	  well	  plates,	  before	  a	  further	  3	  week	  expansion	  on	  transwell	  plates.	  These	  very	  long	  culture	  periods	  made	  it	  not	  only	  very	  had	  to	  generate	  data	  but	  also	  give	  a	  very	  long	  time	  period	  on	  which	  any	  variation	  to	  take	  place.	  	  
6.2 Recommendations	  for	  future	  research	  
	  
6.2.1 Expansion	  of	  the	  Work	  Started	  in	  this	  Thesis	  
The	  bioreactor	  work	   reported	  here	   focused	  on	  adherent	  based	  PSC	  culture.	   Similarly,	   the	  PSC	   to	   RPE	   differentiation	   protocols	   also	   used	   adherent	   cultures	   as	   this	   is	   the	   protocol	  followed	   by	   the	   Moorfields	   group.	   However,	   far	   higher	   volumetric	   productivities	   can	   be	  achieved	   by	   scaling	   cell	   culture	   in	   suspension	  methods	   as	   opposed	   to	   adherent	  methods.	  For	   example	   the	   maximum	   theoretical	   yield	   of	   the	   Xpansion	   system	   is	   0.56m	   cells/cm3	  
(Figure	  6.2)	  yet	  in	  suspension	  cultures	  PSC	  aggregates	  have	  been	  grown	  to	  3.4m	  cells/ml	  spinner	   flasks	   (Kehoe	   et	   al.,	   2010).	   As	   a	   number	   of	   PSC-­‐RPE	   protocols	   already	   use	  suspension	  methods	  (Meyer	  et	  al.,	  2009)	  this	  would	  be	  an	  interesting	  avenue	  of	  research	  to	  explore	  the	  technical	  challenges	  of	  scale-­‐up.	  	  
As	  the	  therapeutic	  dose	  of	  the	  PSC-­‐RPE	  is	  likely	  to	  be	  as	  low	  as	  50,000	  cells	  per	  eye	  the	  scale	  up	   of	   the	   process	   to	   achieve	   economies	   of	   scale	   is	   probably	   less	   of	   a	   concern	   than	   the	  control	   and	   robustness	   of	   the	   process.	   Although	   the	   use	   of	   bioreactors	   and	   their	   control	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systems	   usually	   yields	   a	   greater	   amount	   of	   process	   control,	   it	   could	   be	   argued	   that	  automation	  would	   be	   a	   very	   interesting	   avenue	   for	   investigation.	   An	   automated	  machine	  would	   not	   necessarily	   be	   a	   highly	   complex	   machine.	   For	   instance,	   during	   the	   long	  differentiation	  protocols	  that	  last	  several	  weeks	  the	  only	  operation	  performed	  is	  to	  change	  media	  every	  few	  days,	  therefore	  a	  simple	  automated	  media	  exchanger	  would	  free	  up	  a	  lot	  of	  time	  and	  labour	  costs	  in	  the	  GMP	  culture	  facilities.	  	  
6.2.2 Economic	  and	  resource	  modelling	  The	  question	  of	  where	  resources	  would	  be	  best	  committed	  to	  remove	  both	  bottlenecks	  and	  costs	   from	   the	   process	   became	   critically	   apparent	   during	   work	   on	   this	   thesis.	   This	   is	  because	   there	   are	   a	   vast	   amount	   of	   potential	   issues	   that	   need	   to	   be	   addressed	   in	   the	  creation	  of	  a	  totally	  new	  manufacturing	  process	  to	  produce	  a	  new	  class	  of	  therapeutic.	  To	  this	   end	   work	   was	   initiated	   to	   model	   the	   existing	   process	   used	   by	   the	   clinical	   team	   at	  Moorfields	  as	  accurately	  as	  possible	  in	  a	  way	  which	  would	  allow	  the	  prediction	  of	  how	  key	  aspects	  such	  as	  cost	  per	  patient	  would	  change	  as	  the	  current	  process	  scales.	  The	  eventual	  goal	   was	   to	   then	   make	   suggestions	   of	   alternative	   approaches	   making	   use	   of	   new	  technologies	   such	   as	   automation	   platforms,	   and	   then	   to	   compare	   the	   scenarios.	  Unfortunately	  due	  to	  time	  limitations	  this	  work	  was	  not	  completed	  in	  time	  for	  inclusion	  in	  this	  thesis,	  however,	  preliminary	  results	  of	  the	  model	  are	  discussed	  below	  in	  brief	  as	  they	  represent	  a	  key	  area	  of	  future	  work.	  
The	   current	   lab	   scale	  process	  was	  modelled	   through	  use	  of	  Excel	  macros	   to	   create	   a	   tool	  that	   could	   take	   in	   inputs,	   such	   as	   number	   of	   patients	   to	   be	   treated	   a	   week,	   or	   the	  differentiation	  efficiency,	  and	  from	  this	  generate	  data	  such	  as	  cost	  per	  treatment	  or	  capacity	  utilisation	  of	  the	  facility.	  	  An	  overview	  of	  the	  model	  is	  displayed	  in	  Figure	  6.3	  which	  shows	  the	   model	   inputs	   and	   outputs.	   Using	   the	   model	   an	   initial	   scenario	   was	   run	   based	   on	   a	  requirement	  to	  treat	  3	  patients	  per	  week	  from	  a	  single	  batch	  (with	  an	  additional	  patch	  for	  QC).	  After	  a	  5	  week	  expansion	  phase	  the	  production	  of	  each	  batch	  takes	  24	  weeks,	  and	  from	  this	  data	  the	  charts	  in	  Figure	  6.4	  were	  produced.	  The	  media	  requirements	  are	  dominant	  for	  the	  stages	  prior	   to	   the	  separation	  of	   the	  pigmented	   foci	   (Figure	   6.4	   a).	  The	  reason	  being	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during	   the	   “expansion”	   and	   “differentiation”	   stages	   both	   the	   target	   cell	   type	   and	   the	  contaminate	   cells	   are	   being	   fed	   media	   in	   the	   heterogeneous	   culture.	   Changing	   the	  differentiation	   efficiency	   of	   the	   process	   had	   by	   far	   the	   biggest	   impact	   on	   the	   process	  economics	  due	  to	  this	  relationship.	  Even	  though	  the	  later	  stages	  of	  the	  process	  “hESC-­‐RPE	  expansion”	  and	  “Seeding	  onto	  membrane”	  take	  up	  a	  significant	  amount	  of	  time	  (Figure	  6.4	  
b)	   from	  a	   resourcing	  standpoint	   	   little	   is	  needed	   for	   the	   stages.	  This	   is	  due	   to	   the	  culture	  moving	   from	  T-­‐25	   flasks	   in	   the	  expansion	  and	  differentiation	  phases	   into	  only	  a	   few	  well	  plates	  for	  the	  PSC-­‐RPE	  expansion	  (as	  the	  differentiation	  efficiencies	  are	  relatively	  low	  with	  every	   cm2	   of	   PSC	   producing	   3,800	   PSC-­‐RPE).	   	   Due	   to	   low	   resource	   requirements	   of	   the	  process	  after	  the	  separation	  of	  the	  foci,	   if	  the	  model	  was	  further	  developed	  the	  resourcing	  requirements	  of	   these	  stages	  could	  be	  considered	  to	  be	  either	  negligible	  or	  not	   impacting	  on	   any	   capacity	   constraints	   used	   in	   the	   equations.	   Finally,	   it	   was	   interesting	   to	   see	   how	  many	  media	  changes	  were	  needed	  to	  create	  3	  patches,	  with	  1,340	  needed	  in	  total	  (Figure	  
6.4	  c).	  Future	  work	  would	  explore	  at	  what	  scale	  a	  simple	  automated	  media	  changing	  system	  would	  be	  cost	  effective	  in	  the	  removal	  of	  this	  manual	  effort	  to	  change	  media.	  
The	  overheads	  and	  running	  costs	  for	  the	  lab	  that	  was	  modelled	  included	  2	  FTEs,	  and	  were	  estimated	   to	   be	   £1.7m	   for	   a	   5	   year	   lifespan	   of	   the	   facility	   (based	   on	   personal	  communication,	  and	  the	   figure	  excludes	  admin	  and	  associated	  costs).	  The	  cell	   line	  used	   is	  validated	  to	  produce	  clinical	  material	  over	  43	  passages,	  therefore	  after	  this	  number	  a	  new	  vial	   from	   the	   working	   cell	   bank	   needs	   to	   be	   thawed	   and	   expanded.	   The	   Excel	   macros	  written	  were	   designed	   to	   display	   this	   information	   visually	   as	   shown	   in	  Figure	   6.5.	   This	  allowed	   a	   simple	   scenario	   analysis	   to	   be	   run:	   the	   first	   scenario	   i)	   expands	   cells	   from	   the	  working	   cell	   bank	   and	   produces	   clinical	  material	   until	   the	   43	   passage	   limit,	  whereas	   the	  second	  scenario	  ii)	  involves	  initiation	  the	  thaw	  of	  the	  next	  working	  cell	  bank	  before	  the	  last	  final	   cultures	   of	   the	   previous	   lot	   were	   complete.	   The	   main	   difference	   being	   that	   with	  scenario	  ii)	  capacity	  utilisation	  can	  be	  maximised	  and	  so	  more	  patches	  produced	  over	  the	  5	  year	  facility	   lifetime.	  Based	  on	  the	   limitation	  in	  the	  current	   facility,	  being	  that	  2	  operators	  cannot	  handle	  more	  than	  360	  T25	  flasks	  at	  any	  one	  time	  (180	  flasks	  being	  passaged	  at	  a	  1:2	  ratio	   in	   a	   single	   day	   being	   the	   throughput	   bottleneck),	   the	   plots	   in	   Figure	   6.6	   were	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generated.	  From	  the	  plots,	   it	  can	  be	  observed	  that	   for	  scenario	   ii)	   the	  plants	  capacity	   is	  at	  peak	  (from	  a	  number	  of	  flasks	  perspective)	  for	  nearly	  the	  entire	  lifetime.	  In	  scenario	  i)	  444	  patches	  can	  be	  produced	  in	  the	  5	  years,	  using	  102,000	  litres	  of	  hESC	  media,	  with	  a	  cost	  per	  patch	   of	   £4,526.	   Conversely,	   for	   scenario	   ii)	   684	   patches	   could	   be	   produced	   in	   the	   same	  period	  with	  a	  cost	  per	  patch	  of	  £3,184	  which	  represents	  a	  saving	  of	  30%.	  	  
If	  more	  time	  was	  available	  more	  scenarios	  would	  have	  been	  run	  on	  the	  model	  and	  it	  would	  have	  been	  expanded	  to	  include	  more	  variables	  such	  as	  the	  size	  of	  the	  facility	  and	  number	  of	  operators.	  Ultimately	  a	  decisional	   tool	  would	  have	  been	  developed	   into	  which	  could	  have	  been	  tested	  the	  feasibility	  of	  investment	  into	  automation	  and	  bioreactor	  platforms.	  
	   	  







































































	   	  







































































	   	  

































































































































































































































































































































































































































	   	  
























	   	  













































































	   	  









































	   	  
	   - 199 -	  
ADRION,	  R.	  F.,	  G.	  R.	  SIEBERT,	  C.	  J.	  WECK,	  D.	  YEN,	  AND	  R.	  MANSON	  
1984.	  Optimization	  of	  in	  vivo	  monoclonal	  antibody	  production	  
using	  computer-­‐assisted	  expermental	  design.	  Proceedings	  of	  the	  
First	  Carolina	  Biomedical	  Engineering	  Conference	  	  
ALAZZAM,	  A.,	  ROMAN,	  D.,	  NERGUIZIAN,	  V.,	  STIHARU,	  I.,	  BHAT,	  R.,	  
YASMEEN,	  A.	  &	  AL	  MOUSTAFA,	  A.	  E.	  Real-­‐time	  continuous	  
dielectrophoretic	  separation	  of	  malignant	  cells.	  	  Microsystems	  and	  
Nanoelectronics	  Research	  Conference,	  2008.	  MNRC	  2008.	  1st,	  15-­‐
15	  Oct.	  2008	  2008.	  45-­‐48.	  
ALGE,	  C.	  S.,	  SUPPMANN,	  S.,	  PRIGLINGER,	  S.	  G.,	  NEUBAUER,	  A.	  S.,	  MAY,	  C.	  
A.,	  HAUCK,	  S.,	  WELGE-­‐LUSSEN,	  U.,	  UEFFING,	  M.	  &	  KAMPIK,	  A.	  
2003.	  Comparative	  proteome	  analysis	  of	  native	  differentiated	  and	  
cultured	  dedifferentiated	  human	  RPE	  cells.	  Invest	  Ophthalmol	  Vis	  
Sci,	  44,	  3629-­‐41.	  
ALGVERE,	  P.	  V.,	  BERGLIN,	  L.,	  GOURAS,	  P.,	  SHENG,	  Y.	  &	  KOPP,	  E.	  D.	  1997.	  
Transplantation	  of	  RPE	  in	  age-­‐related	  macular	  degeneration:	  
observations	  in	  disciform	  lesions	  and	  dry	  RPE	  atrophy.	  Graefes	  
Arch	  Clin	  Exp	  Ophthalmol,	  235,	  149-­‐58.	  
ALLISON,	  M.	  2009.	  Genzyme	  backs	  Osiris,	  despite	  Prochymal	  flop.	  Nat	  
Biotech,	  27,	  966-­‐967.	  
AMPS,	  K.,	  ANDREWS,	  P.	  W.,	  ANYFANTIS,	  G.,	  ARMSTRONG,	  L.,	  AVERY,	  S.,	  
BAHARVAND,	  H.,	  BAKER,	  J.,	  (...)	  &	  ZHOU,	  Q.	  2011.	  Screening	  
ethnically	  diverse	  human	  embryonic	  stem	  cells	  identifies	  a	  
chromosome	  20	  minimal	  amplicon	  conferring	  growth	  advantage.	  
Nat	  Biotechnol,	  29,	  1132-­‐44.	  
ANISIMOV,	  S.	  V.,	  MORIZANE,	  A.	  &	  CORREIA,	  A.	  S.	  2010.	  Risks	  and	  
Mechanisms	  of	  Oncological	  Disease	  Following	  Stem	  Cell	  
Transplantation.	  Stem	  Cell	  Rev.	  
BAXTER,	  L.	  L.	  &	  PAVAN,	  W.	  J.	  2003.	  Pmel17	  expression	  is	  Mitf-­‐dependent	  
and	  reveals	  cranial	  melanoblast	  migration	  during	  murine	  
development.	  Gene	  Expr	  Patterns,	  3,	  703-­‐7.	  
BOATRIGHT,	  J.	  H.,	  DALAL,	  N.,	  CHRENEK,	  M.	  A.,	  GARDNER,	  C.,	  ZIESEL,	  A.,	  
JIANG,	  Y.,	  GROSSNIKLAUS,	  H.	  E.	  &	  NICKERSON,	  J.	  M.	  2015.	  
Methodologies	  for	  analysis	  of	  patterning	  in	  the	  mouse	  RPE	  sheet.	  
Mol	  Vis,	  21,	  40-­‐60.	  
BRINDLEY,	  D.	  A.,	  DAVIE,	  N.	  L.,	  CULME-­‐SEYMOUR,	  E.	  J.,	  MASON,	  C.,	  SMITH,	  
D.	  W.	  &	  ROWLEY,	  J.	  A.	  2012.	  Peak	  serum:	  implications	  of	  serum	  
supply	  for	  cell	  therapy	  manufacturing.	  Regen	  Med,	  7,	  7-­‐13.	  
BRUNK,	  U.	  T.	  &	  TERMAN,	  A.	  2002.	  Lipofuscin:	  mechanisms	  of	  age-­‐related	  
accumulation	  and	  influence	  on	  cell	  function.	  Free	  Radical	  Biology	  
and	  Medicine,	  33,	  611-­‐619.	  
BUCHHOLZ,	  D.	  E.,	  PENNINGTON,	  B.	  O.,	  CROZE,	  R.	  H.,	  HINMAN,	  C.	  R.,	  
COFFEY,	  P.	  J.	  &	  CLEGG,	  D.	  O.	  2013.	  Rapid	  and	  Efficient	  Directed	  
	   	  
	   - 200 -	  
Differentiation	  of	  Human	  Pluripotent	  Stem	  Cells	  Into	  Retinal	  
Pigmented	  Epithelium.	  Stem	  Cells	  Translational	  Medicine,	  2,	  384-­‐
393.	  
CARPENTER,	  M.	  K.,	  FREY-­‐VASCONCELLS,	  J.	  &	  RAO,	  M.	  S.	  2009.	  Developing	  
safe	  therapies	  from	  human	  pluripotent	  stem	  cells.	  Nat	  Biotechnol,	  
27,	  606-­‐13.	  
CARR,	  A.	  J.,	  VUGLER,	  A.	  A.,	  HIKITA,	  S.	  T.,	  LAWRENCE,	  J.	  M.,	  GIAS,	  C.,	  CHEN,	  
L.	  L.,	  BUCHHOLZ,	  D.	  E.,	  AHMADO,	  A.,	  SEMO,	  M.,	  SMART,	  M.	  J.,	  
HASAN,	  S.,	  DA	  CRUZ,	  L.,	  JOHNSON,	  L.	  V.,	  CLEGG,	  D.	  O.	  &	  COFFEY,	  P.	  
J.	  2009.	  Protective	  effects	  of	  human	  iPS-­‐derived	  retinal	  pigment	  
epithelium	  cell	  transplantation	  in	  the	  retinal	  dystrophic	  rat.	  PLoS	  
One,	  4,	  e8152.	  
CHAMBERS,	  S.	  M.,	  FASANO,	  C.	  A.,	  PAPAPETROU,	  E.	  P.,	  TOMISHIMA,	  M.,	  
SADELAIN,	  M.	  &	  STUDER,	  L.	  2009.	  Highly	  efficient	  neural	  
conversion	  of	  human	  ES	  and	  iPS	  cells	  by	  dual	  inhibition	  of	  SMAD	  
signaling.	  Nat	  Biotech,	  27,	  275-­‐280.	  
CHEN,	  X.,	  CHEN,	  A.,	  WOO,	  T.	  L.,	  CHOO,	  A.	  B.,	  REUVENY,	  S.	  &	  OH,	  S.	  K.	  
2010.	  Investigations	  into	  the	  metabolism	  of	  two-­‐dimensional	  
colony	  and	  suspended	  microcarrier	  cultures	  of	  human	  embryonic	  
stem	  cells	  in	  serum-­‐free	  media.	  Stem	  Cells	  Dev,	  19,	  1781-­‐92.	  
CHOPDAR,	  A.,	  CHAKRAVARTHY,	  U.	  &	  VERMA,	  D.	  2003.	  Age	  related	  
macular	  degeneration.	  BMJ,	  326,	  485-­‐8.	  
CLAASSEN,	  D.	  A.,	  DESLER,	  M.	  M.	  &	  RIZZINO,	  A.	  2009.	  ROCK	  Inhibition	  
Enhances	  the	  Recovery	  and	  Growth	  of	  Cryopreserved	  Human	  
Embryonic	  Stem	  Cells	  and	  Human	  Induced	  Pluripotent	  Stem	  Cells.	  
Molecular	  Reproduction	  and	  Development,	  76,	  722-­‐732.	  
COOKE,	  M.	  J.,	  STOJKOVIC,	  M.	  &	  PRZYBORSKI,	  S.	  A.	  2006.	  Growth	  of	  
teratomas	  derived	  from	  human	  pluripotent	  stem	  cells	  is	  influenced	  
by	  the	  graft	  site.	  Stem	  Cells	  Dev,	  15,	  254-­‐9.	  
CSASZAR,	  E.,	  CHEN,	  K.,	  CALDWELL,	  J.,	  CHAN,	  W.	  &	  ZANDSTRA,	  P.	  W.	  2013.	  
Real-­‐time	  monitoring	  and	  control	  of	  soluble	  signaling	  factors	  
enables	  enhanced	  progenitor	  cell	  outputs	  from	  human	  cord	  blood	  
stem	  cell	  cultures.	  Biotechnol	  Bioeng.	  
DA	  CRUZ,	  L.,	  CHEN,	  F.	  K.,	  AHMADO,	  A.,	  GREENWOOD,	  J.	  &	  COFFEY,	  P.	  
2007.	  RPE	  transplantation	  and	  its	  role	  in	  retinal	  disease.	  Prog	  Retin	  
Eye	  Res,	  26,	  598-­‐635.	  
DAVIS,	  A.	  A.,	  BERNSTEIN,	  P.	  S.,	  BOK,	  D.,	  TURNER,	  J.,	  NACHTIGAL,	  M.	  &	  
HUNT,	  R.	  C.	  1995.	  A	  human	  retinal	  pigment	  epithelial	  cell	  line	  that	  
retains	  epithelial	  characteristics	  after	  prolonged	  culture.	  Invest	  
Ophthalmol	  Vis	  Sci,	  36,	  955-­‐64.	  
DECARIS,	  M.	  L.	  &	  LEACH,	  J.	  K.	  2011.	  Design	  of	  experiments	  approach	  to	  
engineer	  cell-­‐secreted	  matrices	  for	  directing	  osteogenic	  
differentiation.	  Ann	  Biomed	  Eng,	  39,	  1174-­‐85.	  
	   	  
	   - 201 -	  
DOH,	  I.	  &	  CHO,	  Y.-­‐H.	  2005.	  A	  continuous	  cell	  separation	  chip	  using	  
hydrodynamic	  dielectrophoresis	  (DEP)	  process.	  Sensors	  and	  
Actuators	  A:	  Physical,	  121,	  59-­‐65.	  
DRAPER,	  J.	  S.,	  SMITH,	  K.,	  GOKHALE,	  P.,	  MOORE,	  H.	  D.,	  MALTBY,	  E.,	  
JOHNSON,	  J.,	  MEISNER,	  L.,	  ZWAKA,	  T.	  P.,	  THOMSON,	  J.	  A.	  &	  
ANDREWS,	  P.	  W.	  2004.	  Recurrent	  gain	  of	  chromosomes	  17q	  and	  12	  
in	  cultured	  human	  embryonic	  stem	  cells.	  Nat	  Biotech,	  22,	  53-­‐54.	  
DUPIN,	  E.,	  GLAVIEUX,	  C.,	  VAIGOT,	  P.	  &	  LE	  DOUARIN,	  N.	  M.	  2000.	  
Endothelin	  3	  induces	  the	  reversion	  of	  melanocytes	  to	  glia	  through	  
a	  neural	  crest-­‐derived	  glial-­‐melanocytic	  progenitor.	  Proc	  Natl	  Acad	  
Sci	  U	  S	  A,	  97,	  7882-­‐7.	  
DUTT,	  K.,	  WALDREP,	  J.	  C.,	  KAPLAN,	  H.	  J.,	  DEL	  MONTE,	  M.,	  SEMPLE,	  E.	  &	  
VERLY,	  G.	  1989.	  In	  vitro	  phenotypic	  and	  functional	  characterization	  
of	  human	  pigment	  epithelial	  cell	  lines.	  Curr	  Eye	  Res,	  8,	  435-­‐40.	  
EBRAHIMI,	  K.	  B.	  &	  HANDA,	  J.	  T.	  2011.	  Lipids,	  lipoproteins,	  and	  age-­‐related	  
macular	  degeneration.	  J	  Lipids,	  2011,	  802059.	  
EVANS,	  J.	  R.	  2001.	  Risk	  factors	  for	  age-­‐related	  macular	  degeneration.	  Prog	  
Retin	  Eye	  Res,	  20,	  227-­‐53.	  
FERNANDES,	  A.	  M.,	  MARINHO,	  P.	  A.,	  SARTORE,	  R.	  C.,	  PAULSEN,	  B.	  S.,	  
MARIANTE,	  R.	  M.,	  CASTILHO,	  L.	  R.	  &	  REHEN,	  S.	  K.	  2009.	  Successful	  
scale-­‐up	  of	  human	  embryonic	  stem	  cell	  production	  in	  a	  stirred	  
microcarrier	  culture	  system.	  Braz	  J	  Med	  Biol	  Res,	  42,	  515-­‐22.	  
FLANAGAN,	  L.	  A.,	  LU,	  J.,	  WANG,	  L.,	  MARCHENKO,	  S.	  A.,	  JEON,	  N.	  L.,	  LEE,	  A.	  
P.	  &	  MONUKI,	  E.	  S.	  2008.	  Unique	  Dielectric	  Properties	  Distinguish	  
Stem	  Cells	  and	  Their	  Differentiated	  Progeny.	  Stem	  Cells,	  26,	  656-­‐
665.	  
FORRISTAL,	  C.	  E.,	  WRIGHT,	  K.	  L.,	  HANLEY,	  N.	  A.,	  OREFFO,	  R.	  O.	  &	  
HOUGHTON,	  F.	  D.	  2010.	  Hypoxia	  inducible	  factors	  regulate	  
pluripotency	  and	  proliferation	  in	  human	  embryonic	  stem	  cells	  
cultured	  at	  reduced	  oxygen	  tensions.	  Reproduction,	  139,	  85-­‐97.	  
HAALAND,	  P.	  D.	  1989.	  Experimental	  Design	  in	  Biotechnology,	  Taylor	  &	  
Francis.	  
HAGEMAN,	  G.	  S.,	  LUTHERT,	  P.	  J.,	  VICTOR	  CHONG,	  N.	  H.,	  JOHNSON,	  L.	  V.,	  
ANDERSON,	  D.	  H.	  &	  MULLINS,	  R.	  F.	  2001.	  An	  integrated	  hypothesis	  
that	  considers	  drusen	  as	  biomarkers	  of	  immune-­‐mediated	  
processes	  at	  the	  RPE-­‐Bruch's	  membrane	  interface	  in	  aging	  and	  age-­‐
related	  macular	  degeneration.	  Prog	  Retin	  Eye	  Res,	  20,	  705-­‐32.	  
HERNANDEZ,	  D.,	  RUBAN,	  L.	  &	  MASON,	  C.	  2011.	  Feeder-­‐free	  culture	  of	  
human	  embryonic	  stem	  cells	  for	  scalable	  expansion	  in	  a	  
reproducible	  manner.	  Stem	  Cells	  Dev,	  20,	  1089-­‐98.	  
HEWITT,	  C.	  J.,	  LEE,	  K.,	  NIENOW,	  A.	  W.,	  THOMAS,	  R.	  J.,	  SMITH,	  M.	  &	  
THOMAS,	  C.	  R.	  2011.	  Expansion	  of	  human	  mesenchymal	  stem	  cells	  
on	  microcarriers.	  Biotechnol	  Lett,	  33,	  2325-­‐35.	  
	   	  
	   - 202 -	  
HIRAMI,	  Y.,	  OSAKADA,	  F.,	  TAKAHASHI,	  K.,	  OKITA,	  K.,	  YAMANAKA,	  S.,	  
IKEDA,	  H.,	  YOSHIMURA,	  N.	  &	  TAKAHASHI,	  M.	  2009.	  Generation	  of	  
retinal	  cells	  from	  mouse	  and	  human	  induced	  pluripotent	  stem	  
cells.	  Neurosci	  Lett,	  458,	  126-­‐31.	  
HUNT,	  M.,	  MENG,	  G.,	  RANCOURT,	  D.,	  GATES,	  I.	  D.	  &	  KALLOS,	  M.	  S.	  2013.	  
Factorial	  Experimental	  Design	  for	  the	  Culture	  of	  Human	  Embryonic	  
Stem	  Cells	  as	  Aggregates	  in	  Stirred	  Suspension	  Bioreactors	  Reveals	  
the	  Potential	  for	  Interaction	  Effects	  Between	  Bioprocess	  
Parameters.	  Tissue	  Eng	  Part	  C	  Methods.	  
IDELSON,	  M.,	  ALPER,	  R.,	  OBOLENSKY,	  A.,	  BEN-­‐SHUSHAN,	  E.,	  HEMO,	  I.,	  
YACHIMOVICH-­‐COHEN,	  N.,	  KHANER,	  H.,	  SMITH,	  Y.,	  WISER,	  O.,	  
GROPP,	  M.,	  COHEN,	  M.	  A.,	  EVEN-­‐RAM,	  S.,	  BERMAN-­‐ZAKEN,	  Y.,	  
MATZRAFI,	  L.,	  RECHAVI,	  G.,	  BANIN,	  E.	  &	  REUBINOFF,	  B.	  2009.	  
Directed	  differentiation	  of	  human	  embryonic	  stem	  cells	  into	  
functional	  retinal	  pigment	  epithelium	  cells.	  Cell	  Stem	  Cell,	  5,	  396-­‐
408.	  
JOUSSEN,	  A.	  M.,	  HEUSSEN,	  F.	  M.	  A.,	  JOERES,	  S.,	  LLACER,	  H.,	  PRINZ,	  B.,	  
ROHRSCHNEIDER,	  K.,	  MAAIJWEE,	  K.	  J.	  M.,	  VAN	  MEURS,	  J.	  &	  
KIRCHHOF,	  B.	  2006.	  Autologous	  Translocation	  of	  the	  Choroid	  and	  
Retinal	  Pigment	  Epithelium	  in	  Age-­‐related	  Macular	  Degeneration.	  
American	  Journal	  of	  Ophthalmology,	  142,	  17-­‐30.e8.	  
KEHOE,	  D.	  E.,	  JING,	  D.,	  LOCK,	  L.	  T.	  &	  TZANAKAKIS,	  E.	  S.	  2010.	  Scalable	  
stirred-­‐suspension	  bioreactor	  culture	  of	  human	  pluripotent	  stem	  
cells.	  Tissue	  Eng	  Part	  A,	  16,	  405-­‐21.	  
KLIMANSKAYA,	  I.,	  HIPP,	  J.,	  REZAI,	  K.	  A.,	  WEST,	  M.,	  ATALA,	  A.	  &	  LANZA,	  R.	  
2004.	  Derivation	  and	  comparative	  assessment	  of	  retinal	  pigment	  
epithelium	  from	  human	  embryonic	  stem	  cells	  using	  
transcriptomics.	  Cloning	  Stem	  Cells,	  6,	  217-­‐45.	  
KNOSPEL,	  F.,	  SCHINDLER,	  R.	  K.,	  LUBBERSTEDT,	  M.,	  PETZOLT,	  S.,	  GERLACH,	  
J.	  C.	  &	  ZEILINGER,	  K.	  2010.	  Optimization	  of	  a	  serum-­‐free	  culture	  
medium	  for	  mouse	  embryonic	  stem	  cells	  using	  design	  of	  
experiments	  (DoE)	  methodology.	  Cytotechnology,	  62,	  557-­‐71.	  
KOROHODA,	  W.	  &	  WILK,	  A.	  2008.	  Cell	  electrophoresis	  —	  a	  method	  for	  cell	  
separation	  and	  research	  into	  cell	  surface	  properties.	  Cellular	  &	  
Molecular	  Biology	  Letters,	  13,	  312-­‐326.	  
LANE,	  A.,	  PHILIP,	  L.	  R.,	  RUBAN,	  L.,	  FYNES,	  K.,	  SMART,	  M.,	  CARR,	  A.,	  
MASON,	  C.	  &	  COFFEY,	  P.	  2014.	  Engineering	  Efficient	  Retinal	  
Pigment	  Epithelium	  Differentiation	  From	  Human	  Pluripotent	  Stem	  
Cells.	  Stem	  Cells	  Transl	  Med.	  
LARSEN,	  K.	  B.,	  LUTTERODT,	  M.,	  RATH,	  M.	  F.	  &	  MOLLER,	  M.	  2009.	  
Expression	  of	  the	  homeobox	  genes	  PAX6,	  OTX2,	  and	  OTX1	  in	  the	  
early	  human	  fetal	  retina.	  Int	  J	  Dev	  Neurosci,	  27,	  485-­‐92.	  
	   	  
	   - 203 -	  
LAWRENZ,	  B.,	  SCHILLER,	  H.,	  WILLBOLD,	  E.,	  RUEDIGER,	  M.,	  MUHS,	  A.	  &	  
ESSER,	  S.	  2004.	  Highly	  sensitive	  biosafety	  model	  for	  stem-­‐cell-­‐
derived	  grafts.	  Cytotherapy,	  6,	  212-­‐22.	  
LENSCH,	  M.	  W.	  &	  INCE,	  T.	  A.	  2007.	  The	  terminology	  of	  teratocarcinomas	  
and	  teratomas.	  Nat	  Biotechnol,	  25,	  1211;	  author	  reply	  1211-­‐2.	  
LI,	  F.,	  CHONG,	  Z.	  Z.	  &	  MAIESE,	  K.	  2006.	  Cell	  Life	  Versus	  Cell	  Longevity:	  The	  
Mysteries	  Surrounding	  the	  NAD(+)	  Precursor	  Nicotinamide.	  Current	  
medicinal	  chemistry,	  13,	  883-­‐895.	  
LI,	  Q.,	  CHEUNG,	  W.	  H.,	  CHOW,	  K.	  L.,	  ELLIS-­‐BEHNKE,	  R.	  G.	  &	  CHAU,	  Y.	  2012.	  
Factorial	  analysis	  of	  adaptable	  properties	  of	  self-­‐assembling	  
peptide	  matrix	  on	  cellular	  proliferation	  and	  neuronal	  
differentiation	  of	  pluripotent	  embryonic	  carcinoma.	  Nanomedicine,	  
8,	  748-­‐56.	  
LIAN,	  X.,	  HSIAO,	  C.,	  WILSON,	  G.,	  ZHU,	  K.,	  HAZELTINE,	  L.	  B.,	  AZARIN,	  S.	  M.,	  
RAVAL,	  K.	  K.,	  ZHANG,	  J.,	  KAMP,	  T.	  J.	  &	  PALECEK,	  S.	  P.	  2012.	  Robust	  
cardiomyocyte	  differentiation	  from	  human	  pluripotent	  stem	  cells	  
via	  temporal	  modulation	  of	  canonical	  Wnt	  signaling.	  Proc	  Natl	  
Acad	  Sci	  U	  S	  A,	  109,	  E1848-­‐57.	  
LUND,	  R.	  D.,	  WANG,	  S.,	  KLIMANSKAYA,	  I.,	  HOLMES,	  T.,	  RAMOS-­‐KELSEY,	  R.,	  
LU,	  B.,	  GIRMAN,	  S.,	  BISCHOFF,	  N.,	  SAUVE,	  Y.	  &	  LANZA,	  R.	  2006.	  
Human	  embryonic	  stem	  cell-­‐derived	  cells	  rescue	  visual	  function	  in	  
dystrophic	  RCS	  rats.	  Cloning	  Stem	  Cells,	  8,	  189-­‐99.	  
MARMORSTEIN,	  A.	  D.,	  MARMORSTEIN,	  L.	  Y.,	  RAYBORN,	  M.,	  WANG,	  X.,	  
HOLLYFIELD,	  J.	  G.	  &	  PETRUKHIN,	  K.	  2000.	  Bestrophin,	  the	  product	  
of	  the	  Best	  vitelliform	  macular	  dystrophy	  gene	  (VMD2),	  localizes	  to	  
the	  basolateral	  plasma	  membrane	  of	  the	  retinal	  pigment	  
epithelium.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A,	  97,	  12758-­‐63.	  
MARUOTTI,	  J.,	  WAHLIN,	  K.,	  GORRELL,	  D.,	  BHUTTO,	  I.,	  LUTTY,	  G.	  &	  ZACK,	  D.	  
J.	  2013.	  A	  simple	  and	  scalable	  process	  for	  the	  differentiation	  of	  
retinal	  pigment	  epithelium	  from	  human	  pluripotent	  stem	  cells.	  
Stem	  Cells	  Transl	  Med,	  2,	  341-­‐54.	  
MASON,	  C.	  &	  DUNNILL,	  P.	  2009.	  Quantities	  of	  cells	  used	  for	  regenerative	  
medicine	  and	  some	  implications	  for	  clinicians	  and	  bioprocessors.	  
Regen	  Med,	  4,	  153-­‐7.	  
MCGILL,	  T.	  J.,	  LUND,	  R.	  D.,	  DOUGLAS,	  R.	  M.,	  WANG,	  S.,	  LU,	  B.	  &	  PRUSKY,	  
G.	  T.	  2004.	  Preservation	  of	  vision	  following	  cell-­‐based	  therapies	  in	  
a	  model	  of	  retinal	  degenerative	  disease.	  Vision	  Research,	  44,	  2559-­‐
2566.	  
MEYER,	  J.	  S.,	  SHEARER,	  R.	  L.,	  CAPOWSKI,	  E.	  E.,	  WRIGHT,	  L.	  S.,	  WALLACE,	  K.	  
A.,	  MCMILLAN,	  E.	  L.,	  ZHANG,	  S.	  C.	  &	  GAMM,	  D.	  M.	  2009.	  Modeling	  
early	  retinal	  development	  with	  human	  embryonic	  and	  induced	  
pluripotent	  stem	  cells.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A,	  106,	  16698-­‐703.	  
	   	  
	   - 204 -	  
MILLMAN,	  J.	  R.,	  TAN,	  J.	  H.	  &	  COLTON,	  C.	  K.	  2009.	  The	  effects	  of	  low	  
oxygen	  on	  self-­‐renewal	  and	  differentiation	  of	  embryonic	  stem	  
cells.	  Curr	  Opin	  Organ	  Transplant,	  14,	  694-­‐700.	  
MITALIPOVA,	  M.	  M.,	  RAO,	  R.	  R.,	  HOYER,	  D.	  M.,	  JOHNSON,	  J.	  A.,	  MEISNER,	  
L.	  F.,	  JONES,	  K.	  L.,	  DALTON,	  S.	  &	  STICE,	  S.	  L.	  2005.	  Preserving	  the	  
genetic	  integrity	  of	  human	  embryonic	  stem	  cells.	  Nat	  Biotech,	  23,	  
19-­‐20.	  
MULLEN,	  R.	  J.	  &	  LAVAIL,	  M.	  M.	  1976.	  Inherited	  retinal	  dystrophy:	  primary	  
defect	  in	  pigment	  epithelium	  determined	  with	  experimental	  rat	  
chimeras.	  Science,	  192,	  799-­‐801.	  
NAKANO,	  T.,	  ANDO,	  S.,	  TAKATA,	  N.,	  KAWADA,	  M.,	  MUGURUMA,	  K.,	  
SEKIGUCHI,	  K.,	  SAITO,	  K.,	  YONEMURA,	  S.,	  EIRAKU,	  M.	  &	  SASAI,	  Y.	  
2012.	  Self-­‐formation	  of	  optic	  cups	  and	  storable	  stratified	  neural	  
retina	  from	  human	  ESCs.	  Cell	  Stem	  Cell,	  10,	  771-­‐85.	  
NGUYEN,	  M.	  &	  ARNHEITER,	  H.	  2000.	  Signaling	  and	  transcriptional	  
regulation	  in	  early	  mammalian	  eye	  development:	  a	  link	  between	  
FGF	  and	  MITF.	  Development,	  127,	  3581-­‐91.	  
NIE,	  Y.,	  BERGENDAHL,	  V.,	  HEI,	  D.	  J.,	  JONES,	  J.	  M.	  &	  PALECEK,	  S.	  P.	  2009.	  
Scalable	  culture	  and	  cryopreservation	  of	  human	  embryonic	  stem	  
cells	  on	  microcarriers.	  Biotechnol	  Prog,	  25,	  20-­‐31.	  
NISTOR,	  G.,	  SEILER,	  M.	  J.,	  YAN,	  F.,	  FERGUSON,	  D.	  &	  KEIRSTEAD,	  H.	  S.	  2010.	  
Three-­‐dimensional	  early	  retinal	  progenitor	  3D	  tissue	  constructs	  
derived	  from	  human	  embryonic	  stem	  cells.	  Journal	  of	  Neuroscience	  
Methods,	  In	  Press,	  Uncorrected	  Proof.	  
OSAKADA,	  F.,	  IKEDA,	  H.,	  SASAI,	  Y.	  &	  TAKAHASHI,	  M.	  2009a.	  Stepwise	  
differentiation	  of	  pluripotent	  stem	  cells	  into	  retinal	  cells.	  Nat	  
Protoc,	  4,	  811-­‐24.	  
OSAKADA,	  F.,	  JIN,	  Z.	  B.,	  HIRAMI,	  Y.,	  IKEDA,	  H.,	  DANJYO,	  T.,	  WATANABE,	  K.,	  
SASAI,	  Y.	  &	  TAKAHASHI,	  M.	  2009b.	  In	  vitro	  differentiation	  of	  retinal	  
cells	  from	  human	  pluripotent	  stem	  cells	  by	  small-­‐molecule	  
induction.	  J	  Cell	  Sci,	  122,	  3169-­‐79.	  
PERA,	  M.	  F.	  2004.	  Unnatural	  selection	  of	  cultured	  human	  ES	  cells?	  Nat	  
Biotech,	  22,	  42-­‐43.	  
PHILLIPS,	  B.	  W.,	  HORNE,	  R.,	  LAY,	  T.	  S.,	  RUST,	  W.	  L.,	  TECK,	  T.	  T.	  &	  CROOK,	  J.	  
M.	  2008.	  Attachment	  and	  growth	  of	  human	  embryonic	  stem	  cells	  
on	  microcarriers.	  J	  Biotechnol,	  138,	  24-­‐32.	  
POWERS,	  D.	  E.,	  MILLMAN,	  J.	  R.,	  BONNER-­‐WEIR,	  S.,	  RAPPEL,	  M.	  J.	  &	  
COLTON,	  C.	  K.	  2010.	  Accurate	  control	  of	  oxygen	  level	  in	  cells	  during	  
culture	  on	  silicone	  rubber	  membranes	  with	  application	  to	  stem	  cell	  
differentiation.	  Biotechnol	  Prog,	  26,	  805-­‐18.	  
PRUSZAK,	  J.,	  SONNTAG,	  K.-­‐C.,	  AUNG,	  M.	  H.,	  SANCHEZ-­‐PERNAUTE,	  R.	  &	  
ISACSON,	  O.	  2007.	  Markers	  and	  Methods	  for	  Cell	  Sorting	  of	  Human	  
	   	  
	   - 205 -	  
Embryonic	  Stem	  Cell-­‐Derived	  Neural	  Cell	  Populations.	  Stem	  Cells,	  
25,	  2257-­‐2268.	  
RAMSDEN,	  C.	  M.,	  POWNER,	  M.	  B.,	  CARR,	  A.	  J.,	  SMART,	  M.	  J.,	  DA	  CRUZ,	  L.	  
&	  COFFEY,	  P.	  J.	  2013.	  Stem	  cells	  in	  retinal	  regeneration:	  past,	  
present	  and	  future.	  Development,	  140,	  2576-­‐85.	  
RATCLIFFE,	  E.,	  HOURD,	  P.,	  GUIJARRO-­‐LEACH,	  J.,	  RAYMENT,	  E.,	  WILLIAMS,	  
D.	  J.	  &	  THOMAS,	  R.	  J.	  2013.	  Application	  of	  response	  surface	  
methodology	  to	  maximize	  the	  productivity	  of	  scalable	  automated	  
human	  embryonic	  stem	  cell	  manufacture.	  Regen	  Med,	  8,	  39-­‐48.	  
ROBERTS,	  I.,	  BAILA,	  S.,	  RICE,	  R.	  B.,	  JANSSENS,	  M.	  E.,	  NGUYEN,	  K.,	  MOENS,	  
N.,	  RUBAN,	  L.,	  HERNANDEZ,	  D.,	  COFFEY,	  P.	  &	  MASON,	  C.	  2012.	  
Scale-­‐up	  of	  human	  embryonic	  stem	  cell	  culture	  using	  a	  hollow	  fibre	  
bioreactor.	  Biotechnol	  Lett,	  34,	  2307-­‐15.	  
ROSS,	  P.	  J.,	  SUHR,	  S.	  T.,	  RODRIGUEZ,	  R.	  M.,	  CHANG,	  E.	  A.,	  WANG,	  K.,	  
SIRIPATTARAPRAVAT,	  K.,	  KO,	  T.	  &	  CIBELLI,	  J.	  B.	  2010.	  Human-­‐
induced	  pluripotent	  stem	  cells	  produced	  under	  xeno-­‐free	  
conditions.	  Stem	  Cells	  Dev,	  19,	  1221-­‐9.	  
ROWLAND,	  T.	  J.,	  BUCHHOLZ,	  D.	  E.	  &	  CLEGG,	  D.	  O.	  2012.	  Pluripotent	  
human	  stem	  cells	  for	  the	  treatment	  of	  retinal	  disease.	  J	  Cell	  
Physiol,	  227,	  457-­‐66.	  
SAUVE,	  Y.,	  KLASSEN,	  H.,	  WHITELEY,	  S.	  J.	  &	  LUND,	  R.	  D.	  1998.	  Visual	  field	  
loss	  in	  RCS	  rats	  and	  the	  effect	  of	  RPE	  cell	  transplantation.	  Exp	  
Neurol,	  152,	  243-­‐50.	  
SAVOLAINEN,	  V.,	  JUUTI-­‐UUSITALO,	  K.,	  ONNELA,	  N.,	  VAAJASAARI,	  H.,	  
NARKILAHTI,	  S.,	  SUURONEN,	  R.,	  SKOTTMAN,	  H.	  &	  HYTTINEN,	  J.	  
2011.	  Impedance	  Spectroscopy	  in	  Monitoring	  the	  Maturation	  of	  
Stem	  Cell-­‐Derived	  Retinal	  Pigment	  Epithelium.	  Ann	  Biomed	  Eng.	  
SCHRIEBL,	  K.,	  LIM,	  S.,	  CHOO,	  A.,	  TSCHELIESSNIG,	  A.	  &	  JUNGBAUER,	  A.	  
2010.	  Stem	  cell	  separation:	  A	  bottleneck	  in	  stem	  cell	  therapy.	  
Biotechnology	  Journal,	  5,	  50-­‐61.	  
SCHWARTZ,	  S.	  D.,	  REGILLO,	  C.	  D.,	  LAM,	  B.	  L.,	  ELIOTT,	  D.,	  ROSENFELD,	  P.	  J.,	  
GREGORI,	  N.	  Z.,	  HUBSCHMAN,	  J.-­‐P.,	  DAVIS,	  J.	  L.,	  HEILWELL,	  G.,	  
SPIRN,	  M.,	  MAGUIRE,	  J.,	  GAY,	  R.,	  BATEMAN,	  J.,	  OSTRICK,	  R.	  M.,	  
MORRIS,	  D.,	  VINCENT,	  M.,	  ANGLADE,	  E.,	  DEL	  PRIORE,	  L.	  V.	  &	  
LANZA,	  R.	  2014.	  Human	  embryonic	  stem	  cell-­‐derived	  retinal	  
pigment	  epithelium	  in	  patients	  with	  age-­‐related	  macular	  
degeneration	  and	  Stargardt's	  macular	  dystrophy:	  follow-­‐up	  of	  two	  
open-­‐label	  phase	  1/2	  studies.	  The	  Lancet.	  
SERRA,	  M.,	  BRITO,	  C.,	  SOUSA,	  M.	  F.,	  JENSEN,	  J.,	  TOSTOES,	  R.,	  CLEMENTE,	  
J.,	  STREHL,	  R.,	  HYLLNER,	  J.,	  CARRONDO,	  M.	  J.	  &	  ALVES,	  P.	  M.	  2010.	  
Improving	  expansion	  of	  pluripotent	  human	  embryonic	  stem	  cells	  in	  
perfused	  bioreactors	  through	  oxygen	  control.	  J	  Biotechnol,	  148,	  
208-­‐15.	  
	   	  
	   - 206 -	  
SHEN,	  C.-­‐C.,	  HUANG,	  H.-­‐M.,	  OU,	  H.-­‐C.,	  CHEN,	  H.-­‐L.,	  CHEN,	  W.-­‐C.	  &	  JENG,	  
K.-­‐C.	  2004.	  Protective	  effect	  of	  nicotinamide	  on	  neuronal	  cells	  
under	  oxygen	  and	  glucose	  deprivation	  and	  hypoxia/reoxygenation.	  
Journal	  of	  Biomedical	  Science,	  11,	  472-­‐481.	  
SHI,	  Y.	  &	  CLEGG,	  D.	  O.	  2008.	  Stem	  Cell	  Research	  and	  Therapeutics,	  
Springer.	  
SHIH,	  C.	  C.,	  FORMAN,	  S.	  J.,	  CHU,	  P.	  &	  SLOVAK,	  M.	  2007.	  Human	  embryonic	  
stem	  cells	  are	  prone	  to	  generate	  primitive,	  undifferentiated	  
tumors	  in	  engrafted	  human	  fetal	  tissues	  in	  severe	  combined	  
immunodeficient	  mice.	  Stem	  Cells	  Dev,	  16,	  893-­‐902.	  
STACHELSCHEID,	  H.,	  WULF-­‐GOLDENBERG,	  A.,	  ECKERT,	  K.,	  JENSEN,	  J.,	  
EDSBAGGE,	  J.,	  BJÖRQUIST,	  P.,	  RIVERO,	  M.,	  STREHL,	  R.,	  JOZEFCZUK,	  
J.,	  PRIGIONE,	  A.,	  ADJAYE,	  J.,	  URBANIAK,	  T.,	  BUSSMANN,	  P.,	  
ZEILINGER,	  K.	  &	  GERLACH,	  J.	  C.	  2012.	  Teratoma	  formation	  of	  
human	  embryonic	  stem	  cells	  in	  three-­‐dimensional	  perfusion	  
culture	  bioreactors.	  Journal	  of	  Tissue	  Engineering	  and	  Regenerative	  
Medicine,	  n/a-­‐n/a.	  
STEINER,	  D.,	  KHANER,	  H.,	  COHEN,	  M.,	  EVEN-­‐RAM,	  S.,	  GIL,	  Y.,	  ITSYKSON,	  P.,	  
TURETSKY,	  T.,	  IDELSON,	  M.,	  AIZENMAN,	  E.,	  RAM,	  R.,	  BERMAN-­‐
ZAKEN,	  Y.	  &	  REUBINOFF,	  B.	  2010.	  Derivation,	  propagation	  and	  
controlled	  differentiation	  of	  human	  embryonic	  stem	  cells	  in	  
suspension.	  Nat	  Biotech,	  advance	  online	  publication.	  
STRAUSS,	  O.	  2005.	  The	  retinal	  pigment	  epithelium	  in	  visual	  function.	  
Physiol	  Rev,	  85,	  845-­‐81.	  
SUN,	  X.,	  LONG,	  X.,	  YIN,	  Y.,	  JIANG,	  Y.,	  CHEN,	  X.,	  LIU,	  W.,	  ZHANG,	  W.,	  DU,	  H.,	  
LI,	  S.,	  ZHENG,	  Y.,	  KONG,	  S.,	  PANG,	  Q.,	  SHI,	  Y.,	  HUANG,	  Y.,	  HUANG,	  
S.,	  LIAO,	  B.,	  XIAO,	  G.	  &	  WANG,	  W.	  2008.	  Similar	  biological	  
characteristics	  of	  human	  embryonic	  stem	  cell	  lines	  with	  normal	  
and	  abnormal	  karyotypes.	  Hum	  Reprod,	  23,	  2185-­‐93.	  
TAKAHASHI,	  K.,	  TANABE,	  K.,	  OHNUKI,	  M.,	  NARITA,	  M.,	  ICHISAKA,	  T.,	  
TOMODA,	  K.	  &	  YAMANAKA,	  S.	  2007.	  Induction	  of	  pluripotent	  stem	  
cells	  from	  adult	  human	  fibroblasts	  by	  defined	  factors.	  Cell,	  131,	  
861-­‐72.	  
TESTORF,	  M.	  F.,	  LUNDSTRˆM,	  I.	  &	  ÷BERG,	  P.	  K.	  2001.	  The	  electric	  charge	  
of	  pigment	  granules	  in	  pigment	  cells.	  Biosensors	  and	  
Bioelectronics,	  16,	  31-­‐36.	  
THOMSON,	  J.	  A.,	  ITSKOVITZ-­‐ELDOR,	  J.,	  SHAPIRO,	  S.	  S.,	  WAKNITZ,	  M.	  A.,	  
SWIERGIEL,	  J.	  J.,	  MARSHALL,	  V.	  S.	  &	  JONES,	  J.	  M.	  1998.	  Embryonic	  
stem	  cell	  lines	  derived	  from	  human	  blastocysts.	  Science,	  282,	  1145-­‐
7.	  
TITMARSH,	  D.,	  HIDALGO,	  A.,	  TURNER,	  J.,	  WOLVETANG,	  E.	  &	  COOPER-­‐
WHITE,	  J.	  2011.	  Optimization	  of	  flowrate	  for	  expansion	  of	  human	  
	   	  
	   - 207 -	  
embryonic	  stem	  cells	  in	  perfusion	  microbioreactors.	  Biotechnology	  
and	  Bioengineering,	  108,	  2894-­‐2904.	  
VUGLER,	  A.,	  CARR,	  A.	  J.,	  LAWRENCE,	  J.,	  CHEN,	  L.	  L.,	  BURRELL,	  K.,	  WRIGHT,	  
A.,	  LUNDH,	  P.,	  SEMO,	  M.,	  AHMADO,	  A.,	  GIAS,	  C.,	  DA	  CRUZ,	  L.,	  
MOORE,	  H.,	  ANDREWS,	  P.,	  WALSH,	  J.	  &	  COFFEY,	  P.	  2008.	  
Elucidating	  the	  phenomenon	  of	  HESC-­‐derived	  RPE:	  anatomy	  of	  cell	  
genesis,	  expansion	  and	  retinal	  transplantation.	  Exp	  Neurol,	  214,	  
347-­‐61.	  
WANG,	  L.,	  LU,	  J.,	  MARCHENKO,	  S.	  A.,	  MONUKI,	  E.	  S.,	  FLANAGAN,	  L.	  A.	  &	  
LEE,	  A.	  P.	  2009.	  Dual	  frequency	  dielectrophoresis	  with	  
interdigitated	  sidewall	  electrodes	  for	  microfluidic	  flow-­‐through	  
separation	  of	  beads	  and	  cells.	  Electrophoresis,	  30,	  782-­‐791.	  
WEIL,	  B.	  &	  VERAITCH,	  F.	  2014.	  Bioprocessing	  Challenges	  Associated	  with	  
the	  Purification	  of	  Cellular	  Therapies.	  In:	  AL-­‐RUBEAI,	  M.	  &	  NACIRI,	  
M.	  (eds.)	  Stem	  Cells	  and	  Cell	  Therapy.	  Springer	  Netherlands.	  
WONG,	  W.	  L.,	  SU,	  X.,	  LI,	  X.,	  CHEUNG,	  C.	  M.	  G.,	  KLEIN,	  R.,	  CHENG,	  C.-­‐Y.	  &	  
WONG,	  T.	  Y.	  Global	  prevalence	  of	  age-­‐related	  macular	  
degeneration	  and	  disease	  burden	  projection	  for	  2020	  and	  2040:	  a	  
systematic	  review	  and	  meta-­‐analysis.	  The	  Lancet	  Global	  Health,	  2,	  
e106-­‐e116.	  
YANG,	  X.	  M.,	  YAFAI,	  Y.,	  WIEDEMANN,	  P.,	  KUHRT,	  H.,	  WANG,	  Y.	  S.,	  
REICHENBACH,	  A.	  &	  EICHLER,	  W.	  2012.	  Hypoxia-­‐induced	  
upregulation	  of	  pigment	  epithelium-­‐derived	  factor	  by	  retinal	  glial	  
(Muller)	  cells.	  J	  Neurosci	  Res,	  90,	  257-­‐66.	  
YOUNG,	  R.	  W.	  1987.	  Pathophysiology	  of	  age-­‐related	  macular	  
degeneration.	  Surv	  Ophthalmol,	  31,	  291-­‐306.	  	  
